Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	21754226	21754226	A	C	intergenic	ECE1;NBPF3	dist=82192;dist=12357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	142	chr1	21754226	chr1:21754226	A	C	64	PASS	AN=2;DP=142	GT	0/1
chr1	22928168	22928168	C	A	exonic	EPHA8	.	synonymous SNV	EPHA8:NM_020526:exon17:c.C2952A:p.I984I	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr1	22928168	chr1:22928168	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr1	24987906	24987906	-	T	intronic	SRRM1	.	.	.	0.999999022	9.78E-07	2.02E-17	.	0.5312	0.11301	-0.929520514	9.683887709	90.5423	2.04787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.15	47	chr1	24987906	chr1:24987906	G	GT	11.15	PASS	AN=0;DP=47	GT	0/1
chr1	26781228	26781228	T	-	intronic	DHDDS	.	.	.	0.704700923	0.295148752	0.000150325	.	0.13611	0.82506	-0.093566408	46.7386176	3214.14466	10.80738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	140	chr1	26781227	chr1:26781227	GT	G	63	PASS	AN=2;DP=140	GT	0/1
chr1	36926898	36926898	C	T	exonic	MRPS15	.	synonymous SNV	MRPS15:NM_031280:exon4:c.G267A:p.V89V	0.000342016	0.949346717	0.050311267	.	0.10308	0.06601	-0.093566408	46.7386176	163.76941	2.79543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr1	36926898	chr1:36926898	C	T	.	PASS	AN=0;DP=31	GT	0/1
chr1	42776700	42776700	A	-	intronic	FOXJ3	.	.	.	0.977575009	0.022424814	1.76E-07	.	0.75216	0.14428	0.286674996	71.49681529	467.55831	4.48092	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	125	chr1	42776699	chr1:42776699	GA	G	75	PASS	AN=2;DP=125	GT	0/1
chr1	53351594	53351594	-	T	intronic	ZYG11A	.	.	.	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	chr1	53351594	chr1:53351594	C	CT	58	PASS	AN=2;DP=91	GT	0/1
chr1	70504364	70504364	C	A	exonic	LRRC7	.	nonsynonymous SNV	LRRC7:NM_020794:exon19:c.C2743A:p.R915S,LRRC7:NM_001350216:exon21:c.C2860A:p.R954S,LRRC7:NM_001330635:exon22:c.C2758A:p.R920S	0.999998533	1.47E-06	1.10E-17	.	0.42578	0.12755	-1.368693559	4.482189196	157.64981	2.74333	0.046	0.506	D	0.312	0.311	B	0.14	0.321	B	0.005	0.334	N	0.981	0.403	D	0.695	0.181	N	1.24	0.367	T	-0.55	0.168	N	0.663	0.747	-1.089	0.057	T	0.045	0.195	T	0.008	0.217	T	2.963	0.416	22.1	0.993	0.596	0.925	0.555	D	c	-0.078	0.089	0.993	0.329	0.487	0.133	0	5.67	0.876	3.398	0.521	0.892	0.403	1.000	0.715	0.986	0.517	18.749	0.917	.	.	.	0.5	.	37	chr1	70504364	chr1:70504364	C	A	.	PASS	AN=0;DP=37	GT	0/1
chr1	75038228	75038228	A	C	exonic	ERICH3	.	nonsynonymous SNV	ERICH3:NM_001002912:exon14:c.T3166G:p.L1056V	.	.	.	.	0.15022	.	2.043117123	97.75300778	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.59	0.004	N	2.83	0.108	T	0.78	0.019	N	0.015	0.002	-0.900	0.480	T	0.003	0.010	T	.	.	.	-1.961	0.008	0.001	0.044	0.000	0.001	0.005	N	c	-1.321	-1.249	0.000	0.035	0.549	0.223	0	2.51	0.293	0.067	0.143	-0.095	0.117	0.000	0.063	0.014	0.122	7.414	0.260	.	.	.	1	147	46	chr1	75038228	chr1:75038228	A	C	147	PASS	AN=2;DP=46	GT	1/1
chr1	110888159	110888159	A	T	splicing	RBM15	NM_022768:exon2:c.2864-2A>T	.	.	0.999853093	0.000146907	2.00E-11	DISEASE: Note=A chromosomal aberration involving RBM15 may be a cause of acute megakaryoblastic leukemia. Translocation t(1;22)(p13;q13) with MKL1. Although both reciprocal fusion transcripts are detected in acute megakaryoblastic leukemia (AMKL, FAB-M7), the RBM15-MKL1 chimeric protein has all the putative functional domains encoded by each gene and is the candidate oncogene. {ECO:0000269|PubMed:11344311, ECO:0000269|PubMed:11431691}.; 	0.41164	0.42963	-0.949752638	9.32413305	173.34726	2.86702	.	.	.	.	.	.	.	.	.	.	.	.	0.969	0.257	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.828	0.401	21.5	0.952	0.258	0.126	0.172	N	c	0.597	0.331	1.000	0.747	0.123	0.025	0	3.94	0.446	0.311	0.190	1.199	0.960	0.000	0.063	0.984	0.507	8.451	0.319	.	.	.	0.5	.	32	chr1	110888159	chr1:110888159	A	T	.	PASS	AN=0;DP=32	GT	0/1
chr1	113735255	113735255	T	-	intergenic	LRIG2;LOC643441	dist=67431;dist=4149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	171	chr1	113735254	chr1:113735254	CT	C	92	PASS	AN=2;DP=171	GT	0/1
chr1	114092112	114092112	T	-	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	49	chr1	114092111	chr1:114092111	GT	G	66	PASS	AN=2;DP=49	GT	0/1
chr1	142797415	142797415	G	C	intergenic	ANKRD20A12P;LOC102723769	dist=83810;dist=337188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	165	chr1	142797415	chr1:142797415	G	C	.	PASS	AN=0;DP=165	GT	0/1
chr1	144854698	144854698	C	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	180	chr1	144854698	chr1:144854698	C	A	.	PASS	AN=0;DP=180	GT	0/1
chr1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	137	413	chr1	144856817	chr1:144856817	T	C	137	PASS	AN=2;DP=413	GT	0/1
chr1	146420088	146420088	A	G	exonic	NBPF12;NBPF20	.	synonymous SNV	NBPF12:NM_001278141:exon25:c.A2736G:p.S912S,NBPF20:NM_001278267:exon100:c.A11058G:p.S3686S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	600	chr1	146420088	chr1:146420088	A	G	116	PASS	AN=2;DP=600	GT	0/1
chr1	146420119	146420119	T	C	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2767C:p.S923P,NBPF20:NM_001278267:exon100:c.T11089C:p.S3697P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.002	T	.	.	.	.	.	.	.	.	c	-1.171	-1.403	0.000	0.012	0.693	0.558	0	-1.45	0.083	0.885	0.277	0.095	0.197	0.970	0.340	0.532	0.276	4.744	0.123	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	131	814	chr1	146420119	chr1:146420119	T	C	131	PASS	AN=2;DP=814	GT	0/1
chr1	152944379	152944379	C	A	exonic	SPRR4	.	nonsynonymous SNV	SPRR4:NM_173080:exon2:c.C13A:p.Q5K	0.582181679	0.375036467	0.042781855	.	0.11466	0.05263	0.369407109	74.95281906	771.02285	5.49621	0.0	0.912	D	0.092	0.237	B	0.007	0.121	B	.	.	.	0.999	0.214	N	.	.	.	2.15	0.193	T	-2.22	0.498	N	0.263	0.320	-0.982	0.346	T	0.015	0.060	T	0.003	0.069	T	1.455	0.237	13.08	0.822	0.136	0.607	0.310	D	c	-0.473	-0.456	0.975	0.296	0.487	0.133	0	1.71	0.233	0.313	0.190	0.485	0.279	0.815	0.297	0.140	0.202	6.736	0.225	.	.	.	0.5	.	181	chr1	152944379	chr1:152944379	C	A	.	PASS	AN=0;DP=181	GT	0/1
chr1	153920564	153920564	A	G	UTR3	CRTC2	NM_181715:c.*21T>C	.	.	0.996361791	0.003638199	1.01E-08	.	0.25674	0.23695	-0.690637458	15.12149092	1834.62554	7.89581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	58	chr1	153920564	chr1:153920564	A	G	108	PASS	AN=2;DP=58	GT	0/1
chr1	156012038	156012038	G	A	intronic	UBQLN4	.	.	.	0.99752242	0.002477484	9.67E-08	.	0.27058	0.13363	0.062575634	58.74026893	4087.61153	12.68896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	279	chr1	156012038	chr1:156012038	G	A	.	PASS	AN=0;DP=279	GT	0/1
chr1	156106164	156106164	C	T	exonic	LMNA	.	synonymous SNV	LMNA:NM_001257374:exon7:c.C981T:p.R327R,LMNA:NM_001282626:exon7:c.C1317T:p.R439R,LMNA:NM_005572:exon7:c.C1317T:p.R439R,LMNA:NM_170707:exon7:c.C1317T:p.R439R,LMNA:NM_170708:exon7:c.C1317T:p.R439R,LMNA:NM_001282624:exon8:c.C1074T:p.R358R,LMNA:NM_001282625:exon10:c.C1317T:p.R439R	0.993449023	0.006550767	2.10E-07	DISEASE: Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:14985400, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:20848652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:22431096}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11561226, ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:12486434, ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12920062, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15140538, ECO:0000269|PubMed:15219508, ECO:0000269|PubMed:16061563, ECO:0000269|PubMed:20160190, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]: A disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol. {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10655060, ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:12015247, ECO:0000269|PubMed:12196663, ECO:0000269|PubMed:12629077, ECO:0000269|PubMed:17250669, ECO:0000269|PubMed:24485160}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 1B (LGMD1B) [MIM:159001]: An autosomal dominant degenerative myopathy with age-related atrioventricular cardiac conduction disturbances, dilated cardiomyopathy, and the absence of early contractures. Characterized by slowly progressive skeletal muscle weakness of the hip and shoulder girdles. Muscle biopsy shows mild dystrophic changes. {ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11525883, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:17136397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced. {ECO:0000269|PubMed:11799477}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]: Rare genetic disorder characterized by features reminiscent of marked premature aging. {ECO:0000269|PubMed:12714972, ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:15286156, ECO:0000269|PubMed:15622532, ECO:0000269|PubMed:21791255, ECO:0000269|PubMed:22355414, ECO:0000269|PubMed:23666920}. Note=The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972). {ECO:0000269|PubMed:12714972}.; DISEASE: Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]: A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. {ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:17150192, ECO:0000269|PubMed:19283854}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased. {ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:15998779, ECO:0000269|PubMed:16278265}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Heart-hand syndrome Slovenian type (HHS-Slovenian) [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co- occurrence of a congenital cardiac disease and limb malformations. {ECO:0000269|PubMed:18611980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269|PubMed:18551513}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade. {ECO:0000269|PubMed:23666920}.; 	0.55819	0.98592	-0.911109353	9.961075725	32.23482	1.00909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	chr1	156106164	chr1:156106164	C	T	.	PASS	AN=0;DP=166	GT	0/1
chr1	156294696	156294696	C	G	intronic	CCT3	.	.	.	0.998745413	0.001254583	3.72E-09	.	0.92111	0.69617	-0.380166007	27.88393489	753.2878	5.44224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	172	chr1	156294696	chr1:156294696	C	G	60	PASS	AN=2;DP=172	GT	0/1
chr1	156340956	156340956	T	-	intronic	RHBG	.	.	.	3.73E-10	0.093786647	0.906213352	.	0.04516	0.11744	.	.	6525.59053	16.96932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.21	80	chr1	156340955	chr1:156340955	CT	C	11.21	PASS	AN=0;DP=80	GT	0/1
chr1	162729685	162729685	G	T	exonic	DDR2	.	synonymous SNV	DDR2:NM_006182:exon8:c.G771T:p.V257V,DDR2:NM_001014796:exon9:c.G771T:p.V257V	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	chr1	162729685	chr1:162729685	G	T	.	PASS	AN=0;DP=74	GT	0/1
chr1	168549282	168549282	-	T	intronic	XCL1	.	.	.	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	40	chr1	168549282	chr1:168549282	G	GT	50	PASS	AN=2;DP=40	GT	0/1
chr1	179089397	179089397	C	A	exonic	ABL2	.	stopgain	ABL2:NM_001136001:exon5:c.G910T:p.E304X,ABL2:NM_001168236:exon5:c.G910T:p.E304X,ABL2:NM_001168238:exon5:c.G910T:p.E304X,ABL2:NM_001168239:exon5:c.G865T:p.E289X,ABL2:NM_001136000:exon6:c.G928T:p.E310X,ABL2:NM_001168237:exon6:c.G973T:p.E325X,ABL2:NM_005158:exon6:c.G928T:p.E310X,ABL2:NM_007314:exon6:c.G973T:p.E325X	0.009702577	0.990293634	3.79E-06	.	0.8871	0.21266	-0.992035476	8.604623732	182.10584	2.93109	.	.	.	.	.	.	.	.	.	0.081	0.209	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.269	0.990	41	0.996	0.734	0.989	0.877	D	c	1.083	0.923	1.000	0.747	0.672	0.522	0	4.88	0.630	7.818	0.846	0.876	0.383	1.000	0.715	1.000	0.888	17.101	0.865	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase-like domain|SH2 domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase, ATP binding site|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase-like domain|SH2 domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	.	42	chr1	179089397	chr1:179089397	C	A	.	PASS	AN=0;DP=42	GT	0/1
chr1	181059534	181059534	-	AGAGCAC	UTR3	IER5	NM_016545:c.*512_*513insAGAGCAC	.	.	0.666267931	0.311334265	0.022397803	.	0.07907	0.10373	.	.	2285.7254	8.84614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	94	chr1	181059534	chr1:181059534	A	AAGAGCAC	83	PASS	AN=2;DP=94	GT	0/1
chr1	200583451	200583451	G	A	exonic	KIF14	.	stopgain	KIF14:NM_014875:exon4:c.C1450T:p.Q484X	6.03E-05	0.999939646	7.94E-08	DISEASE: Meckel syndrome 12 (MKS12) [MIM:616258]: A form of Meckel syndrome, a disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:24128419}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06815	0.11654	-0.027643533	51.41542817	315.29337	3.77299	.	.	.	.	.	.	.	.	.	0.003	0.360	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.256	0.973	37	0.997	0.831	0.879	0.473	D	c	0.739	0.571	0.977	0.297	0.651	0.465	0	3.8	0.427	1.096	0.304	0.154	0.240	0.848	0.302	0.997	0.653	10.435	0.434	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	27	chr1	200583451	chr1:200583451	G	A	.	PASS	AN=0;DP=27	GT	0/1
chr1	205901802	205901802	C	T	intronic	SLC26A9	.	.	.	0.002985459	0.996911146	0.000103395	.	0.17926	0.11651	-0.143334748	42.35079028	424.02635	4.30029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr1	205901802	chr1:205901802	C	T	.	PASS	AN=0;DP=52	GT	0/1
chr1	236703818	236703818	T	-	intronic	LGALS8	.	.	.	0.000188797	0.896973744	0.102837458	.	0.48105	0.17047	1.063778722	91.58410002	6987.34024	17.79441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	53	chr1	236703817	chr1:236703817	GT	G,GTT	40	PASS	AN=2;DP=53	GT	0/1
chr1	236703818	236703818	-	T	intronic	LGALS8	.	.	.	0.000188797	0.896973744	0.102837458	.	0.48105	0.17047	1.063778722	91.58410002	6987.34024	17.79441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	53	chr1	236703817	chr1:236703817	GT	G,GTT	40	PASS	AN=2;DP=53	GT	0/1
chr1	242540222	242540222	G	A	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr1	242540222	chr1:242540222	G	A	.	PASS	AN=0;DP=35	GT	0/1
chr1	242540223	242540223	G	T	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr1	242540223	chr1:242540223	G	T	.	PASS	AN=0;DP=36	GT	0/1
chr1	243218249	243218249	A	T	intergenic	PLD5;LINC01347	dist=530251;dist=1367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	chr1	243218249	chr1:243218249	A	T	.	PASS	AN=0;DP=189	GT	0/1
chr1	244869242	244869242	A	-	UTR3	DESI2	NM_001297746:c.*151delA;NM_016076:c.*151delA	.	.	0.915084441	0.084325944	0.000589615	.	0.11628	0.07259	0.21326276	67.71644256	11.70962	0.42542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	21	chr1	244869241	chr1:244869241	CA	C	43	PASS	AN=2;DP=21	GT	0/1
chr2	1500507	1500507	G	T	exonic	TPO	.	stopgain	TPO:NM_175722:exon11:c.G1837T:p.G613X,TPO:NM_001206745:exon12:c.G2185T:p.G729X,TPO:NM_175719:exon12:c.G2185T:p.G729X,TPO:NM_175721:exon12:c.G2356T:p.G786X,TPO:NM_000547:exon13:c.G2356T:p.G786X,TPO:NM_001206744:exon13:c.G2356T:p.G786X	1.36E-07	0.988057948	0.011941916	DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can cause Graves' disease.; DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder due to defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18628	0.48162	-0.14151689	42.36258552	2837.88244	10.06894	.	.	.	.	.	.	.	.	.	0.043	0.238	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.455	0.983	39	0.992	0.537	0.808	0.401	D	c	0.767	0.513	0.998	0.359	0.581	0.326	0	4.2	0.486	3.523	0.530	0.902	0.416	0.994	0.380	0.007	0.100	14.183	0.650	Sushi/SCR/CCP domain	.	.	0.5	.	94	chr2	1500507	chr2:1500507	G	T	.	PASS	AN=0;DP=94	GT	0/1
chr2	1893021	1893021	C	G	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon16:c.G2512C:p.D838H,MYT1L:NM_001329845:exon16:c.G2512C:p.D838H,MYT1L:NM_001329846:exon16:c.G2506C:p.D836H,MYT1L:NM_001329847:exon16:c.G2506C:p.D836H,MYT1L:NM_001329848:exon16:c.G2506C:p.D836H,MYT1L:NM_001329849:exon16:c.G2506C:p.D836H,MYT1L:NM_001329851:exon16:c.G2512C:p.D838H,MYT1L:NM_001329852:exon16:c.G2506C:p.D836H,MYT1L:NM_015025:exon16:c.G2506C:p.D836H,MYT1L:NM_001329844:exon17:c.G2512C:p.D838H	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.652	0.395	P	0.382	0.421	B	0.005	0.328	N	0.997	0.433	D	0.695	0.181	N	0.73	0.507	T	-1.15	0.295	N	0.245	0.355	-0.960	0.392	T	0.094	0.356	T	0.010	0.259	T	4.432	0.593	24.2	0.995	0.687	0.994	0.953	D	c	0.194	0.324	1.000	0.747	0.487	0.133	0	5.01	0.663	5.405	0.659	0.807	0.329	1.000	0.715	0.137	0.201	18.279	0.900	Myelin transcription factor 1	.	.	0.5	.	33	chr2	1893021	chr2:1893021	C	G	.	PASS	AN=0;DP=33	GT	0/1
chr2	61411443	61411443	G	C	intronic	AHSA2	.	.	.	5.61E-06	0.140152678	0.859841708	.	0.05809	.	-0.339715008	30.06605331	275.26294	3.55364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	71	chr2	61411443	chr2:61411443	G	C	102	PASS	AN=2;DP=71	GT	0/1
chr2	71209708	71209708	T	A	exonic	ANKRD53	.	nonsynonymous SNV	ANKRD53:NM_001115116:exon5:c.T784A:p.F262I,ANKRD53:NM_024933:exon5:c.T784A:p.F262I	0.000455608	0.867354929	0.132189463	.	0.06661	0.09362	1.26585432	93.59518754	1459.41609	7.12227	0.1	0.390	T	1.0	0.899	D	0.998	0.875	D	0.002	0.366	N	0.984	0.408	D	0.18	0.091	N	-0.11	0.706	T	-1.19	0.342	N	0.67	0.680	-0.280	0.756	T	0.335	0.702	T	0.036	0.572	D	5.365	0.727	25.9	0.992	0.539	0.898	0.502	D	c	0.426	0.478	1.000	0.747	0.554	0.283	0	5.57	0.840	1.972	0.399	0.964	0.580	1.000	0.715	0.995	0.604	13.988	0.637	Ankyrin repeat-containing domain	.	.	0.5	.	68	chr2	71209708	chr2:71209708	T	A	.	PASS	AN=0;DP=68	GT	0/1
chr2	71896341	71896341	G	A	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr2	71896341	chr2:71896341	G	A	.	PASS	AN=0;DP=36	GT	0/1
chr2	73496111	73496111	G	A	exonic	FBXO41	.	synonymous SNV	FBXO41:NM_001080410:exon1:c.C648T:p.D216D	0.951773201	0.048220951	5.85E-06	.	0.30259	0.1115	.	.	1132.93967	6.42282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr2	73496111	chr2:73496111	G	A	.	PASS	AN=0;DP=40	GT	0/1
chr2	89339848	89339848	C	G	intergenic	MIR4436A;NONE	dist=227880;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	259	chr2	89339848	chr2:89339848	C	G	85	PASS	AN=2;DP=259	GT	0/1
chr2	89399635	89399635	T	G	intergenic	MIR4436A;NONE	dist=287667;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	260	chr2	89399635	chr2:89399635	T	G	132	PASS	AN=2;DP=260	GT	0/1
chr2	91777719	91777719	G	A	intergenic	NONE;LOC654342	dist=NONE;dist=46990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	chr2	91777719	chr2:91777719	G	A	.	PASS	AN=0;DP=144	GT	0/1
chr2	95940557	95940557	A	T	exonic	PROM2	.	nonsynonymous SNV	PROM2:NM_001165977:exon1:c.A224T:p.Q75L,PROM2:NM_001165978:exon1:c.A224T:p.Q75L,PROM2:NM_144707:exon1:c.A224T:p.Q75L	7.90E-08	0.994662578	0.005337343	.	0.12478	0.0927	-0.369255208	28.25548478	1092.43407	6.32455	0.002	0.721	D	0.999	0.764	D	0.984	0.745	D	0.001	0.428	D	1.000	0.495	D	2.93	0.848	M	0.81	0.485	T	-5.55	0.862	D	0.527	0.674	-0.634	0.634	T	0.268	0.640	T	0.173	0.850	D	4.590	0.615	24.4	0.993	0.575	0.707	0.344	D	c	0.400	0.310	1.000	0.747	0.609	0.351	0	4.94	0.645	2.723	0.467	1.028	0.649	0.998	0.411	0.909	0.387	10.981	0.465	.	.	.	0.5	.	90	chr2	95940557	chr2:95940557	A	T	.	PASS	AN=0;DP=90	GT	0/1
chr2	96517502	96517502	A	C	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon87:c.T6351G:p.I2117M	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.038	0.427	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.27	0.361	T	0.01	0.069	N	0.067	0.112	-1.027	0.214	T	0.037	0.162	T	.	.	.	-0.910	0.035	0.025	0.253	0.012	0.004	0.021	N	c	-1.567	-1.743	0.000	0.044	0.651	0.465	0	-3.59	0.043	-0.643	0.055	-1.236	0.015	0.000	0.063	0.000	0.016	0.308	0.003	Ankyrin repeat-containing domain	.	.	0.5	110	87	chr2	96517502	chr2:96517502	A	C	110	PASS	AN=2;DP=87	GT	0/1
chr2	97317533	97317536	TCAT	-	intronic	FER1L5	.	.	.	.	.	.	.	0.16074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	96	chr2	97317532	chr2:97317532	CTCAT	C,CCAT	53	PASS	AN=2;DP=96	GT	0/1
chr2	97317533	97317533	T	-	intronic	FER1L5	.	.	.	.	.	.	.	0.16074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	96	chr2	97317532	chr2:97317532	CTCAT	C,CCAT	53	PASS	AN=2;DP=96	GT	0/1
chr2	109421324	109421324	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	27	chr2	109421324	chr2:109421324	G	GT	50	PASS	AN=2;DP=27	GT	0/1
chr2	110036009	110036009	G	T	exonic	SH3RF3	.	synonymous SNV	SH3RF3:NM_001099289:exon5:c.G1314T:p.S438S	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	chr2	110036009	chr2:110036009	G	T	.	PASS	AN=0;DP=118	GT	0/1
chr2	112615888	112615888	C	G	exonic	ANAPC1	.	nonsynonymous SNV	ANAPC1:NM_022662:exon11:c.G1353C:p.Q451H	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	0.125	0.273	T	0.006	0.126	B	0.005	0.104	B	0.147	0.181	N	0.993	0.418	D	1.71	0.444	L	.	.	.	-0.9	0.242	N	0.431	0.487	-0.992	0.320	T	0.136	0.452	T	.	.	.	1.479	0.240	13.20	0.969	0.310	0.888	0.487	D	c	-0.624	-0.489	0.002	0.094	0.732	0.924	0	3.2	0.357	1.258	0.323	-0.467	0.054	1.000	0.715	0.973	0.468	7.272	0.253	.	.	.	0.5	73	132	chr2	112615888	chr2:112615888	C	G	73	PASS	AN=2;DP=132	GT	0/1
chr2	119599910	119599910	C	A	UTR3	EN1	NM_001426:c.*604G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	chr2	119599910	chr2:119599910	C	A	.	PASS	AN=0;DP=88	GT	0/1
chr2	119599911	119599911	C	A	UTR3	EN1	NM_001426:c.*603G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr2	119599911	chr2:119599911	C	A	.	PASS	AN=0;DP=87	GT	0/1
chr2	128370201	128370201	G	T	intronic	MYO7B	.	.	.	6.38E-16	0.999852793	0.000147207	.	0.11748	.	1.019668216	90.92356688	5040.89055	14.51846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr2	128370201	chr2:128370201	G	T	.	PASS	AN=0;DP=66	GT	0/1
chr2	131414196	131414196	A	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon15:c.A1863T:p.L621L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	163	chr2	131414196	chr2:131414196	A	T	.	PASS	AN=0;DP=163	GT	0/1
chr2	131976061	131976061	G	T	exonic	POTEE	.	nonsynonymous SNV	POTEE:NM_001083538:exon1:c.G86T:p.C29F	.	.	.	.	.	.	.	.	513.98926	4.63955	0.12	0.279	T	0.676	0.394	P	0.308	0.396	B	.	.	.	1	0.090	N	0.55	0.145	N	-0.97	0.757	T	-0.37	0.132	N	0.421	0.478	-0.900	0.480	T	0.209	0.569	T	0.030	0.525	D	-0.368	0.064	0.461	0.652	0.075	0.010	0.039	N	c	-0.930	-1.136	0.000	0.012	0.554	0.246	0	0.1	0.138	0.059	0.141	0.303	0.270	0.004	0.165	0.007	0.100	.	.	.	.	.	0.5	.	370	chr2	131976061	chr2:131976061	G	T	.	PASS	AN=0;DP=370	GT	0/1
chr2	133426045	133426045	G	T	exonic	LYPD1	.	nonsynonymous SNV	LYPD1:NM_144586:exon2:c.C118A:p.P40T,LYPD1:NM_001321234:exon3:c.C166A:p.P56T	0.000238591	0.313658655	0.686102754	.	0.21654	.	0.3032669	72.009908	18.3074	0.63566	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1.000	0.810	D	2.045	0.562	M	-1.48	0.812	T	-2.85	0.600	D	0.724	0.723	0.127	0.847	D	0.525	0.823	D	0.092	0.758	D	5.793	0.792	27.1	0.998	0.897	0.972	0.733	D	c	0.730	0.775	1.0	0.983	0.652	0.477	0	5.43	0.789	8.986	0.930	1.048	0.713	1.000	0.715	0.999	0.750	17.605	0.879	Ly-6 antigen / uPA receptor -like	.	.	0.5	.	65	chr2	133426045	chr2:133426045	G	T	.	PASS	AN=0;DP=65	GT	0/1
chr2	135870866	135870866	G	T	intronic	RAB3GAP1	.	.	.	3.66E-05	0.99995942	3.97E-06	.	0.42054	0.14874	0.202129237	67.42745931	2290.07687	8.85637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr2	135870866	chr2:135870866	G	T	.	PASS	AN=0;DP=34	GT	0/1
chr2	144008050	144008050	C	G	intronic	ARHGAP15	.	.	.	5.25E-06	0.964756522	0.035238224	.	0.77364	0.12676	-0.624497208	17.16206653	736.83485	5.38892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	62	chr2	144008050	chr2:144008050	C	G	67	PASS	AN=2;DP=62	GT	0/1
chr2	160729091	160729091	T	A	exonic	LY75;LY75-CD302	.	nonsynonymous SNV	LY75-CD302:NM_001198759:exon13:c.A1988T:p.E663V,LY75-CD302:NM_001198760:exon13:c.A1988T:p.E663V,LY75:NM_002349:exon13:c.A1988T:p.E663V	.	.	.	.	.	.	.	.	.	.	0.001	0.784	D	0.993	0.764	D	0.96	0.686	D	0.004	0.343	U	1.000	0.588	D	2.63	0.772	M	3.13	0.080	T	-5.39	0.850	D	0.49	0.545	-1.025	0.220	T	0.082	0.323	T	0.036	0.570	D	5.036	0.678	25.2	0.992	0.539	0.957	0.655	D	c	0.686	0.632	0.525	0.211	0.707	0.730	0	4.9	0.635	6.299	0.726	1.011	0.635	1.000	0.715	0.994	0.587	13.797	0.625	C-type lectin|C-type lectin fold|C-type lectin-like	.	.	0.5	.	28	chr2	160729091	chr2:160729091	T	A	.	PASS	AN=0;DP=28	GT	0/1
chr2	168931640	168931640	T	A	exonic	STK39	.	nonsynonymous SNV	STK39:NM_013233:exon11:c.A1191T:p.K397N	0.999462431	0.000537568	4.72E-10	.	0.35513	0.21966	-0.337894035	30.37272942	4051.69126	12.61535	0.14	0.256	T	0.085	0.233	B	0.032	0.208	B	0.000	0.843	D	1.000	0.504	D	1.65	0.424	L	-0.79	0.737	T	-2.49	0.542	N	0.274	0.332	-0.867	0.508	T	0.253	0.624	T	0.031	0.536	D	2.931	0.413	22.0	0.997	0.778	0.895	0.498	D	c	-0.375	-0.259	0.927	0.268	0.693	0.558	0	1.73	0.235	0.292	0.186	-0.121	0.113	0.993	0.376	0.989	0.536	9.350	0.371	.	.	.	0.5	.	64	chr2	168931640	chr2:168931640	T	A	.	PASS	AN=0;DP=64	GT	0/1
chr2	169830401	169830401	C	G	intronic	ABCB11	.	.	.	2.19E-10	0.998263927	0.001736073	DISEASE: Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:10579978, ECO:0000269|PubMed:11815775, ECO:0000269|PubMed:24969679, ECO:0000269|PubMed:9806540}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]: A disorder characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically. {ECO:0000269|PubMed:15300568, ECO:0000269|PubMed:16039748}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10912	0.39265	-1.140954241	6.387119604	532.30214	4.70663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	41	chr2	169830401	chr2:169830401	C	G	43	PASS	AN=2;DP=41	GT	0/1
chr2	173341108	173341108	C	T	intronic	ITGA6	.	.	.	0.009913603	0.990086247	1.50E-07	DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB- PA) [MIM:226730]: An autosomal recessive, frequently lethal, epidermolysis bullosa with variable involvement of skin, nails, mucosa, and with variable effects on the digestive system. It is characterized by mucocutaneous fragility, aplasia cutis congenita, and gastrointestinal atresia, which most commonly affects the pylorus. Pyloric atresia is a primary manifestation rather than a scarring process secondary to epidermolysis bullosa. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.61813	0.48979	0.249861693	69.66265629	3306.75309	10.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr2	173341108	chr2:173341108	C	T	.	PASS	AN=0;DP=33	GT	0/1
chr2	174908994	174908994	G	A	intergenic	LINC01960;OLA1	dist=17109;dist=28181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	230	chr2	174908994	chr2:174908994	G	A	65	PASS	AN=2;DP=230	GT	0/1
chr2	176965470	176965470	G	T	exonic	HOXD12	.	nonsynonymous SNV	HOXD12:NM_021193:exon2:c.G795T:p.Q265H	0.003345917	0.610026817	0.386627266	.	0.8886	0.19255	0.395088462	76.15003539	604.16052	4.97604	0.242	0.176	T	0.126	0.253	B	0.041	0.226	B	0.000	0.559	D	0.993	0.810	D	1.06	0.271	L	-3.25	0.935	D	-1.16	0.297	N	0.435	0.490	-0.329	0.742	T	0.587	0.852	D	0.064	0.693	D	2.791	0.396	21.3	0.991	0.526	0.903	0.511	D	c	-0.349	-0.215	0.941	0.274	0.598	0.340	0	1.68	0.231	1.051	0.298	-0.189	0.103	1.000	0.715	0.975	0.474	8.264	0.308	.	.	.	0.5	.	108	chr2	176965470	chr2:176965470	G	T	.	PASS	AN=0;DP=108	GT	0/1
chr2	186692860	186692860	T	-	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	29	chr2	186692859	chr2:186692859	CT	C	74	PASS	AN=2;DP=29	GT	0/1
chr2	190925148	190925148	C	A	exonic	MSTN	.	nonsynonymous SNV	MSTN:NM_005259:exon2:c.G387T:p.M129I	0.812914736	0.186112611	0.000972653	DISEASE: Muscle hypertrophy (MSLHP) [MIM:614160]: A condition characterized by increased muscle bulk and strength. Affected individuals are exceptionally strong. {ECO:0000269|PubMed:15215484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83937	0.74393	0.663285274	84.55414013	913.77022	5.87603	0.271	0.160	T	0.0	0.026	B	0.0	0.013	B	0.001	0.407	D	0.830	0.287	N	0	0.065	N	-0.1	0.643	T	0.39	0.035	N	0.159	0.191	-1.014	0.256	T	0.104	0.382	T	0.017	0.383	T	0.556	0.147	7.847	0.856	0.154	0.207	0.209	N	c	-0.737	-0.579	0.991	0.323	0.487	0.133	0	4.89	0.632	0.051	0.139	0.059	0.165	0.029	0.202	0.947	0.422	6.745	0.225	Transforming growth factor-beta, N-terminal	.	.	0.5	.	60	chr2	190925148	chr2:190925148	C	A	.	PASS	AN=0;DP=60	GT	0/1
chr2	200136195	200136195	T	-	UTR3	SATB2	NM_001172509:c.*739delA;NM_001172517:c.*739delA;NM_015265:c.*739delA	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	33	chr2	200136194	chr2:200136194	CT	C	54	PASS	AN=2;DP=33	GT	0/1
chr2	205989177	205989177	A	-	exonic	PARD3B	.	frameshift deletion	PARD3B:NM_001302769:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_057177:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_152526:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_205863:exon9:c.1292delA:p.D431Afs*5	8.65E-08	0.999805592	0.000194321	.	0.48627	0.09509	0.126687467	62.75064874	840.37721	5.67705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	56	chr2	205989176	chr2:205989176	GA	G	100	PASS	AN=2;DP=56	GT	1/0
chr2	206581007	206581007	C	T	exonic	NRP2	.	synonymous SNV	NRP2:NM_003872:exon3:c.C342T:p.I114I,NRP2:NM_018534:exon3:c.C342T:p.I114I,NRP2:NM_201264:exon3:c.C342T:p.I114I,NRP2:NM_201266:exon3:c.C342T:p.I114I,NRP2:NM_201267:exon3:c.C342T:p.I114I,NRP2:NM_201279:exon3:c.C342T:p.I114I	0.00171165	0.998241695	4.67E-05	.	0.30972	0.15109	-1.080231599	7.277659825	168.69076	2.83534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	chr2	206581007	chr2:206581007	C	T	.	PASS	AN=0;DP=61	GT	0/1
chr2	206581012	206581012	C	T	exonic	NRP2	.	nonsynonymous SNV	NRP2:NM_003872:exon3:c.C347T:p.S116L,NRP2:NM_018534:exon3:c.C347T:p.S116L,NRP2:NM_201264:exon3:c.C347T:p.S116L,NRP2:NM_201266:exon3:c.C347T:p.S116L,NRP2:NM_201267:exon3:c.C347T:p.S116L,NRP2:NM_201279:exon3:c.C347T:p.S116L	0.00171165	0.998241695	4.67E-05	.	0.30972	0.15109	-1.080231599	7.277659825	168.69076	2.83534	0.007	0.632	D	0.999	0.764	D	0.903	0.623	P	0.000	0.843	D	1	0.810	D	1.91	0.513	L	2.14	0.194	T	-3.01	0.693	D	0.798	0.858	-0.964	0.385	T	0.150	0.478	T	0.106	0.782	D	7.796	0.955	35	0.999	0.997	0.968	0.710	D	c	0.880	0.892	1.0	0.983	0.758	0.990	0	6.17	0.997	7.905	0.864	0.935	0.490	1.000	0.715	0.961	0.442	20.879	0.999	CUB domain	.	.	0.5	.	61	chr2	206581012	chr2:206581012	C	T	.	PASS	AN=0;DP=61	GT	0/1
chr2	215851354	215851354	C	T	exonic	ABCA12	.	nonsynonymous SNV	ABCA12:NM_015657:exon20:c.G3121A:p.V1041I,ABCA12:NM_173076:exon28:c.G4075A:p.V1359I	2.02E-07	0.999999798	2.70E-13	DISEASE: Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:12915478, ECO:0000269|PubMed:17508018, ECO:0000269|PubMed:18284401, ECO:0000269|PubMed:19262603, ECO:0000269|PubMed:22257947}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]: A rare, very severe form of congenital ichthyosis, in which the neonate is born with a thick covering of armor-like scales. The skin dries out to form hard diamond-shaped plaques separated by fissures, resembling 'armor plating'. The normal facial features are severely affected, with distortion of the lips (eclabion), eyelids (ectropion), ears, and nostrils. Affected babies are often born prematurely and rarely survive the perinatal period. Babies who survive into infancy and beyond develop skin changes resembling severe non-bullous congenital ichthyosiform erythroderma. {ECO:0000269|PubMed:15756637, ECO:0000269|PubMed:16675967, ECO:0000269|PubMed:16902423}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16262	0.15786	-0.299763455	32.26586459	2992.15591	10.38229	0.413	0.100	T	0.0	0.067	B	0.001	0.093	B	0.358	0.137	N	0.999	0.213	N	0.225	0.096	N	-3.24	0.935	D	-0.7	0.199	N	0.061	0.077	-0.509	0.683	T	0.545	0.833	D	0.032	0.539	D	2.069	0.310	16.65	0.968	0.308	0.210	0.210	N	c	-0.677	-0.544	0.001	0.081	0.693	0.558	0	1.25	0.204	0.583	0.234	-0.170	0.106	0.415	0.261	0.862	0.360	7.885	0.286	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	44	chr2	215851354	chr2:215851354	C	T	.	PASS	AN=0;DP=44	GT	0/1
chr2	219695497	219695497	C	T	exonic	PRKAG3	.	synonymous SNV	PRKAG3:NM_017431:exon3:c.G201A:p.E67E	9.67E-05	0.939090481	0.06081282	.	0.21868	0.15227	0.268267497	70.64166077	1227.80308	6.62527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	chr2	219695497	chr2:219695497	C	T	.	PASS	AN=0;DP=117	GT	0/1
chr2	219745839	219745839	T	C	intronic	WNT10A	.	.	.	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	84	chr2	219745839	chr2:219745839	T	C	95	PASS	AN=2;DP=84	GT	0/1
chr2	219826587	219826587	G	T	UTR3	CDK5R2	NM_003936:c.*941G>T	.	.	.	.	.	.	0.44177	0.11161	.	.	35.94	1.07912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	156	chr2	219826587	chr2:219826587	G	T	.	PASS	AN=0;DP=156	GT	0/1
chr2	231115765	231115765	G	A	exonic	SP140	.	nonsynonymous SNV	SP140:NM_001278452:exon9:c.G968A:p.R323K,SP140:NM_001278451:exon10:c.G1046A:p.R349K,SP140:NM_007237:exon10:c.G1046A:p.R349K	2.00E-08	0.998412016	0.001587964	.	0.02782	0.06218	0.316000233	72.80018872	737.24204	5.38969	0.22	0.461	T	0.841	0.473	P	0.745	0.540	P	.	.	.	1	0.090	N	1.845	0.488	L	-0.17	0.729	T	-0.31	0.125	N	0.064	0.098	-0.880	0.498	T	0.220	0.583	T	0.011	0.276	T	-0.736	0.043	0.060	0.482	0.039	0.024	0.068	N	c	-1.109	-1.220	0.000	0.052	0.672	0.522	0	0.813	0.178	-0.009	0.126	-0.241	0.092	0.000	0.063	0.021	0.135	9.005	0.351	.	.	.	0.5	.	33	chr2	231115765	chr2:231115765	G	A	.	PASS	AN=0;DP=33	GT	0/1
chr2	238274611	238274627	CTTCTGGGCCACAAAAA	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon9:c.3731_3747del:p.V1244Gfs*45,COL6A3:NM_057167:exon11:c.4934_4950del:p.V1645Gfs*45,COL6A3:NM_004369:exon12:c.5552_5568del:p.V1851Gfs*45	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	128	chr2	238274610	chr2:238274610	CCTTCTGGGCCACAAAAA	C	86	PASS	AN=2;DP=128	GT	0/1
chr2	241622318	241622318	C	A	upstream	AQP12B	dist=1	.	.	0.004358648	0.431917163	0.563724189	.	0.16011	.	.	.	3743.83383	11.95806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	209	chr2	241622318	chr2:241622318	C	A	.	PASS	AN=0;DP=209	GT	0/1
chr2	242925339	242925339	A	G	ncRNA_intronic	LINC01237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	110	chr2	242925339	chr2:242925339	A	G	72	PASS	AN=2;DP=110	GT	0/1
chr3	369955	369955	T	A	exonic	CHL1	.	synonymous SNV	CHL1:NM_001253388:exon3:c.T303A:p.S101S,CHL1:NM_001253387:exon5:c.T303A:p.S101S,CHL1:NM_006614:exon5:c.T303A:p.S101S	2.05E-06	0.999947701	5.02E-05	.	0.39224	0.09664	-0.158112528	41.92026421	1165.89885	6.49553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	chr3	369955	chr3:369955	T	A	.	PASS	AN=0;DP=58	GT	0/1
chr3	9512194	9512194	A	T	exonic	SETD5	.	nonsynonymous SNV	SETD5:NM_001080517:exon19:c.A2776T:p.N926Y,SETD5:NM_001292043:exon21:c.A2482T:p.N828Y,SETD5:NM_001349451:exon22:c.A2482T:p.N828Y	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	0.002	0.721	D	0.776	0.422	P	0.526	0.466	P	0.000	0.447	D	0.653	0.305	N	0.55	0.145	N	-2.67	0.922	D	-1.79	0.422	N	0.279	0.349	-0.916	0.461	T	0.113	0.403	T	0.030	0.529	D	3.788	0.512	23.4	0.991	0.528	0.964	0.686	D	c	0.154	0.269	1.000	0.747	0.719	0.830	0	5.31	0.750	4.384	0.591	1.028	0.649	1.000	0.715	1.000	0.888	15.254	0.732	.	.	.	0.5	.	35	chr3	9512194	chr3:9512194	A	T	.	PASS	AN=0;DP=35	GT	0/1
chr3	9730571	9730571	G	-	intronic	MTMR14	.	.	.	0.002939821	0.99695446	0.000105719	.	0.30998	0.11304	-0.911109353	9.961075725	98.92051	2.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	146	chr3	9730570	chr3:9730570	TG	T	127	PASS	AN=2;DP=146	GT	0/1
chr3	9912079	9912079	G	T	intronic	CIDEC	.	.	.	0.001416632	0.665901653	0.332681714	DISEASE: Note=In omental adipose tissue of obese patients matched for BMI, expression levels tend to correlate with insulin sensitivity. Expression is increased 2-3 fold in the group of patients with high insulin sensitivity, compared to the insulin- resistant group. This observation is consistent with the idea that triglyceride storage in adipocytes plays an important role in sequestering triglycerides and fatty acids away from the circulation and peripheral tissues, thus enhancing insulin sensitivity in liver and muscle. This effect is not significant in subcutaneous adipose tissue (PubMed:18509062). In subcutaneous adipose tissue of diabetic patients, tends to negatively correlate with body mass index and total fat mass, independently of insulin sensitivity (PubMed:18334488). {ECO:0000269|PubMed:18334488, ECO:0000269|PubMed:18509062}.; DISEASE: Lipodystrophy, familial partial, 5 (FPLD5) [MIM:615238]: A form of lipodystrophy characterized by loss of subcutaneous adipose tissue affecting limb, femorogluteal and subcutaneous abdominal fat, preservation of visceral, neck and axilliary fat, hepatomegaly, hepatic steatosis and insulin-resistant diabetes. {ECO:0000269|PubMed:20049731}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20849	.	0.262810045	70.43524416	157.22556	2.74041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr3	9912079	chr3:9912079	G	T	.	PASS	AN=0;DP=45	GT	0/1
chr3	14520577	14520577	C	T	intronic	SLC6A6	.	.	.	0.98227565	0.017723862	4.88E-07	.	0.32797	.	-0.291981272	33.20358575	72.45796	1.77348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr3	14520577	chr3:14520577	C	T	.	PASS	AN=0;DP=51	GT	0/1
chr3	39194899	39194899	C	A	intronic	CSRNP1	.	.	.	0.599530989	0.398521925	0.001947085	.	0.23152	0.09962	-0.222203495	37.54423213	58.28318	1.54604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr3	39194899	chr3:39194899	C	A	.	PASS	AN=0;DP=52	GT	0/1
chr3	39307372	39307372	-	A	exonic	CX3CR1	.	frameshift insertion	CX3CR1:NM_001171171:exon2:c.628dupT:p.C210Lfs*21,CX3CR1:NM_001171172:exon2:c.628dupT:p.C210Lfs*21,CX3CR1:NM_001171174:exon2:c.724dupT:p.C242Lfs*21,CX3CR1:NM_001337:exon2:c.628dupT:p.C210Lfs*21	0.107291641	0.775970084	0.116738275	DISEASE: Macular degeneration, age-related, 12 (ARMD12) [MIM:613784]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:15208270}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.33672	0.36637	0.92967242	89.79122435	996.80543	6.08548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.63	36	chr3	39307372	chr3:39307372	C	CA	20.63	PASS	AN=0;DP=36	GT	0/1
chr3	41266113	41266113	C	T	exonic	CTNNB1	.	nonsynonymous SNV	CTNNB1:NM_001098209:exon3:c.C110T:p.S37F,CTNNB1:NM_001098210:exon3:c.C110T:p.S37F,CTNNB1:NM_001904:exon3:c.C110T:p.S37F,CTNNB1:NM_001330729:exon4:c.C89T:p.S30F	0.99981275	0.00018725	3.61E-11	DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:9065402}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.; DISEASE: Pilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:11703283}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10391090}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.; DISEASE: Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle- shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. {ECO:0000269|PubMed:11464291}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 19 (MRD19) [MIM:615075]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD19 features include severe intellectual disability with absent or very limited speech, microcephaly, and spasticity which severely impaired the ability to walk. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:25326669}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99997	0.9963	-0.582225231	18.44184949	10.25364	0.37429	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.66	0.781	M	0.73	0.507	T	-5.85	0.885	D	0.305	0.852	-0.337	0.740	T	0.351	0.715	T	0.072	0.716	D	6.048	0.832	28.0	0.998	0.910	0.963	0.684	D	c	0.917	0.895	1.0	0.983	0.707	0.730	0	5.76	0.907	7.905	0.864	0.935	0.490	1.000	0.715	1.000	0.888	19.960	0.972	.	.	.	0.5	.	40	chr3	41266113	chr3:41266113	C	T	.	PASS	AN=0;DP=40	GT	0/1
chr3	48682911	48682911	G	A	exonic	CELSR3	.	nonsynonymous SNV	CELSR3:NM_001407:exon24:c.C7762T:p.L2588F	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	0.036	0.433	D	0.002	0.546	B	0.012	0.582	B	.	.	.	0.926	0.368	D	1.585	0.400	L	1.15	0.382	T	-2.18	0.491	N	0.219	0.440	-0.894	0.486	T	0.147	0.472	T	0.032	0.540	D	3.539	0.483	23.1	0.987	0.443	0.899	0.504	D	c	0.067	0.133	0.805	0.242	0.696	0.567	0	4.23	0.492	1.426	0.343	0.939	0.529	1.000	0.715	0.999	0.750	14.076	0.643	GPCR, family 2-like	.	.	0.5	.	79	chr3	48682911	chr3:48682911	G	A	.	PASS	AN=0;DP=79	GT	0/1
chr3	48684190	48684190	G	C	intronic	CELSR3	.	.	.	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	137	chr3	48684190	chr3:48684190	G	C	110	PASS	AN=2;DP=137	GT	0/1
chr3	53919752	53919752	C	A	intronic	SELENOK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr3	53919752	chr3:53919752	C	A	.	PASS	AN=0;DP=55	GT	0/1
chr3	58368401	58368401	C	G	exonic	PXK	.	nonsynonymous SNV	PXK:NM_001289096:exon2:c.C263G:p.P88R,PXK:NM_001289100:exon2:c.C263G:p.P88R,PXK:NM_001349490:exon2:c.C263G:p.P88R,PXK:NM_001349500:exon2:c.C263G:p.P88R,PXK:NM_001349522:exon2:c.C263G:p.P88R,PXK:NM_001349524:exon2:c.C263G:p.P88R,PXK:NM_001289095:exon3:c.C311G:p.P104R,PXK:NM_001349494:exon3:c.C314G:p.P105R,PXK:NM_001349495:exon3:c.C314G:p.P105R,PXK:NM_001349496:exon3:c.C311G:p.P104R,PXK:NM_001349497:exon3:c.C311G:p.P104R,PXK:NM_001349501:exon3:c.C314G:p.P105R,PXK:NM_001349502:exon3:c.C311G:p.P104R,PXK:NM_001349510:exon3:c.C314G:p.P105R,PXK:NM_001349511:exon3:c.C314G:p.P105R,PXK:NM_001349512:exon3:c.C314G:p.P105R,PXK:NM_001349514:exon3:c.C311G:p.P104R,PXK:NM_001349515:exon3:c.C311G:p.P104R,PXK:NM_001349516:exon3:c.C314G:p.P105R,PXK:NM_001349517:exon3:c.C311G:p.P104R,PXK:NM_001349518:exon3:c.C311G:p.P104R,PXK:NM_001289098:exon4:c.C362G:p.P121R,PXK:NM_001289099:exon4:c.C113G:p.P38R,PXK:NM_001349488:exon4:c.C362G:p.P121R,PXK:NM_001349492:exon4:c.C362G:p.P121R,PXK:NM_001349493:exon4:c.C362G:p.P121R,PXK:NM_001349498:exon4:c.C302G:p.P101R,PXK:NM_001349499:exon4:c.C362G:p.P121R,PXK:NM_001349503:exon4:c.C362G:p.P121R,PXK:NM_001349504:exon4:c.C362G:p.P121R,PXK:NM_001349506:exon4:c.C362G:p.P121R,PXK:NM_001349507:exon4:c.C362G:p.P121R,PXK:NM_001349508:exon4:c.C362G:p.P121R,PXK:NM_001349509:exon4:c.C362G:p.P121R,PXK:NM_001349519:exon4:c.C362G:p.P121R,PXK:NM_001349520:exon4:c.C362G:p.P121R,PXK:NM_001349527:exon4:c.C362G:p.P121R,PXK:NM_017771:exon4:c.C362G:p.P121R,PXK:NM_001349489:exon5:c.C113G:p.P38R,PXK:NM_001349513:exon5:c.C113G:p.P38R,PXK:NM_001349521:exon5:c.C113G:p.P38R,PXK:NM_001349528:exon5:c.C113G:p.P38R,PXK:NM_001349529:exon5:c.C113G:p.P38R,PXK:NM_001349530:exon5:c.C113G:p.P38R,PXK:NM_001349531:exon5:c.C113G:p.P38R	0.932144256	0.06785563	1.15E-07	.	0.13995	0.09839	0.266447942	70.5826846	2672.1939	9.71802	0.045	0.784	D	0.751	0.487	P	0.327	0.479	B	0.000	0.843	D	1	0.810	D	3.1	0.878	M	1.06	0.398	T	-6.39	0.913	D	0.839	0.827	-0.699	0.605	T	0.203	0.561	T	0.028	0.508	D	5.715	0.780	26.8	0.996	0.710	0.986	0.847	D	c	0.610	0.657	1.000	0.747	0.732	0.924	0	5.57	0.840	7.347	0.784	0.935	0.490	1.000	0.715	1.000	0.888	19.545	0.953	Phox homologous domain;Phox homologous domain|Protein kinase domain	.	.	0.5	91	24	chr3	58368401	chr3:58368401	C	G	91	PASS	AN=2;DP=24	GT	0/1
chr3	59737880	59737880	C	A	UTR3	FHIT	NM_001320901:c.*72G>T;NM_001320900:c.*72G>T;NM_001320899:c.*72G>T	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr3	59737880	chr3:59737880	C	A	.	PASS	AN=0;DP=56	GT	0/1
chr3	62535675	62535675	C	A	exonic	CADPS	.	synonymous SNV	CADPS:NM_003716:exon11:c.G1869T:p.T623T,CADPS:NM_183393:exon11:c.G1869T:p.T623T,CADPS:NM_183394:exon11:c.G1869T:p.T623T	0.052816468	0.94718353	2.47E-09	.	0.46523	.	-1.346642726	4.62962963	108.92082	2.26567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	chr3	62535675	chr3:62535675	C	A	.	PASS	AN=0;DP=96	GT	0/1
chr3	63820995	63820995	A	C	ncRNA_intronic	C3orf49	.	.	.	.	.	.	.	0.11088	.	.	.	1468.35326	7.14177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	64	chr3	63820995	chr3:63820995	A	C	98	PASS	AN=2;DP=64	GT	0/1
chr3	63898180	63898180	G	T	intronic	ATXN7	.	.	.	0.928556028	0.071440779	3.19E-06	DISEASE: Spinocerebellar ataxia 7 (SCA7) [MIM:164500]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA7 belongs to the autosomal dominant cerebellar ataxias type II (ADCA II) which are characterized by cerebellar ataxia with retinal degeneration and pigmentary macular dystrophy. {ECO:0000269|PubMed:9288099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40116	0.43982	0.205769367	67.49823071	3924.42931	12.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	113	chr3	63898180	chr3:63898180	G	T	.	PASS	AN=0;DP=113	GT	0/1
chr3	73432720	73432720	C	T	exonic	PDZRN3	.	synonymous SNV	PDZRN3:NM_001303139:exon8:c.G2091A:p.R697R,PDZRN3:NM_001303140:exon8:c.G1968A:p.R656R,PDZRN3:NM_001303141:exon8:c.G2163A:p.R721R,PDZRN3:NM_001303142:exon8:c.G2148A:p.R716R,PDZRN3:NM_015009:exon10:c.G2997A:p.R999R	0.908376144	0.091617814	6.04E-06	.	0.4722	0.13321	-0.990222991	8.634111819	1513.34426	7.23005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	chr3	73432720	chr3:73432720	C	T	.	PASS	AN=0;DP=81	GT	0/1
chr3	88101443	88101443	C	A	UTR3	CGGBP1	NM_003663:c.*3180G>T;NM_001195308:c.*3180G>T;NM_001008390:c.*3180G>T	.	.	0.777631518	0.215081104	0.007287378	.	0.22371	0.11109	0.013025609	54.62962963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr3	88101443	chr3:88101443	C	A	.	PASS	AN=0;DP=36	GT	0/1
chr3	100348457	100348457	C	G	exonic	ADGRG7	.	stopgain	ADGRG7:NM_032787:exon2:c.C131G:p.S44X	.	.	.	.	0.04884	0.06553	0.806491657	87.72705827	.	.	.	.	.	.	.	.	.	.	.	0.092	0.025	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.712	0.918	32	0.958	0.272	0.025	0.070	N	c	0.114	-0.286	0.998	0.358	0.487	0.133	0	0.351	0.152	0.267	0.182	0.077	0.185	0.000	0.063	0.000	0.016	3.166	0.061	.	.	.	0.5	81	98	chr3	100348457	chr3:100348457	C	G	81	PASS	AN=2;DP=98	GT	0/1
chr3	101006886	101006886	C	A	intronic	IMPG2	.	.	.	1.47E-08	0.997551473	0.002448512	DISEASE: Retinitis pigmentosa 56 (RP56) [MIM:613581]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:20673862}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD5 features include late- onset moderate visual impairment and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:20673862, ECO:0000269|PubMed:25085631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11371	0.11319	-0.837696902	11.45317292	209.43193	3.12459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	203	chr3	101006886	chr3:101006886	C	A	.	PASS	AN=0;DP=203	GT	0/1
chr3	108183701	108183701	C	A	intronic	MYH15	.	.	.	4.74E-39	0.000158734	0.999841266	.	0.10968	0.09113	0.464695413	78.59754659	3550.47942	11.51131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	chr3	108183701	chr3:108183701	C	A	.	PASS	AN=0;DP=22	GT	0/1
chr3	113236435	113236435	T	C	intergenic	SPICE1;SIDT1	dist=2401;dist=14783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	161	chr3	113236435	chr3:113236435	T	C	84	PASS	AN=2;DP=161	GT	0/1
chr3	116163752	116163752	C	T	exonic	LSAMP	.	nonsynonymous SNV	LSAMP:NM_001318915:exon1:c.G127A:p.V43M,LSAMP:NM_002338:exon1:c.G127A:p.V43M	0.946283747	0.053678415	3.78E-05	.	0.72117	0.19389	0.03689118	56.64071715	22.84835	0.76216	0.001	0.912	D	0.984	0.899	D	0.738	0.774	P	0.004	0.344	N	0.832	0.355	D	3.89	0.961	H	-0.63	0.720	T	-1.81	0.473	N	0.461	0.525	0.552	0.913	D	0.597	0.856	D	0.105	0.780	D	6.619	0.909	32	0.999	0.966	0.862	0.451	D	c	0.768	0.692	1.000	0.747	0.652	0.477	0	4.47	0.536	5.574	0.669	0.932	0.445	1.000	0.715	1.000	0.888	16.369	0.831	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	81	chr3	116163752	chr3:116163752	C	T	.	PASS	AN=0;DP=81	GT	0/1
chr3	119533787	119533787	C	-	intronic	NR1I2	.	.	.	0.000129417	0.846347083	0.1535235	.	0.4518	0.65028	-0.552898813	19.86317528	99.56266	2.15923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	83	chr3	119533786	chr3:119533786	TC	T	82	PASS	AN=2;DP=83	GT	0/1
chr3	121616268	121616268	A	G	exonic	SLC15A2	.	nonsynonymous SNV	SLC15A2:NM_001145998:exon3:c.A227G:p.H76R,SLC15A2:NM_021082:exon3:c.A227G:p.H76R	1.50E-10	0.937563918	0.062436082	.	0.61335	0.17076	-0.176292081	40.56381222	6543.27894	17.03613	0.666	0.069	T	0.021	0.172	B	0.015	0.162	B	0.075	0.213	N	0.998	0.449	D	1.995	0.543	M	0.23	0.597	T	-1.58	0.545	N	0.215	0.371	-0.953	0.405	T	0.150	0.477	T	0.005	0.140	T	0.781	0.168	9.349	0.919	0.206	0.911	0.525	D	c	-0.071	0.135	0.643	0.221	0.554	0.283	0	5.75	0.904	6.173	0.717	1.088	0.866	1.000	0.715	0.998	0.697	14.018	0.639	Major facilitator superfamily domain	.	.	0.5	112	72	chr3	121616268	chr3:121616268	A	G	112	PASS	AN=2;DP=72	GT	1/0
chr3	125648158	125648158	G	T	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	253	chr3	125648158	chr3:125648158	G	T	.	PASS	AN=0;DP=253	GT	0/1
chr3	126229438	126229438	C	A	intronic	UROC1	.	.	.	3.36E-10	0.734541324	0.265458675	DISEASE: Urocanase deficiency (UROCD) [MIM:276880]: An inborn error of histidine metabolism resulting in urocanic aciduria and neurological manifestations including mental retardation, ataxia, episodic aggressive behavior or exaggerated affection-seeking. {ECO:0000269|PubMed:19304569}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10659	0.13811	0.319642692	72.82967681	647.41865	5.10863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	chr3	126229438	chr3:126229438	C	A	.	PASS	AN=0;DP=136	GT	0/1
chr3	133614314	133614314	G	T	UTR5	RAB6B	NM_016577:c.-4C>A	.	.	0.893311149	0.106470904	0.000217948	.	0.70633	0.14229	0.014844891	54.94810097	3.08689	0.1111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	chr3	133614314	chr3:133614314	G	T	.	PASS	AN=0;DP=129	GT	0/1
chr3	138362810	138362810	T	-	intergenic	FAIM;PIK3CB	dist=10597;dist=8730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	160	chr3	138362809	chr3:138362809	CT	C	90	PASS	AN=2;DP=160	GT	0/1
chr3	145841052	145841052	C	G	intronic	PLOD2	.	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	109	chr3	145841052	chr3:145841052	C	G	77	PASS	AN=2;DP=109	GT	0/1
chr3	148711906	148711906	-	T	intronic	GYG1	.	.	.	6.91E-07	0.4631179	0.536881409	DISEASE: Glycogen storage disease 15 (GSD15) [MIM:613507]: A metabolic disorder resulting in muscle weakness, associated with the glycogen depletion in skeletal muscle, and cardiac arrhythmia, associated with the accumulation of abnormal storage material in the heart. The skeletal muscle shows a marked predominance of slow-twitch, oxidative muscle fibers and mitochondrial proliferation. {ECO:0000269|PubMed:20357282}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]: A glycogen storage disease characterized by polyglucosan accumulation in muscle, and skeletal myopathy without cardiac involvement. Most patients manifest slowly progressive, hip girdle, shoulder girdle, and/or hand and leg muscle weakness. Polyglucosan contains abnormally long and poorly branched glucosyl chains and is variably resistant to digestion by alpha-amylase. {ECO:0000269|PubMed:25272951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17298	0.16384	-0.069700724	48.54328851	98.90905	2.15121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	chr3	148711906	chr3:148711906	G	GT	58	PASS	AN=2;DP=91	GT	0/1
chr3	153842088	153842088	G	T	intronic	ARHGEF26	.	.	.	5.99E-06	0.993649364	0.006344644	.	.	.	0.580556395	82.31304553	2005.54992	8.24753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr3	153842088	chr3:153842088	G	T	.	PASS	AN=0;DP=52	GT	0/1
chr3	159711453	159711453	C	T	ncRNA_intronic	IL12A-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr3	159711453	chr3:159711453	C	T	.	PASS	AN=0;DP=27	GT	0/1
chr3	160119820	160119820	A	G	exonic	SMC4	.	nonsynonymous SNV	SMC4:NM_005496:exon2:c.A257G:p.H86R,SMC4:NM_001002800:exon3:c.A257G:p.H86R,SMC4:NM_001288753:exon3:c.A182G:p.H61R	0.105530996	0.894468908	9.61E-08	.	0.99449	0.27637	-0.992035476	8.604623732	434.06529	4.34898	0.252	0.193	T	0.984	0.588	D	0.86	0.594	P	0.000	0.843	D	1	0.810	D	1.17	0.299	L	3.47	0.085	T	-3.4	0.717	D	0.865	0.852	-1.109	0.031	T	0.033	0.143	T	0.016	0.368	T	1.876	0.286	15.44	0.997	0.774	0.980	0.786	D	c	0.335	0.416	1.000	0.747	0.660	0.490	0	5.19	0.713	9.083	0.934	1.028	0.649	1.000	0.715	1.000	0.888	15.042	0.713	P-loop containing nucleoside triphosphate hydrolase|RecF/RecN/SMC, N-terminal	.	.	0.5	105	93	chr3	160119820	chr3:160119820	A	G	105	PASS	AN=2;DP=93	GT	0/1
chr3	166784093	166784093	T	G	intergenic	LOC105374194;ZBBX	dist=134481;dist=173984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	155	chr3	166784093	chr3:166784093	T	G	54	PASS	AN=2;DP=155	GT	0/1
chr3	180559378	180559378	T	C	ncRNA_intronic	LOC101928882	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	90	chr3	180559378	chr3:180559378	T	C	116	PASS	AN=2;DP=90	GT	0/1
chr3	182897192	182897192	C	G	exonic	MCF2L2	.	synonymous SNV	MCF2L2:NM_015078:exon30:c.G3321C:p.P1107P	1.61E-12	0.999318945	0.000681055	.	0.57276	0.09212	0.854236942	88.51144138	3783.20077	12.04253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	67	chr3	182897192	chr3:182897192	C	G	50	PASS	AN=2;DP=67	GT	0/1
chr3	183210014	183210014	C	A	exonic	KLHL6	.	nonsynonymous SNV	KLHL6:NM_130446:exon7:c.G1567T:p.G523W	3.43E-06	0.797610641	0.202385932	.	0.22527	0.11012	-0.907472583	10.07313046	190.44155	2.99478	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.04	0.971	H	-3.47	0.945	D	-6.35	0.910	D	0.98	0.982	1.074	0.987	D	0.935	0.979	D	0.441	0.942	D	6.806	0.925	32	0.995	0.671	0.997	0.986	D	c	0.873	0.780	1.000	0.747	0.707	0.730	0	5.53	0.825	7.376	0.788	0.892	0.403	1.000	0.715	0.234	0.225	19.448	0.948	Kelch-type beta propeller	.	.	0.5	.	109	chr3	183210014	chr3:183210014	C	A	.	PASS	AN=0;DP=109	GT	0/1
chr3	186358318	186358318	G	T	exonic	FETUB	.	nonsynonymous SNV	FETUB:NM_001308077:exon1:c.G69T:p.Q23H,FETUB:NM_001308079:exon1:c.G69T:p.Q23H,FETUB:NM_014375:exon1:c.G69T:p.Q23H	6.88E-05	0.732564853	0.26736631	.	0.02716	.	0.621009802	83.41589998	583.45117	4.89852	0.226	0.245	T	0.641	0.385	P	0.275	0.383	B	0.000	0.003	N	1	0.090	N	0.805	0.203	L	0.93	0.441	T	-1.23	0.322	N	0.069	0.114	-1.064	0.109	T	0.071	0.289	T	0.010	0.262	T	-1.031	0.031	0.014	0.949	0.252	0.074	0.133	N	c	-1.190	-1.264	1.000	0.747	0.497	0.185	0	-0.705	0.106	-0.098	0.109	-0.443	0.057	0.000	0.063	0.000	0.016	2.956	0.055	Cystatin domain	.	.	0.5	.	73	chr3	186358318	chr3:186358318	G	T	.	PASS	AN=0;DP=73	GT	0/1
chr3	188592084	188592084	C	A	intronic	LPP	.	.	.	0.582399908	0.417507007	9.31E-05	DISEASE: Note=A chromosomal aberration involving LPP is associated with pulmonary chondroid hamartomas. Translocation t(3;12)(q27- q28;q14-q15) with HMGA2 is detected in pulmonary chondroid hamartomas.; DISEASE: Note=A chromosomal aberration involving LPP is associated with parosteal lipomas. Translocation t(3;12)(q28;q14) with HMGA2 is also shown in one parosteal lipoma.; DISEASE: Note=A chromosomal aberration involving LPP is associated with acute monoblastic leukemia. Translocation t(3;11)(q28;q23) with KMT2A/MLL1 is associated with acute monoblastic leukemia.; 	0.24469	0.15914	1.050838371	91.36588818	2291.9413	8.8632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr3	188592084	chr3:188592084	C	A	.	PASS	AN=0;DP=52	GT	0/1
chr3	196159011	196159011	G	-	ncRNA_intronic	UBXN7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	189	chr3	196159010	chr3:196159010	CG	C	67	PASS	AN=2;DP=189	GT	0/1
chr3	197610474	197610474	G	T	intergenic	LRCH3;IQCG	dist=12018;dist=5472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr3	197610474	chr3:197610474	G	T	.	PASS	AN=0;DP=66	GT	0/1
chr4	59454	59454	G	T	splicing	ZNF718	NM_001039127:exon2:c.133+2G>T;NM_001289931:exon2:c.37+2G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	chr4	59454	chr4:59454	G	T	.	PASS	AN=0;DP=263	GT	0/1
chr4	38937317	38937317	T	-	intronic	FAM114A1	.	.	.	2.38E-08	0.457538177	0.542461799	.	0.11964	.	0.358272123	74.66383581	2541.88338	9.41853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	41	chr4	38937316	chr4:38937316	CT	C	76	PASS	AN=2;DP=41	GT	0/1
chr4	47915946	47915946	G	A	intronic	NFXL1	.	.	.	0.00788898	0.992109984	1.04E-06	.	0.11984	0.07985	0.222355725	68.44184949	4983.51379	14.41291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	chr4	47915946	chr4:47915946	G	A	.	PASS	AN=0;DP=166	GT	0/1
chr4	66388644	66388644	G	T	intronic	EPHA5	.	.	.	0.00039007	0.999530763	7.92E-05	.	0.29288	0.13579	-1.238203625	5.490681765	548.86151	4.76544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr4	66388644	chr4:66388644	G	T	.	PASS	AN=0;DP=53	GT	0/1
chr4	74847618	74847618	C	A	exonic	PF4	.	nonsynonymous SNV	PF4:NM_002619:exon1:c.G53T:p.G18V	0.033296817	0.613399998	0.353303185	.	0.05528	0.31251	-0.009020804	52.8544468	13.35188	0.48559	0.072	0.349	T	0.998	0.715	D	0.785	0.557	P	0.197	0.167	N	0.821	0.348	D	0.975	0.246	L	.	.	.	-1.29	0.324	N	0.426	0.482	-0.974	0.363	T	0.095	0.359	T	0.003	0.064	T	1.814	0.279	15.07	0.933	0.224	0.209	0.210	N	c	-0.411	-0.548	1.000	0.747	0.206	0.033	2	2.25	0.272	0.905	0.279	0.637	0.291	0.347	0.255	0.198	0.217	7.947	0.290	.	.	.	0.5	.	133	chr4	74847618	chr4:74847618	C	A	.	PASS	AN=0;DP=133	GT	0/1
chr4	76787418	76787418	A	T	exonic	PPEF2	.	nonsynonymous SNV	PPEF2:NM_006239:exon15:c.T1844A:p.V615E	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	0.005	0.632	D	0.963	0.537	D	0.642	0.503	P	0.000	0.537	D	0.924	0.368	D	2.95	0.852	M	0.84	0.475	T	-4.43	0.775	D	0.788	0.779	-0.589	0.653	T	0.195	0.549	T	0.054	0.659	D	5.948	0.817	27.6	0.984	0.409	0.927	0.561	D	c	0.451	0.424	0.988	0.314	0.554	0.246	0	4.67	0.579	3.858	0.554	1.140	0.893	1.000	0.715	0.987	0.523	12.130	0.531	EF-hand domain pair	.	.	0.5	.	65	chr4	76787418	chr4:76787418	A	T	.	PASS	AN=0;DP=65	GT	0/1
chr4	76817383	76817383	T	C	intronic	PPEF2	.	.	.	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr4	76817383	chr4:76817383	T	C	.	PASS	AN=0;DP=67	GT	0/1
chr4	85165687	85165687	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr4	85165687	chr4:85165687	C	A	.	PASS	AN=0;DP=42	GT	0/1
chr4	85166011	85166011	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr4	85166011	chr4:85166011	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr4	90830450	90830450	C	A	exonic	MMRN1	.	nonsynonymous SNV	MMRN1:NM_007351:exon2:c.C647A:p.T216N	9.35E-17	0.008835231	0.991164769	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	0.236	0.179	T	0.992	0.715	D	0.856	0.728	P	0.000	0.537	D	0.979	0.810	D	1.94	0.524	M	0.78	0.494	T	-1.92	0.446	N	0.318	0.380	-0.817	0.542	T	0.202	0.559	T	0.019	0.416	T	4.018	0.540	23.6	0.990	0.498	0.919	0.543	D	c	0.279	0.256	0.978	0.299	0.672	0.522	0	4.45	0.532	2.965	0.486	0.935	0.490	1.000	0.715	0.945	0.419	14.979	0.708	EMI domain	.	.	0.5	.	48	chr4	90830450	chr4:90830450	C	A	.	PASS	AN=0;DP=48	GT	0/1
chr4	106557482	106557482	A	G	intronic	ARHGEF38	.	.	.	0.005631717	0.720124339	0.274243944	.	.	.	.	.	2057.23092	8.3587	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	13	chr4	106557482	chr4:106557482	A	G	43	PASS	AN=2;DP=13	GT	0/1
chr4	111482530	111482530	G	T	intronic	ENPEP	.	.	.	3.58E-19	0.016944416	0.983055584	.	0.21927	0.47886	0.385781814	75.678226	422.73046	4.29372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr4	111482530	chr4:111482530	G	T	.	PASS	AN=0;DP=36	GT	0/1
chr4	120986916	120986916	G	A	exonic	MAD2L1	.	nonsynonymous SNV	MAD2L1:NM_002358:exon2:c.C131T:p.T44I	0.013167455	0.861483837	0.125348708	.	0.99211	0.15588	0.03689118	56.64071715	19.38659	0.66662	0.017	0.512	D	0.986	0.657	D	0.951	0.672	D	0.000	0.843	D	1	0.810	D	2.405	0.698	M	.	.	.	-3.54	0.686	D	0.789	0.784	-0.373	0.729	T	0.381	0.738	T	0.010	0.267	T	3.706	0.502	23.3	0.998	0.854	0.942	0.603	D	c	0.749	0.729	1.000	0.747	0.628	0.401	0	4.78	0.605	9.498	0.969	1.048	0.713	1.000	0.715	0.995	0.604	18.181	0.897	HORMA domain	.	.	0.5	.	56	chr4	120986916	chr4:120986916	G	A	.	PASS	AN=0;DP=56	GT	0/1
chr4	143000716	143000716	G	T	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr4	143000716	chr4:143000716	G	T	.	PASS	AN=0;DP=66	GT	0/1
chr4	143011461	143011461	T	-	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.92	69	chr4	143011460	chr4:143011460	AT	A	21.92	PASS	AN=0;DP=69	GT	0/1
chr4	146026683	146026683	A	G	intronic	ABCE1	.	.	.	0.999982597	1.74E-05	5.48E-13	.	0.54899	0.31462	-0.251530012	35.42108988	5.45332	0.20296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	68	chr4	146026683	chr4:146026683	A	G	99	PASS	AN=2;DP=68	GT	1/0
chr4	167012390	167012390	C	A	exonic	TLL1	.	nonsynonymous SNV	TLL1:NM_012464:exon19:c.C2553A:p.N851K	0.327496391	0.672503562	4.66E-08	DISEASE: Atrial septal defect 6 (ASD6) [MIM:613087]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:18830233}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54651	0.13658	-0.927704399	9.719273414	309.19572	3.74397	0.108	0.294	T	0.234	0.290	B	0.119	0.306	B	0.001	0.432	U	0.895	0.360	D	0.8	0.197	N	2.37	0.160	T	-1.05	0.275	N	0.151	0.179	-1.058	0.122	T	0.027	0.114	T	0.004	0.110	T	3.017	0.423	22.3	0.994	0.604	0.845	0.432	D	c	-0.128	0.045	0.964	0.287	0.534	0.214	0	5.3	0.746	1.950	0.397	0.892	0.403	1.000	0.715	0.997	0.653	6.899	0.233	CUB domain	.	.	0.5	.	36	chr4	167012390	chr4:167012390	C	A	.	PASS	AN=0;DP=36	GT	0/1
chr4	167656229	167656229	T	C	exonic	SPOCK3	.	nonsynonymous SNV	SPOCK3:NM_001251967:exon8:c.A860G:p.E287G,SPOCK3:NM_001204355:exon9:c.A866G:p.E289G,SPOCK3:NM_001204353:exon10:c.A794G:p.E265G,SPOCK3:NM_001204354:exon10:c.A878G:p.E293G,SPOCK3:NM_001204356:exon10:c.A1025G:p.E342G,SPOCK3:NM_001040159:exon11:c.A1145G:p.E382G,SPOCK3:NM_001204352:exon12:c.A1001G:p.E334G,SPOCK3:NM_016950:exon12:c.A1154G:p.E385G	0.495144484	0.504669024	0.000186492	.	0.12678	0.11885	0.042348793	57.31304553	237.48342	3.32713	0.435	0.224	T	0.981	0.629	D	0.704	0.612	P	0.000	0.629	D	1.000	0.530	D	2.67	0.784	M	0.98	0.421	T	-0.87	0.268	N	0.795	0.790	-0.924	0.451	T	0.176	0.521	T	0.020	0.426	T	4.070	0.546	23.7	0.998	0.874	0.952	0.637	D	c	0.460	0.485	0.051	0.149	0.554	0.246	0	5.11	0.691	5.956	0.698	0.954	0.563	1.000	0.715	0.998	0.697	14.913	0.703	EF-hand domain pair|SPARC/Testican, calcium-binding domain;Thyroglobulin type-1	.	.	0.5	89	93	chr4	167656229	chr4:167656229	T	C	89	PASS	AN=2;DP=93	GT	0/1
chr4	169315628	169315628	T	-	exonic	DDX60L	.	frameshift deletion	DDX60L:NM_001012967:exon28:c.3798delA:p.I1269Lfs*2,DDX60L:NM_001291510:exon28:c.3801delA:p.I1270Lfs*2,DDX60L:NM_001345927:exon28:c.3801delA:p.I1270Lfs*2	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	140	chr4	169315627	chr4:169315627	CT	C	147	PASS	AN=2;DP=140	GT	1/0
chr4	187630808	187630808	C	A	exonic	FAT1	.	nonsynonymous SNV	FAT1:NM_005245:exon2:c.G174T:p.K58N	1.78E-10	1	5.46E-11	.	0.43649	0.17117	-0.392997457	27.05826846	12587.77428	24.10511	0.002	0.721	D	1.0	0.899	D	0.982	0.739	D	0.000	0.843	D	1.000	0.588	D	2.955	0.853	M	0.16	0.606	T	-3.56	0.750	D	0.2	0.245	-0.406	0.718	T	0.354	0.718	T	0.048	0.634	D	4.395	0.588	24.1	0.997	0.828	0.876	0.469	D	c	0.405	0.282	1.000	0.747	0.554	0.246	0	4.12	0.473	2.061	0.408	0.041	0.156	1.000	0.715	0.246	0.227	6.273	0.200	Cadherin|Cadherin-like	.	.	0.5	.	37	chr4	187630808	chr4:187630808	C	A	.	PASS	AN=0;DP=37	GT	0/1
chr5	24511520	24511520	G	T	exonic	CDH10	.	stopgain	CDH10:NM_001317224:exon5:c.C918A:p.Y306X,CDH10:NM_006727:exon6:c.C918A:p.Y306X	0.309152977	0.690814761	3.23E-05	.	0.42021	0.11113	-0.800872469	12.33191791	34.27199	1.04877	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.073	0.972	37	0.996	0.746	0.858	0.447	D	c	0.454	0.253	0.003	0.102	0.554	0.246	0	-0.294	0.121	1.501	0.351	0.067	0.174	1.000	0.715	0.999	0.750	10.529	0.440	Cadherin|Cadherin-like	.	.	0.5	.	52	chr5	24511520	chr5:24511520	G	T	.	PASS	AN=0;DP=52	GT	0/1
chr5	34830879	34830879	C	G	UTR3	RAI14	NM_015577:c.*9C>G;NM_001145522:c.*9C>G;NM_001145520:c.*9C>G;NM_001145525:c.*9C>G;NM_001145521:c.*9C>G;NM_001145523:c.*9C>G	.	.	0.487656416	0.512341946	1.64E-06	.	0.2442	0.11401	-0.216746887	37.69757018	3767.60269	12.00361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	39	chr5	34830879	chr5:34830879	C	G	54	PASS	AN=2;DP=39	GT	0/1
chr5	55042105	55042105	G	T	intronic	DDX4	.	.	.	0.998516038	0.001483962	4.64E-11	.	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	chr5	55042105	chr5:55042105	G	T	.	PASS	AN=0;DP=37	GT	0/1
chr5	64756006	64756006	C	T	exonic	ADAMTS6	.	nonsynonymous SNV	ADAMTS6:NM_197941:exon4:c.G622A:p.G208R	0.998800473	0.001199527	1.13E-12	.	0.4309	0.11953	-0.574945567	18.90186365	218.20018	3.19214	0.021	0.491	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.455	0.715	M	0.14	0.609	T	-3.74	0.710	D	0.864	0.858	-0.396	0.722	T	0.368	0.728	T	0.067	0.701	D	6.838	0.927	33	0.999	0.997	0.988	0.872	D	c	0.759	0.797	1.000	0.747	0.707	0.730	0	6.06	0.983	7.435	0.794	0.935	0.490	1.000	0.715	1.000	0.888	20.640	0.995	.	.	.	0.5	.	50	chr5	64756006	chr5:64756006	C	T	.	PASS	AN=0;DP=50	GT	0/1
chr5	65029420	65029420	G	T	intronic	NLN	.	.	.	3.60E-07	0.985541392	0.014458248	.	0.39163	0.14364	-0.354480518	29.42911064	1132.42209	6.4199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	140	chr5	65029420	chr5:65029420	G	T	.	PASS	AN=0;DP=140	GT	0/1
chr5	76640691	76640691	G	T	exonic	PDE8B	.	nonsynonymous SNV	PDE8B:NM_001029853:exon6:c.G751T:p.V251L,PDE8B:NM_001029851:exon7:c.G811T:p.V271L,PDE8B:NM_001029852:exon7:c.G811T:p.V271L,PDE8B:NM_001029854:exon7:c.G811T:p.V271L,PDE8B:NM_001349748:exon7:c.G808T:p.V270L,PDE8B:NM_001349751:exon7:c.G808T:p.V270L,PDE8B:NM_001349752:exon7:c.G505T:p.V169L,PDE8B:NM_003719:exon7:c.G811T:p.V271L,PDE8B:NM_001349749:exon8:c.G874T:p.V292L,PDE8B:NM_001349750:exon8:c.G571T:p.V191L,PDE8B:NM_001349753:exon8:c.G439T:p.V147L	0.986862336	0.013137655	9.57E-09	DISEASE: Striatal degeneration autosomal dominant (ADSD) [MIM:609161]: A movement disorder affecting the striatal part of the basal ganglia and characterized by bradykinesia, dysarthria and muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but tremor is not present. {ECO:0000269|PubMed:20085714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 3 (PPNAD3) [MIM:614190]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:18431404}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47483	.	-0.688817379	15.20405756	135.71543	2.53301	0.856	0.031	T	0.018	0.165	B	0.074	0.267	B	0.005	0.330	N	1.000	0.516	D	-1.065	0.010	N	-0.24	0.749	T	0.18	0.138	N	0.519	0.591	-0.887	0.492	T	0.117	0.414	T	0.019	0.420	T	1.689	0.264	14.34	0.840	0.145	0.906	0.517	D	c	-0.378	-0.069	0.172	0.178	0.554	0.246	0	5.01	0.663	2.235	0.424	1.048	0.713	1.000	0.715	1.000	0.888	11.329	0.485	PAS domain	.	.	0.5	.	29	chr5	76640691	chr5:76640691	G	T	.	PASS	AN=0;DP=29	GT	0/1
chr5	79945913	79945913	A	G	UTR5	MTRNR2L2	NM_001190470:c.-8T>C	.	.	.	.	.	.	.	.	.	.	22.30248	0.74815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	chr5	79945913	chr5:79945913	A	G	.	PASS	AN=0;DP=58	GT	0/1
chr5	86564459	86564459	G	T	exonic	RASA1	.	nonsynonymous SNV	RASA1:NM_002890:exon1:c.G191T:p.G64V	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	0.01	0.564	D	0.889	0.469	P	0.238	0.368	B	0.239	0.036	N	0.995	0.426	D	0.695	0.181	N	-0.67	0.725	T	-0.43	0.144	N	0.453	0.511	-0.828	0.534	T	0.184	0.533	T	0.144	0.827	D	4.731	0.634	24.6	0.983	0.397	0.127	0.172	N	c	-0.132	-0.054	1.000	0.747	0.442	0.072	0	3.7	0.414	0.568	0.232	0.877	0.384	0.902	0.312	0.983	0.502	12.682	0.561	.	.	.	0.5	.	48	chr5	86564459	chr5:86564459	G	T	.	PASS	AN=0;DP=48	GT	0/1
chr5	89999592	89999592	G	T	exonic	ADGRV1	.	stopgain	ADGRV1:NM_032119:exon35:c.G8266T:p.G2756X	.	.	.	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.07741	0.17025	8.124040712	99.95281906	.	.	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.580	0.999	51	0.990	0.505	0.994	0.960	D	c	1.211	1.057	1.000	0.747	0.554	0.246	0	5.15	0.702	9.222	0.943	1.048	0.713	1.000	0.715	0.877	0.367	18.825	0.920	Na-Ca exchanger/integrin-beta4	.	.	0.5	.	40	chr5	89999592	chr5:89999592	G	T	.	PASS	AN=0;DP=40	GT	0/1
chr5	108680378	108680378	C	T	intronic	PJA2	.	.	.	0.466603862	0.533163979	0.000232159	.	0.32444	0.09509	-0.132199953	43.97853267	2997.44585	10.38957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr5	108680378	chr5:108680378	C	T	.	PASS	AN=0;DP=45	GT	0/1
chr5	118309599	118309599	G	A	intronic	DTWD2	.	.	.	2.16E-05	0.484452633	0.515525762	.	0.17158	0.1149	-0.448125345	24.19202642	92.81718	2.06998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	chr5	118309599	chr5:118309599	G	A	.	PASS	AN=0;DP=117	GT	0/1
chr5	126253834	126253834	G	C	exonic	MARCH3	.	synonymous SNV	MARCH3:NM_178450:exon2:c.C30G:p.P10P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	chr5	126253834	chr5:126253834	G	C	.	PASS	AN=0;DP=122	GT	0/1
chr5	127872118	127872118	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C314A:p.P105H	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.001	0.784	D	0.999	0.764	D	0.935	0.653	D	0.000	0.629	D	1.000	0.810	D	1.78	0.463	L	-1.96	0.869	D	-4.83	0.925	D	0.729	0.731	0.262	0.869	D	0.632	0.871	D	0.066	0.699	D	5.064	0.682	25.2	0.997	0.831	0.959	0.665	D	c	0.540	0.639	1.0	0.983	0.726	0.872	0	5.32	0.753	9.898	0.986	1.048	0.713	1.000	0.715	0.999	0.750	19.186	0.936	.	.	.	0.5	.	102	chr5	127872118	chr5:127872118	G	T	.	PASS	AN=0;DP=102	GT	0/1
chr5	127872119	127872119	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C313A:p.P105T	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.066	0.365	T	0.208	0.282	B	0.068	0.262	B	0.000	0.629	D	1.000	0.588	D	1.32	0.331	L	-1.91	0.865	D	-4.1	0.860	D	0.708	0.716	-0.381	0.726	T	0.382	0.739	T	0.040	0.595	D	3.058	0.427	22.4	0.998	0.861	0.821	0.411	D	c	-0.104	0.122	1.000	0.747	0.726	0.872	0	5.32	0.753	2.895	0.481	1.048	0.713	1.000	0.715	0.998	0.697	13.803	0.625	.	.	.	0.5	.	103	chr5	127872119	chr5:127872119	G	T	.	PASS	AN=0;DP=103	GT	0/1
chr5	140080299	140080299	G	T	intronic	ZMAT2	.	.	.	0.97143376	0.028527624	3.86E-05	.	0.64216	0.11262	-0.031067188	51.03798066	2.53643	0.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	chr5	140080299	chr5:140080299	G	T	.	PASS	AN=0;DP=54	GT	0/1
chr5	140201593	140201593	T	A	exonic	PCDHA5	.	nonsynonymous SNV	PCDHA5:NM_018908:exon1:c.T233A:p.L78Q,PCDHA5:NM_031501:exon1:c.T233A:p.L78Q	0.003538248	0.986919756	0.009541996	.	0.09837	.	0.100999032	60.76315169	773.98299	5.50488	0.037	0.430	D	0.899	0.475	P	0.59	0.486	P	.	.	.	1	0.810	D	1.725	0.447	L	1.17	0.379	T	-4.49	0.780	D	0.207	0.479	-0.972	0.369	T	0.107	0.389	T	0.053	0.654	D	4.407	0.590	24.1	0.992	0.538	0.397	0.260	N	c	-0.293	-0.357	0.374	0.199	0.517	0.208	0	2.83	0.320	-0.729	0.050	0.908	0.420	0.000	0.063	1.000	0.888	3.128	0.060	Cadherin|Cadherin, N-terminal|Cadherin-like	.	.	0.5	.	340	chr5	140201593	chr5:140201593	T	A	.	PASS	AN=0;DP=340	GT	0/1
chr5	140257373	140257373	C	T	exonic	PCDHA12	.	synonymous SNV	PCDHA12:NM_018903:exon1:c.C2316T:p.F772F,PCDHA12:NM_031864:exon1:c.C2316T:p.F772F	3.52E-10	0.090786698	0.909213301	.	0.1303	.	1.234540528	93.27671621	295.25165	3.66735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	186	chr5	140257373	chr5:140257373	C	T	.	PASS	AN=0;DP=186	GT	0/1
chr5	145435519	145435519	-	A	intronic	SH3RF2	.	.	.	1.79E-11	0.111247308	0.888752692	.	0.17894	0.09775	-0.146971018	42.31540458	238.18509	3.33526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.53	32	chr5	145435519	chr5:145435519	T	TA	13.53	PASS	AN=0;DP=32	GT	0/1
chr5	148579955	148579955	G	A	exonic	ABLIM3	.	nonsynonymous SNV	ABLIM3:NM_001301015:exon4:c.G412A:p.A138T,ABLIM3:NM_001301028:exon4:c.G412A:p.A138T,ABLIM3:NM_001345861:exon4:c.G412A:p.A138T,ABLIM3:NM_001301018:exon5:c.G412A:p.A138T,ABLIM3:NM_001301027:exon5:c.G436A:p.A146T,ABLIM3:NM_001345858:exon5:c.G412A:p.A138T,ABLIM3:NM_001345859:exon5:c.G412A:p.A138T,ABLIM3:NM_001345860:exon5:c.G412A:p.A138T,ABLIM3:NM_014945:exon5:c.G412A:p.A138T	0.016025349	0.983972836	1.82E-06	.	0.44749	0.10843	-1.150005948	6.286860109	169.47144	2.84089	0.42	0.098	T	0.0	0.026	B	0.0	0.063	B	0.002	0.382	N	0.997	0.228	N	-0.41	0.029	N	1.01	0.411	T	-0.03	0.095	N	0.019	0.080	-1.024	0.224	T	0.032	0.139	T	0.005	0.112	T	1.796	0.277	14.96	0.946	0.246	0.611	0.311	D	c	-0.602	-0.377	1.000	0.458	0.646	0.442	0	2.54	0.295	2.231	0.424	-0.513	0.050	1.000	0.715	0.995	0.604	4.614	0.117	Zinc finger, LIM-type	.	.	0.5	.	77	chr5	148579955	chr5:148579955	G	A	.	PASS	AN=0;DP=77	GT	0/1
chr5	149678006	149678006	G	T	exonic	ARSI	.	nonsynonymous SNV	ARSI:NM_001012301:exon2:c.C481A:p.R161S	1.05E-09	0.089882668	0.910117331	.	0.1223	0.15805	-1.03976177	7.802547771	156.19896	2.73165	0.162	0.248	T	0.26	0.298	B	0.233	0.367	B	0.000	0.843	D	1	0.810	D	0.73	0.189	N	-3.93	0.961	D	-2.07	0.563	N	0.903	0.909	0.380	0.888	D	0.743	0.912	D	0.099	0.772	D	3.232	0.448	22.8	0.992	0.537	0.953	0.641	D	c	-0.022	0.130	1.000	0.747	0.615	0.372	0	4.58	0.559	4.886	0.626	0.953	0.551	1.000	0.715	0.998	0.697	17.591	0.878	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain|Sulfatase, N-terminal	.	.	0.5	.	152	chr5	149678006	chr5:149678006	G	T	.	PASS	AN=0;DP=152	GT	0/1
chr5	154169883	154169883	A	G	splicing	LARP1	NM_015315:exon2:c.206-2A>G	.	.	0.999952189	4.78E-05	5.32E-14	.	0.27569	0.0905	-1.350267166	4.600141543	57.4938	1.52959	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.357	0.583	24.1	0.995	0.685	0.998	0.994	D	c	1.065	0.893	1.000	0.747	0.257	0.036	0	5.39	0.775	7.727	0.837	1.199	0.960	1.000	0.715	0.907	0.385	15.442	0.748	.	.	.	0.5	80	69	chr5	154169883	chr5:154169883	A	G	80	PASS	AN=2;DP=69	GT	0/1
chr5	158126222	158126222	-	A	intronic	EBF1	.	.	.	0.996264497	0.00373545	5.33E-08	.	0.9897	0.28911	-0.47017169	23.25430526	46.86767	1.32389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.88	31	chr5	158126222	chr5:158126222	T	TA	17.88	PASS	AN=0;DP=31	GT	0/1
chr5	168137995	168137995	C	A	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon25:c.G2624T:p.G875V,SLIT3:NM_003062:exon25:c.G2624T:p.G875V	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.015	0.546	D	0.981	0.577	D	0.938	0.656	D	0.000	0.843	D	1	0.810	D	2.075	0.572	M	-0.99	0.759	T	-5.58	0.867	D	0.854	0.888	0.185	0.857	D	0.561	0.841	D	0.097	0.767	D	6.759	0.922	32	0.998	0.882	0.975	0.747	D	c	0.699	0.649	0.999	0.399	0.554	0.283	0	4.8	0.610	4.939	0.630	0.935	0.490	1.000	0.715	0.986	0.517	18.416	0.905	Cysteine-rich flanking region, C-terminal|Leucine-rich repeat domain, L domain-like	.	.	0.5	.	126	chr5	168137995	chr5:168137995	C	A	.	PASS	AN=0;DP=126	GT	0/1
chr5	175819527	175819527	A	-	UTR3	CLTB	NM_001834:c.*248delT;NM_007097:c.*248delT	.	.	0.11549246	0.85740865	0.02709889	.	0.42524	0.24613	-0.229483771	36.86010852	6.86616	0.25469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	108	chr5	175819526	chr5:175819526	GA	G	55	PASS	AN=2;DP=108	GT	0/1
chr6	10756688	10756688	T	C	intronic	TMEM14B	.	.	.	6.48E-07	0.077805418	0.922193935	.	.	0.07094	-0.073340031	48.11866006	72.00791	1.76647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr6	10756688	chr6:10756688	T	C	.	PASS	AN=0;DP=46	GT	0/1
chr6	18256118	18256118	A	T	intronic	DEK	.	.	.	0.102359187	0.890489819	0.007150994	DISEASE: Note=A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non- lymphocytic leukemia (PubMed:1549122). Translocation t(6;9)(p23;q34) with NUP214/CAN (PubMed:1549122). It results in the formation of a DEK-NUP214 fusion gene (PubMed:1549122). {ECO:0000269|PubMed:1549122}.; 	0.89842	.	-0.381986487	27.68931352	22.40799	0.75211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	94	chr6	18256118	chr6:18256118	A	T	58	PASS	AN=2;DP=94	GT	0/1
chr6	18256134	18256134	A	T	intronic	DEK	.	.	.	0.102359187	0.890489819	0.007150994	DISEASE: Note=A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non- lymphocytic leukemia (PubMed:1549122). Translocation t(6;9)(p23;q34) with NUP214/CAN (PubMed:1549122). It results in the formation of a DEK-NUP214 fusion gene (PubMed:1549122). {ECO:0000269|PubMed:1549122}.; 	0.89842	.	-0.381986487	27.68931352	22.40799	0.75211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	97	chr6	18256134	chr6:18256134	A	T	58	PASS	AN=2;DP=97	GT	0/1
chr6	27834598	27834598	C	A	UTR3	HIST1H1B	NM_005322:c.*29G>T	.	.	0.509138756	0.421807909	0.069053335	.	0.27585	0.20571	0.575097644	82.1656051	458.1171	4.44431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr6	27834598	chr6:27834598	C	A	.	PASS	AN=0;DP=55	GT	0/1
chr6	27839699	27839699	C	G	exonic	HIST1H3I	.	nonsynonymous SNV	HIST1H3I:NM_003533:exon1:c.G395C:p.R132P	0.360879945	0.587736996	0.051383059	.	0.31574	.	-0.09720619	46.20193442	6.59255	0.24364	.	.	.	.	.	.	.	.	.	.	.	.	0.999	0.456	D	.	.	.	.	.	.	.	.	.	0.909	0.899	-0.099	0.801	T	0.425	0.769	T	0.200	0.867	D	7.189	0.945	34	0.993	0.568	0.760	0.369	D	c	0.431	0.468	1.0	0.983	0.243	0.034	2	4.12	0.473	7.701	0.834	0.848	0.348	1.000	0.715	0.971	0.463	16.634	0.848	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	107	168	chr6	27839699	chr6:27839699	C	G	107	PASS	AN=2;DP=168	GT	0/1
chr6	35263513	35263513	C	G	UTR3	ZNF76	NM_003427:c.*488C>G;NM_001292032:c.*488C>G	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	chr6	35263513	chr6:35263513	C	G	.	PASS	AN=0;DP=130	GT	0/1
chr6	42176568	42176568	C	A	intronic	MRPS10	.	.	.	0.028212146	0.922237701	0.049550153	.	0.19668	0.10229	-0.0274281	51.65723048	31.89637	1.00349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	chr6	42176568	chr6:42176568	C	A	.	PASS	AN=0;DP=61	GT	0/1
chr6	43237695	43237695	-	C	intronic	TTBK1	.	.	.	0.997306963	0.002693036	9.81E-10	.	0.26651	0.11543	-0.459259448	23.69072895	6694.9523	17.33817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	322	chr6	43237695	chr6:43237695	G	GC	88	PASS	AN=2;DP=322	GT	0/1
chr6	44200534	44200534	G	T	intronic	SLC29A1	.	.	.	0.964281535	0.035704824	1.36E-05	.	0.51344	0.22208	0.573279816	82.08303845	81.44022	1.91023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	192	chr6	44200534	chr6:44200534	G	T	.	PASS	AN=0;DP=192	GT	0/1
chr6	47576839	47576839	T	-	intronic	CD2AP	.	.	.	0.813221347	0.186777009	1.64E-06	DISEASE: Focal segmental glomerulosclerosis 3 (FSGS3) [MIM:607832]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:12764198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.69543	0.37908	-0.354480518	29.42911064	262.95445	3.47978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	62	chr6	47576838	chr6:47576838	AT	A	39	PASS	AN=2;DP=62	GT	0/1
chr6	57393144	57393144	A	T	exonic	PRIM2	.	unknown	UNKNOWN	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	0.134	0.257	B	0.091	0.284	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.391	0.451	.	.	.	.	.	.	.	.	.	2.510	0.363	19.53	0.889	0.178	0.926	0.558	D	n	1.419	0.069	1.000	0.747	0.258	0.037	0	4.7	0.586	5.569	0.669	1.093	0.878	1.000	0.715	0.948	0.423	10.683	0.448	.	.	.	0.5	.	69	chr6	57393144	chr6:57393144	A	T	.	PASS	AN=0;DP=69	GT	0/1
chr6	70048747	70048747	-	T	intronic	ADGRB3	.	.	.	.	.	.	.	0.46112	.	-1.74358502	2.394432649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	32	chr6	70048747	chr6:70048747	A	AT	39	PASS	AN=2;DP=32	GT	0/1
chr6	76618183	76618183	T	-	intronic	MYO6	.	.	.	0.017788399	0.9822116	5.28E-10	DISEASE: Deafness, autosomal dominant, 22 (DFNA22) [MIM:606346]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness. {ECO:0000269|PubMed:11468689}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 37 (DFNB37) [MIM:607821]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12687499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, sensorineural, with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346]: An autosomal dominant sensorineural deafness associated with hypertrophic cardiomyopathy. {ECO:0000269|PubMed:15060111}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26137	0.31948	-0.369255208	28.25548478	419.15519	4.27823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	25	chr6	76618182	chr6:76618182	AT	A	58	PASS	AN=2;DP=25	GT	0/1
chr6	99374464	99374464	T	C	exonic	FBXL4	.	nonsynonymous SNV	FBXL4:NM_012160:exon3:c.A401G:p.Q134R,FBXL4:NM_001278716:exon4:c.A401G:p.Q134R	0.007908799	0.989068654	0.003022548	.	0.42917	0.09922	-0.933156985	9.54824251	139.80195	2.5782	0.513	0.074	T	0.167	0.270	B	0.062	0.255	B	0.000	0.843	D	0.912	0.364	D	0.345	0.112	N	2.57	0.136	T	-0.45	0.148	N	0.104	0.130	-0.946	0.417	T	0.006	0.021	T	0.008	0.208	T	1.392	0.231	12.75	0.931	0.221	0.940	0.595	D	c	-0.263	-0.027	0.800	0.241	0.707	0.730	0	4.33	0.509	3.785	0.549	1.061	0.807	1.000	0.715	1.000	0.888	12.079	0.528	.	.	.	0.5	.	47	chr6	99374464	chr6:99374464	T	C	.	PASS	AN=0;DP=47	GT	0/1
chr6	102247559	102247559	G	A	exonic	GRIK2	.	nonsynonymous SNV	GRIK2:NM_001166247:exon7:c.G988A:p.V330M,GRIK2:NM_021956:exon7:c.G988A:p.V330M,GRIK2:NM_175768:exon7:c.G988A:p.V330M	0.994567954	0.005432045	1.10E-09	DISEASE: Mental retardation, autosomal recessive 6 (MRT6) [MIM:611092]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic mental retardation. MRT6 patients display mild to severe mental retardation and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal. {ECO:0000269|PubMed:17847003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53627	.	-1.131590109	6.481481481	129.48869	2.48041	0.043	0.473	D	0.998	0.715	D	0.936	0.654	D	0.000	0.843	D	1.000	0.588	D	2.27	0.647	M	-1.63	0.825	D	-0.74	0.383	N	0.671	0.710	0.230	0.864	D	0.594	0.855	D	0.101	0.774	D	6.493	0.895	31	0.999	0.982	0.991	0.912	D	c	0.794	0.811	1.000	0.747	0.554	0.283	0	5.44	0.793	9.602	0.976	1.048	0.713	1.000	0.715	1.000	0.888	19.253	0.939	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	.	50	chr6	102247559	chr6:102247559	G	A	.	PASS	AN=0;DP=50	GT	0/1
chr6	123696766	123696766	G	C	exonic	TRDN	.	nonsynonymous SNV	TRDN:NM_001251987:exon19:c.C1260G:p.D420E,TRDN:NM_006073:exon19:c.C1257G:p.D419E	1.82E-10	0.82694144	0.17305856	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18235	0.15914	1.976952171	97.61146497	4408.1144	13.27537	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.327	0.142	N	1.000	0.090	P	-0.805	0.016	N	2.57	0.136	T	0.22	0.047	N	0.027	0.009	-0.910	0.469	T	0.004	0.012	T	0.018	0.402	T	0.655	0.156	8.529	0.298	0.016	0.425	0.267	N	c	-1.057	-0.785	0.000	0.052	0.487	0.133	0	4.14	0.477	0.616	0.239	-0.339	0.072	1.000	0.715	0.987	0.523	9.685	0.391	.	.	.	0.5	83	49	chr6	123696766	chr6:123696766	G	C	83	PASS	AN=2;DP=49	GT	0/1
chr6	129511373	129511373	T	C	exonic	LAMA2	.	synonymous SNV	LAMA2:NM_000426:exon11:c.T1491C:p.C497C,LAMA2:NM_001079823:exon11:c.T1491C:p.C497C	1.18E-24	0.999999998	2.28E-09	DISEASE: Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]: Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI. {ECO:0000269|PubMed:11591858, ECO:0000269|PubMed:12552556}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30049	0.63589	0.497724973	79.64142486	3368.62227	11.11486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	19	chr6	129511373	chr6:129511373	T	C	54	PASS	AN=2;DP=19	GT	0/1
chr6	168355108	168355108	T	-	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	76	chr6	168355107	chr6:168355107	CT	C,CTT	54	PASS	AN=2;DP=76	GT	0/1
chr6	168355108	168355108	-	T	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	76	chr6	168355107	chr6:168355107	CT	C,CTT	54	PASS	AN=2;DP=76	GT	0/1
chr7	4843227	4843227	C	A	exonic	RADIL	.	nonsynonymous SNV	RADIL:NM_018059:exon11:c.G2449T:p.G817C	1.31E-12	0.089137837	0.910862163	.	.	.	0.236922632	68.73083274	3259.52862	10.87748	0.016	0.518	D	0.989	0.637	D	0.584	0.559	P	0.736	0.064	N	1	0.090	N	0.69	0.170	N	3.33	0.062	T	-1.68	0.401	N	0.25	0.305	-1.030	0.203	T	0.019	0.080	T	0.045	0.621	D	4.241	0.568	23.9	0.988	0.468	0.022	0.064	N	c	-0.880	-1.102	0.005	0.108	0.646	0.450	0	-1.01	0.096	-1.559	0.022	-0.823	0.031	0.000	0.063	0.016	0.126	2.796	0.050	.	.	.	0.5	.	206	chr7	4843227	chr7:4843227	C	A	.	PASS	AN=0;DP=206	GT	0/1
chr7	6068175	6068175	A	G	intronic	EIF2AK1	.	.	.	0.000121058	0.997788588	0.002090354	.	0.13551	0.29413	0.356452144	74.62845011	1369.09001	6.94068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	98	chr7	6068175	chr7:6068175	A	G	43	PASS	AN=2;DP=98	GT	0/1
chr7	6470111	6470111	C	A	exonic	DAGLB	.	nonsynonymous SNV	DAGLB:NM_139179:exon6:c.G929T:p.C310F	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	0.032	0.477	D	0.038	0.202	B	0.034	0.212	B	0.000	0.843	N	1	0.810	D	2.855	0.832	M	0.31	0.588	T	-6.27	0.906	D	0.915	0.916	-0.585	0.655	T	0.275	0.647	T	0.076	0.725	D	5.215	0.704	25.6	0.970	0.315	0.960	0.667	D	c	0.311	0.405	1.000	0.747	0.632	0.408	0	4.85	0.622	7.186	0.771	0.932	0.445	1.000	0.715	0.995	0.604	18.316	0.901	Alpha/Beta hydrolase fold	.	.	0.5	.	106	chr7	6470111	chr7:6470111	C	A	.	PASS	AN=0;DP=106	GT	0/1
chr7	11091407	11091407	G	A	exonic	PHF14	.	synonymous SNV	PHF14:NM_014660:exon14:c.G2481A:p.T827T	0.20653924	0.793444436	1.63E-05	.	0.53698	0.10653	-0.532670911	20.78320359	132.45351	2.50445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr7	11091407	chr7:11091407	G	A	.	PASS	AN=0;DP=56	GT	0/1
chr7	19748658	19748658	C	A	UTR5	TWISTNB	NM_001002926:c.-19G>T	.	.	0.309424388	0.672567774	0.018007838	.	0.14338	0.12628	-0.404032746	26.53338051	60.1892	1.57562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	173	chr7	19748658	chr7:19748658	C	A	.	PASS	AN=0;DP=173	GT	0/1
chr7	20784999	20784999	G	A	exonic	ABCB5	.	nonsynonymous SNV	ABCB5:NM_178559:exon17:c.G2032A:p.D678N,ABCB5:NM_001163941:exon26:c.G3367A:p.D1123N	1.17E-23	0.02699293	0.97300707	.	0.14704	0.09307	4.176155702	99.69922151	9731.34505	21.45196	0.049	0.398	D	0.014	0.156	B	0.021	0.205	B	0.238	0.158	N	1.000	0.213	N	1.33	0.334	L	-2.71	0.906	D	-2.7	0.643	D	0.042	0.051	-0.249	0.764	T	0.576	0.847	D	0.015	0.352	T	2.891	0.408	21.8	0.997	0.792	0.780	0.381	D	c	-0.348	-0.280	0.971	0.292	0.666	0.498	0	2.85	0.322	3.426	0.523	0.974	0.594	1.000	0.715	0.949	0.424	8.517	0.322	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	60	chr7	20784999	chr7:20784999	G	A	.	PASS	AN=0;DP=60	GT	0/1
chr7	29771637	29771637	C	A	intergenic	DPY19L2P3;WIPF3	dist=43778;dist=74533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr7	29771637	chr7:29771637	C	A	.	PASS	AN=0;DP=66	GT	0/1
chr7	30795291	30795291	G	T	exonic	INMT	.	nonsynonymous SNV	INMT:NM_001199219:exon3:c.G613T:p.V205L,INMT:NM_006774:exon3:c.G616T:p.V206L	0.000120278	0.385695	0.614184722	.	0.10895	0.11082	1.976952171	97.61146497	4681.43934	13.79634	0.009	0.574	D	0.986	0.596	D	0.874	0.603	P	0.003	0.355	N	0.909	0.364	D	1.91	0.513	L	3.92	0.035	T	-2.07	0.473	N	0.284	0.420	-1.073	0.088	T	0.023	0.100	T	0.002	0.050	T	4.535	0.607	24.3	0.994	0.604	0.773	0.377	D	c	0.333	0.248	1.000	0.747	0.625	0.395	0	2.78	0.316	2.354	0.435	0.857	0.375	1.000	0.715	0.905	0.384	8.857	0.342	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	.	74	chr7	30795291	chr7:30795291	G	T	.	PASS	AN=0;DP=74	GT	0/1
chr7	32861170	32861171	AT	-	intergenic	LINC00997;DPY19L1P2	dist=58634;dist=4743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	51	chr7	32861169	chr7:32861169	CAT	C	92	PASS	AN=2;DP=51	GT	0/1
chr7	44097842	44097842	C	G	exonic	DBNL	.	nonsynonymous SNV	DBNL:NM_001284313:exon5:c.C358G:p.R120G,DBNL:NM_001284315:exon5:c.C382G:p.R128G,DBNL:NM_001014436:exon7:c.C667G:p.R223G,DBNL:NM_001122956:exon7:c.C667G:p.R223G,DBNL:NM_014063:exon7:c.C667G:p.R223G	0.070981914	0.926323701	0.002694385	.	0.20108	0.72014	-0.023789244	52.09365416	77.70496	1.85644	0.015	0.574	D	0.799	0.577	P	0.401	0.585	B	0.001	0.393	N	0.999	0.506	D	3.4	0.918	M	1.8	0.338	T	-3.83	0.790	D	0.238	0.523	-1.076	0.082	T	0.092	0.352	T	0.079	0.733	D	6.393	0.883	29.6	0.996	0.729	0.519	0.288	D	c	-0.122	-0.110	1.000	0.747	0.722	0.854	0	4.05	0.462	-0.098	0.109	0.935	0.490	0.008	0.178	0.996	0.625	7.320	0.255	ADF-H/Gelsolin-like domain|Actin-depolymerising factor homology domain	.	.	0.5	117	118	chr7	44097842	chr7:44097842	C	G	117	PASS	AN=2;DP=118	GT	0/1
chr7	44282825	44282825	G	T	intronic	CAMK2B	.	.	.	0.468620194	0.531370436	9.37E-06	.	0.30429	0.29938	-0.624497208	17.16206653	1301.92267	6.78858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr7	44282825	chr7:44282825	G	T	.	PASS	AN=0;DP=66	GT	0/1
chr7	45956171	45956171	C	T	exonic	IGFBP3	.	synonymous SNV	IGFBP3:NM_000598:exon3:c.G726A:p.K242K,IGFBP3:NM_001013398:exon3:c.G744A:p.K248K	0.362251902	0.586835044	0.050913054	.	0.28872	0.82225	.	.	2102.84042	8.44477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr7	45956171	chr7:45956171	C	T	.	PASS	AN=0;DP=42	GT	0/1
chr7	55242391	55242391	G	C	intronic	EGFR	.	.	.	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	88	chr7	55242391	chr7:55242391	G	C	122	PASS	AN=2;DP=88	GT	1/0
chr7	57069658	57069658	G	T	intergenic	MIR4283-1;ZNF479	dist=46087;dist=117668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr7	57069658	chr7:57069658	G	T	.	PASS	AN=0;DP=112	GT	0/1
chr7	63538100	63538100	A	G	exonic	ZNF727	.	nonsynonymous SNV	ZNF727:NM_001159522:exon4:c.A673G:p.K225E	1.56E-07	0.065227374	0.93477247	.	.	.	2.34827224	98.40764331	260.10396	3.46546	.	.	.	0.001	0.067	B	0.002	0.063	B	.	.	.	0.999	0.212	N	-1.56	0.005	N	.	.	.	.	.	.	0.073	0.062	-0.943	0.422	T	0.014	0.058	T	0.006	0.155	T	-0.057	0.088	2.070	0.755	0.107	0.000	0.002	N	c	-1.104	-1.127	0.001	0.078	0.487	0.133	0	-1.49	0.082	3.387	0.520	-0.892	0.027	1.000	0.715	0.082	0.182	3.985	0.089	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	86	57	chr7	63538100	chr7:63538100	A	G	86	PASS	AN=2;DP=57	GT	0/1
chr7	73530070	73530070	G	T	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	chr7	73530070	chr7:73530070	G	T	.	PASS	AN=0;DP=102	GT	0/1
chr7	75141604	75141604	C	G	ncRNA_intronic	PMS2P3	.	.	.	.	.	.	.	0.17911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	258	chr7	75141604	chr7:75141604	C	G	120	PASS	AN=2;DP=258	GT	0/1
chr7	75684340	75684340	G	T	intronic	MDH2	.	.	.	0.177605136	0.809688717	0.012706147	.	0.32327	0.90548	-0.334253673	30.70299599	208.93323	3.11958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	chr7	75684340	chr7:75684340	G	T	.	PASS	AN=0;DP=65	GT	0/1
chr7	76610356	76610356	C	-	ncRNA_exonic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	770	chr7	76610355	chr7:76610355	AC	A	107	PASS	AN=2;DP=770	GT	0/1
chr7	92765209	92765209	C	T	exonic	SAMD9L	.	nonsynonymous SNV	SAMD9L:NM_001303500:exon4:c.G76A:p.D26N,SAMD9L:NM_001350083:exon4:c.G76A:p.D26N,SAMD9L:NM_001303496:exon5:c.G76A:p.D26N,SAMD9L:NM_001303498:exon5:c.G76A:p.D26N,SAMD9L:NM_001350085:exon5:c.G76A:p.D26N,SAMD9L:NM_152703:exon5:c.G76A:p.D26N,SAMD9L:NM_001303497:exon6:c.G76A:p.D26N,SAMD9L:NM_001350082:exon6:c.G76A:p.D26N,SAMD9L:NM_001350084:exon6:c.G76A:p.D26N	3.80E-10	0.921807367	0.078192632	.	0.12163	0.0905	-0.033100763	50.56027365	662.11912	5.15496	0.142	0.267	T	0.919	0.489	P	0.59	0.486	P	0.011	0.297	N	1	0.090	N	2.015	0.552	M	1.96	0.838	T	-1.06	0.456	N	0.037	0.017	-0.535	0.674	T	0.449	0.784	T	0.055	0.661	D	0.893	0.179	10.04	0.993	0.566	0.026	0.071	N	c	-0.522	-0.646	0.006	0.112	0.707	0.730	0	1.86	0.244	0.045	0.138	-0.041	0.124	0.000	0.063	0.657	0.300	5.984	0.185	Sterile alpha motif domain|Sterile alpha motif/pointed domain	.	.	0.5	.	64	chr7	92765209	chr7:92765209	C	T	.	PASS	AN=0;DP=64	GT	0/1
chr7	100645661	100645661	C	A	exonic	MUC12	.	synonymous SNV	MUC12:NM_001164462:exon2:c.C11817A:p.T3939T	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	474	chr7	100645661	chr7:100645661	C	A	.	PASS	AN=0;DP=474	GT	0/1
chr7	107221265	107221265	A	T	exonic	BCAP29	.	synonymous SNV	BCAP29:NM_001008405:exon1:c.A48T:p.I16I,BCAP29:NM_018844:exon2:c.A48T:p.I16I	0.220058296	0.771634792	0.008306911	.	0.08739	0.08176	0.17280645	65.75843359	329.90016	3.8596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr7	107221265	chr7:107221265	A	T	.	PASS	AN=0;DP=56	GT	0/1
chr7	127326714	127326714	G	A	exonic	SND1	.	synonymous SNV	SND1:NM_014390:exon2:c.G126A:p.G42G	0.999917089	8.29E-05	4.11E-14	.	0.73895	0.12655	-1.063626766	7.484076433	188.34653	2.98065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	chr7	127326714	chr7:127326714	G	A	.	PASS	AN=0;DP=130	GT	0/1
chr7	132174174	132174174	G	T	exonic	PLXNA4	.	synonymous SNV	PLXNA4:NM_001105543:exon3:c.C1248A:p.S416S,PLXNA4:NM_020911:exon3:c.C1248A:p.S416S,PLXNA4:NM_181775:exon4:c.C1248A:p.S416S	0.999999702	2.98E-07	4.57E-20	.	0.16772	0.11298	-0.194946553	39.21325784	462.81286	4.45854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr7	132174174	chr7:132174174	G	T	.	PASS	AN=0;DP=52	GT	0/1
chr7	135614509	135614509	-	T	UTR5;UTR3	LUZP6;MTPN	NM_001128619:c.-2312_-2311insA;NM_145808:c.*164_*165insA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	92	chr7	135614509	chr7:135614509	A	AT	50	PASS	AN=2;DP=92	GT	0/1
chr7	141671685	141671685	A	G	downstream	TAS2R38	dist=746	.	.	0.065390402	0.729870734	0.204738864	.	0.1324	0.10729	1.196071381	92.92285916	1623.12511	7.45029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	81	chr7	141671685	chr7:141671685	A	G	105	PASS	AN=2;DP=81	GT	0/1
chr7	141987184	141987184	C	T	intergenic	TRY2P;MTRNR2L6	dist=15116;dist=386947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	chr7	141987184	chr7:141987184	C	T	.	PASS	AN=0;DP=26	GT	0/1
chr7	142032275	142032275	C	A	intergenic	TRY2P;MTRNR2L6	dist=60207;dist=341856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr7	142032275	chr7:142032275	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr7	142983878	142983878	G	T	exonic	TMEM139	.	nonsynonymous SNV	TMEM139:NM_001282876:exon3:c.G607T:p.D203Y,TMEM139:NM_153345:exon3:c.G607T:p.D203Y,TMEM139:NM_001242773:exon4:c.G607T:p.D203Y,TMEM139:NM_001242775:exon4:c.G607T:p.D203Y,TMEM139:NM_001282877:exon4:c.G607T:p.D203Y,TMEM139:NM_001242774:exon5:c.G607T:p.D203Y	0.018754136	0.731195381	0.250050483	.	0.00814	0.04021	0.703746784	85.42108988	71.67324	1.7618	0.002	0.721	D	0.952	0.522	P	0.785	0.557	P	0.009	0.305	N	1	0.090	N	1.545	0.392	L	.	.	.	-5.56	0.863	D	0.472	0.522	-0.966	0.380	T	0.158	0.491	T	0.003	0.053	T	4.025	0.541	23.6	0.990	0.497	0.206	0.209	N	c	-0.127	-0.328	1.000	0.454	0.625	0.396	0	2.62	0.302	1.672	0.369	0.065	0.171	0.011	0.184	0.020	0.134	6.974	0.237	.	.	.	0.5	.	70	chr7	142983878	chr7:142983878	G	T	.	PASS	AN=0;DP=70	GT	0/1
chr7	148311249	148311249	A	G	exonic	C7orf33	.	nonsynonymous SNV	C7orf33:NM_145304:exon2:c.A320G:p.Q107R	0.000634926	0.49300977	0.506355304	.	0.18666	.	0.681699246	84.93158764	125.57575	2.43933	0.0	0.912	D	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0	0.065	N	.	.	.	-4.0	0.740	D	0.177	0.215	-1.047	0.151	T	0.055	0.232	T	0.002	0.036	T	-1.541	0.016	0.002	0.255	0.012	0.001	0.007	N	c	-1.466	-1.593	0.003	0.100	0.666	0.498	0	-2.16	0.066	-1.070	0.035	-0.163	0.107	0.014	0.188	0.025	0.141	2.832	0.051	.	.	.	0.5	105	58	chr7	148311249	chr7:148311249	A	G	105	PASS	AN=2;DP=58	GT	0/1
chr7	149518641	149518641	G	T	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	chr7	149518641	chr7:149518641	G	T	.	PASS	AN=0;DP=108	GT	0/1
chr7	151878157	151878157	C	A	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon36:c.G6788T:p.G2263V	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.092	0.329	T	0.014	0.156	B	0.011	0.145	B	0.002	0.385	N	0.999	0.459	D	2.32	0.666	M	-1.81	0.840	D	-4.03	0.749	D	0.408	0.466	-0.401	0.720	T	0.405	0.755	T	0.072	0.715	D	1.809	0.278	15.04	0.985	0.420	0.913	0.531	D	c	-0.373	-0.280	0.542	0.212	0.707	0.730	0	2.91	0.328	1.520	0.353	0.870	0.379	1.000	0.715	0.958	0.437	10.289	0.426	.	.	.	0.5	.	63	chr7	151878157	chr7:151878157	C	A	.	PASS	AN=0;DP=63	GT	0/1
chr7	155567837	155567837	G	T	UTR3	RBM33	NM_053043:c.*102G>T	.	.	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	167	chr7	155567837	chr7:155567837	G	T	.	PASS	AN=0;DP=167	GT	0/1
chr8	42176208	42176208	T	-	intronic	IKBKB	.	.	.	0.998786699	0.001213301	5.75E-12	DISEASE: Immunodeficiency 15 (IMD15) [MIM:615592]: An autosomal recessive primary immunodeficiency disorder characterized by onset in infancy of life-threatening bacterial, fungal, and viral infections and failure to thrive. Laboratory studies show hypo- or agammaglobulinemia with relatively normal numbers of B and T- cells, and impaired differentiation and activation of immune cells. {ECO:0000269|PubMed:24369075}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43187	0.81149	-0.754958418	13.57631517	247.23048	3.39162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	76	chr8	42176207	chr8:42176207	CT	C	55	PASS	AN=2;DP=76	GT	0/1
chr8	52321066	52321066	C	T	exonic	PXDNL	.	nonsynonymous SNV	PXDNL:NM_144651:exon17:c.G3118A:p.V1040M	1.94E-27	0.000599486	0.999400514	.	.	.	2.732433216	98.95022411	6585.72871	17.14983	0.004	0.654	D	0.998	0.715	D	0.95	0.671	D	0.000	0.469	D	0.541	0.320	D	2.84	0.828	M	-0.74	0.732	T	-2.12	0.481	N	0.208	0.398	0.565	0.914	D	0.615	0.864	D	0.006	0.165	T	4.884	0.656	24.9	0.997	0.809	0.111	0.162	N	c	0.087	-0.190	0.475	0.207	0.646	0.450	0	3.82	0.430	0.328	0.193	0.700	0.299	0.001	0.137	0.001	0.043	13.168	0.588	.	.	.	0.5	.	39	chr8	52321066	chr8:52321066	C	T	.	PASS	AN=0;DP=39	GT	0/1
chr8	65494784	65494784	G	C	UTR3	BHLHE22	NM_152414:c.*291G>C	.	.	0.677980337	0.301773469	0.020246194	.	0.83732	0.19325	.	.	465.53138	4.46972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	81	chr8	65494784	chr8:65494784	G	C	62	PASS	AN=2;DP=81	GT	0/1
chr8	70667786	70667786	C	G	exonic	SLCO5A1	.	nonsynonymous SNV	SLCO5A1:NM_001146008:exon3:c.G1131C:p.K377N,SLCO5A1:NM_001146009:exon3:c.G1131C:p.K377N,SLCO5A1:NM_030958:exon4:c.G1131C:p.K377N	1.52E-05	0.962450752	0.03753401	.	0.44543	0.10196	0.516238257	80.33734371	3042.61323	10.48038	0.024	0.555	D	0.995	0.715	D	0.945	0.682	D	0.066	0.022	N	0.999	0.451	D	1.945	0.524	M	1.05	0.400	T	-1.96	0.454	N	0.236	0.289	-0.980	0.351	T	0.256	0.627	T	0.008	0.217	T	4.603	0.617	24.4	0.999	0.942	0.958	0.660	D	c	0.404	0.417	1.000	0.409	0.563	0.310	0	4.49	0.540	3.851	0.554	0.935	0.490	1.000	0.715	1.000	0.888	10.16	0.418	Major facilitator superfamily domain	.	.	0.5	76	105	chr8	70667786	chr8:70667786	C	G	76	PASS	AN=2;DP=105	GT	0/1
chr8	77765437	77765437	C	A	exonic	ZFHX4	.	nonsynonymous SNV	ZFHX4:NM_024721:exon10:c.C6280A:p.Q2094K	0.999999642	3.58E-07	1.44E-20	.	0.92237	0.08897	-1.737130259	2.435715971	2869.66786	10.14403	0.017	0.512	D	0.924	0.524	P	0.857	0.650	P	0.001	0.421	U	1	0.810	D	1.2	0.304	L	0.63	0.531	T	-2.51	0.545	D	0.382	0.442	-0.781	0.562	T	0.191	0.543	T	0.025	0.481	T	4.580	0.613	24.4	0.951	0.256	0.961	0.674	D	c	0.386	0.361	1.0	0.983	0.554	0.246	0	3.76	0.422	4.724	0.614	0.932	0.445	1.000	0.715	0.130	0.199	14.640	0.682	Homeobox domain|Homeodomain-like	.	.	0.5	.	125	chr8	77765437	chr8:77765437	C	A	.	PASS	AN=0;DP=125	GT	0/1
chr8	92365183	92365183	C	A	exonic	SLC26A7	.	synonymous SNV	SLC26A7:NM_001282357:exon11:c.C370A:p.R124R,SLC26A7:NM_052832:exon11:c.C1273A:p.R425R,SLC26A7:NM_134266:exon11:c.C1273A:p.R425R,SLC26A7:NM_001282356:exon12:c.C1273A:p.R425R	3.32E-08	0.923716211	0.076283756	.	0.50174	0.12722	0.112125503	62.09601321	242.55786	3.36166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr8	92365183	chr8:92365183	C	A	.	PASS	AN=0;DP=55	GT	0/1
chr8	101730036	101730036	-	C	exonic	PABPC1	.	frameshift insertion	PABPC1:NM_002568:exon3:c.467_468insG:p.M158Nfs*7	0.999692443	0.000307557	1.21E-10	.	0.49883	0.4528	-0.383807564	27.41802312	3992.89486	12.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	48	chr8	101730036	chr8:101730036	T	TC	63	PASS	AN=2;DP=48	GT	0/1
chr8	103317396	103317396	C	G	exonic	UBR5	.	nonsynonymous SNV	UBR5:NM_001282873:exon21:c.G2744C:p.R915T,UBR5:NM_015902:exon21:c.G2744C:p.R915T	1	4.65E-20	3.53E-49	.	0.81886	0.14055	-2.918150067	0.572068884	77.52713	1.85304	0.003	0.682	D	0.967	0.544	D	0.879	0.606	P	0.000	0.843	D	1	0.810	D	2.455	0.715	M	0.82	0.481	T	-4.51	0.782	D	0.867	0.917	-0.585	0.654	T	0.248	0.618	T	0.110	0.788	D	6.052	0.833	28.0	0.985	0.412	0.993	0.945	D	c	0.647	0.648	1.000	0.747	0.707	0.730	0	5.03	0.669	7.905	0.864	0.892	0.403	1.000	0.715	1.000	0.888	18.373	0.903	.	.	.	0.5	84	83	chr8	103317396	chr8:103317396	C	G	84	PASS	AN=2;DP=83	GT	0/1
chr8	106573525	106573525	A	-	intronic	ZFPM2	.	.	.	0.999955694	4.43E-05	5.33E-12	DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:14517948, ECO:0000269|PubMed:20807224}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Diaphragmatic hernia 3 (DIH3) [MIM:610187]: Form of congenital diaphragmatic hernia (CDH). CDH refers to a group of congenital defects in the structural integrity of the diaphragm associated with often lethal pulmonary hypoplasia and pulmonary hypertension. {ECO:0000269|PubMed:16103912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 9 (SRXY9) [MIM:616067]: A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females or have ambiguous external genitalia. {ECO:0000269|PubMed:24549039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269|PubMed:20807224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5623	0.26433	0.519883383	80.37272942	1899.90602	8.01507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	27	chr8	106573524	chr8:106573524	CA	C	84	PASS	AN=2;DP=27	GT	0/1
chr8	113871300	113871300	G	A	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr8	113871300	chr8:113871300	G	A	.	PASS	AN=0;DP=39	GT	0/1
chr8	120818427	120818427	G	C	intronic	TAF2	.	.	.	0.56608706	0.433912904	3.61E-08	.	0.41383	0.119	-0.042196577	50.49539986	1043.41092	6.19966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	54	chr8	120818427	chr8:120818427	G	C	46	PASS	AN=2;DP=54	GT	0/1
chr8	128428591	128428591	G	A	exonic	POU5F1B	.	synonymous SNV	POU5F1B:NM_001159542:exon1:c.G480A:p.L160L	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	chr8	128428591	chr8:128428591	G	A	.	PASS	AN=0;DP=84	GT	0/1
chr8	139145002	139145002	G	T	exonic	FAM135B	.	nonsynonymous SNV	FAM135B:NM_015912:exon20:c.C4055A:p.P1352H	0.999998682	1.32E-06	2.06E-16	.	0.08052	0.09691	-1.425829947	4.051663128	148.31692	2.65323	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	2.85	0.831	M	2.3	0.170	T	-8.44	0.972	D	0.811	0.800	-0.912	0.466	T	0.145	0.469	T	0.051	0.647	D	6.407	0.884	29.6	0.997	0.789	0.993	0.943	D	c	0.971	0.946	1.000	0.747	0.487	0.133	0	5.74	0.900	9.754	0.981	1.048	0.713	1.000	0.715	0.996	0.625	18.906	0.924	.	.	.	0.5	.	46	chr8	139145002	chr8:139145002	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr8	144774499	144774499	A	G	exonic	ZNF707	.	synonymous SNV	ZNF707:NM_001288807:exon5:c.A36G:p.L12L	0.012770085	0.857656122	0.129573793	.	0.17147	0.10299	0.264628794	70.5178108	77.30133	1.84692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	475	chr8	144774499	chr8:144774499	A	G	139	PASS	AN=2;DP=475	GT	0/1
chr9	15433520	15433520	-	T	intronic	SNAPC3	.	.	.	5.54E-05	0.883341296	0.116603314	.	0.17643	0.10767	-0.069700724	48.54328851	386.09549	4.13838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	27	chr9	15433520	chr9:15433520	A	AT	50	PASS	AN=2;DP=27	GT	0/1
chr9	18706829	18706829	G	T	exonic	ADAMTSL1	.	synonymous SNV	ADAMTSL1:NM_001040272:exon14:c.G1659T:p.L553L	8.83E-05	0.999911689	4.59E-08	.	.	.	-0.860112269	10.89879689	3092.36494	10.5706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	chr9	18706829	chr9:18706829	G	T	.	PASS	AN=0;DP=62	GT	0/1
chr9	19350926	19350926	-	T	intronic	DENND4C	.	.	.	0.406967594	0.593032405	1.03E-09	.	0.38649	.	-0.957327604	9.017456947	1816.18274	7.85903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	28	chr9	19350926	chr9:19350926	C	CT	50	PASS	AN=2;DP=28	GT	0/1
chr9	36058803	36058803	T	-	intronic	RECK	.	.	.	0.000196798	0.999760397	4.28E-05	.	0.37337	0.19959	-0.951568548	9.271054494	1398.34528	6.99259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	61	chr9	36058802	chr9:36058802	CT	C	54	PASS	AN=2;DP=61	GT	0/1
chr9	37708421	37708421	C	-	exonic	FRMPD1	.	frameshift deletion	FRMPD1:NM_014907:exon4:c.285delC:p.P96Lfs*7	3.53E-10	0.995711787	0.004288213	.	0.15661	0.09359	1.70862952	96.44373673	4200.93656	12.88726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	15	chr9	37708420	chr9:37708420	TC	T	95	PASS	AN=2;DP=15	GT	1/0
chr9	101052938	101052938	G	A	exonic	GABBR2	.	synonymous SNV	GABBR2:NM_005458:exon19:c.C2754T:p.C918C	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	chr9	101052938	chr9:101052938	G	A	.	PASS	AN=0;DP=100	GT	0/1
chr9	136103948	136103948	T	C	intergenic	OBP2B;ABO	dist=19311;dist=26615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	chr9	136103948	chr9:136103948	T	C	.	PASS	AN=0;DP=137	GT	0/1
chr9	140177108	140177108	G	A	downstream	TOR4A	dist=15	.	.	0.215534136	0.647904223	0.136561641	.	0.09004	0.12134	.	.	186.39911	2.9648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr9	140177108	chr9:140177108	G	A	.	PASS	AN=0;DP=51	GT	0/1
chr9	140396079	140396079	C	-	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	433	chr9	140396078	chr9:140396078	GC	G	101	PASS	AN=2;DP=433	GT	0/1
chr10	18430127	18430127	C	A	exonic	CACNB2	.	nonsynonymous SNV	CACNB2:NM_001167945:exon1:c.C19A:p.L7M,CACNB2:NM_201571:exon1:c.C19A:p.L7M,CACNB2:NM_201572:exon1:c.C19A:p.L7M	0.001820338	0.997139378	0.001040285	DISEASE: Brugada syndrome 4 (BRGDA4) [MIM:611876]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18213	0.15589	-0.705410796	14.77942911	766.55161	5.48442	0.141	0.330	T	0.742	0.442	P	0.047	0.293	B	.	.	.	1.000	0.516	D	.	.	.	-1.74	0.836	D	0.49	0.031	N	0.096	0.100	-0.844	0.524	T	0.163	0.500	T	0.098	0.770	D	2.148	0.319	17.17	0.967	0.301	0.340	0.247	N	c	-0.354	-0.239	1.000	0.405	0.598	0.340	0	2.63	0.303	1.396	0.339	0.739	0.307	1.000	0.715	1.000	0.888	6.157	0.194	.	.	.	0.5	.	59	chr10	18430127	chr10:18430127	C	A	.	PASS	AN=0;DP=59	GT	0/1
chr10	21803522	21803522	A	G	UTR3	SKIDA1	NM_207371:c.*503T>C	.	.	.	.	.	.	0.891	.	.	.	438.2434	4.36472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	277	chr10	21803522	chr10:21803522	A	G	134	PASS	AN=2;DP=277	GT	0/1
chr10	27054256	27054256	A	-	intronic	ABI1	.	.	.	0.632775183	0.367164391	6.04E-05	DISEASE: Note=A chromosomal aberration involving ABI1 is a cause of acute leukemias. Translocation t(10;11)(p11.2;q23) with KMT2A/MLL1. ABI1 isoform 2 was found to be present in acute leukemia KMT2A/MLL1-ABI1 fusion transcript. {ECO:0000269|PubMed:9694699}.; 	0.52357	0.29688	-0.315847836	31.68789809	53.85297	1.46346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	128	chr10	27054255	chr10:27054255	GA	G	73	PASS	AN=2;DP=128	GT	0/1
chr10	37442560	37442560	G	A	exonic	ANKRD30A	.	nonsynonymous SNV	ANKRD30A:NM_052997:exon13:c.G1600A:p.E534K	1.26E-23	0.003987679	0.996012321	.	0.05405	.	2.702925512	98.90304317	3097.8543	10.58328	0.0	0.912	D	0.963	0.537	D	0.424	0.434	B	.	.	.	1	0.090	N	0.695	0.181	N	3.4	0.057	T	-0.76	0.295	N	0.111	0.120	-0.965	0.381	T	0.014	0.058	T	0.001	0.014	T	2.209	0.327	17.57	0.989	0.471	0.017	0.054	N	c	-0.569	-0.769	0.060	0.152	0.487	0.133	0	1.47	0.217	1.040	0.297	0.636	0.291	0.041	0.208	0.006	0.095	6.435	0.209	.	.	.	0.5	.	77	chr10	37442560	chr10:37442560	G	A	.	PASS	AN=0;DP=77	GT	0/1
chr10	61549576	61549576	C	A	UTR3	CCDC6	NM_005436:c.*3099G>T	.	.	0.967799856	0.03219801	2.13E-06	DISEASE: Note=A chromosomal aberration involving CCDC6 is found in papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.; 	0.4367	0.16675	-0.137658575	43.57159707	4670.49647	13.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	chr10	61549576	chr10:61549576	C	A	.	PASS	AN=0;DP=76	GT	0/1
chr10	70450718	70450718	A	T	exonic	TET1	.	nonsynonymous SNV	TET1:NM_030625:exon12:c.A5558T:p.K1853M	0.999563278	0.000436722	9.65E-14	DISEASE: Note=A chromosomal aberration involving TET1 may be a cause of acute leukemias (PubMed:12646957). Translocation t(10;11)(q22;q23) with KMT2A/MLL1. This is a rare chromosomal translocation 5' KMT2A/MLL1-TET1 3' (PubMed:12124344, PubMed:12646957). {ECO:0000269|PubMed:12124344, ECO:0000269|PubMed:12646957}.; 	0.67616	0.10932	0.398551838	76.31516867	4993.56015	14.43135	0.002	0.721	D	0.997	0.689	D	0.911	0.630	D	0.000	0.005	N	1	0.090	N	2.175	0.612	M	3.11	0.082	T	-0.66	0.191	N	0.371	0.432	-1.094	0.049	T	0.060	0.252	T	0.008	0.217	T	3.872	0.522	23.5	0.990	0.497	0.225	0.216	N	c	-0.085	-0.272	0.033	0.141	0.672	0.522	0	2.78	0.316	1.406	0.340	1.199	0.960	0.014	0.188	0.016	0.126	7.701	0.276	2OGFeDO domain, nucleic acid-modifying type	.	.	0.5	.	52	chr10	70450718	chr10:70450718	A	T	.	PASS	AN=0;DP=52	GT	0/1
chr10	75053203	75053203	T	-	intronic	CFAP70	.	.	.	.	.	.	.	0.108	.	0.293954043	71.62066525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	25	chr10	75053202	chr10:75053202	GT	G	92	PASS	AN=2;DP=25	GT	0/1
chr10	81667395	81667398	TTTG	-	ncRNA_intronic	BMS1P21	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	41	chr10	81667394	chr10:81667394	TTTTG	T	50	PASS	AN=2;DP=41	GT	0/1
chr10	92656136	92656136	G	T	exonic	RPP30	.	synonymous SNV	RPP30:NM_001104546:exon10:c.G684T:p.A228A,RPP30:NM_006413:exon10:c.G684T:p.A228A	2.35E-05	0.912665745	0.08731072	.	0.25392	0.24934	0.106667882	61.73036093	95.28898	2.10698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	chr10	92656136	chr10:92656136	G	T	.	PASS	AN=0;DP=70	GT	0/1
chr10	96073026	96073026	G	C	exonic	PLCE1	.	nonsynonymous SNV	PLCE1:NM_001165979:exon27:c.G5095C:p.E1699Q,PLCE1:NM_001288989:exon28:c.G5971C:p.E1991Q,PLCE1:NM_016341:exon28:c.G6019C:p.E2007Q	0.204555596	0.795444404	7.85E-14	DISEASE: Nephrotic syndrome 3 (NPHS3) [MIM:610725]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. Most patients with NPHS3 show diffuse mesangial sclerosis on renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes, thickened basement membranes, and diminished patency of the capillary lumen. {ECO:0000269|PubMed:17086182}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08183	0.11603	0.356282176	74.58716678	11765.49279	23.41934	0.102	0.308	T	0.998	0.764	D	0.991	0.832	D	0.000	0.843	D	1.000	0.588	D	2.515	0.735	M	1.73	0.264	T	-0.85	0.258	N	0.61	0.640	-0.993	0.320	T	0.153	0.482	T	0.010	0.263	T	5.366	0.727	25.9	0.998	0.922	0.997	0.991	D	c	0.820	0.828	1.000	0.747	0.554	0.246	0	5.6	0.849	9.659	0.979	1.048	0.713	1.000	0.715	0.999	0.750	19.238	0.938	Ubiquitin-related domain	.	.	0.5	71	79	chr10	96073026	chr10:96073026	G	C	71	PASS	AN=2;DP=79	GT	0/1
chr10	99126522	99126524	CTC	-	exonic	RRP12	.	nonframeshift deletion	RRP12:NM_001284337:exon24:c.2890_2892del:p.E964del,RRP12:NM_001145114:exon25:c.3007_3009del:p.E1003del,RRP12:NM_015179:exon27:c.3190_3192del:p.E1064del	4.36E-06	0.999994938	6.97E-07	.	0.36713	0.09995	-0.981182694	8.657702288	7215.81402	18.30427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	276	chr10	99126521	chr10:99126521	GCTC	G	115	PASS	AN=2;DP=276	GT	0/1
chr10	104162673	104162673	A	-	UTR3	PSD	NM_001270966:c.*284delT;NM_001270965:c.*284delT;NM_002779:c.*284delT	.	.	0.987334022	0.012665969	8.75E-09	.	0.11541	0.10253	-1.322782544	4.759377212	234.01091	3.30663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	383	chr10	104162672	chr10:104162672	CA	C,CAA	70	PASS	AN=2;DP=383	GT	0/1
chr10	104162673	104162673	-	A	UTR3	PSD	NM_001270966:c.*283_*284insT;NM_001270965:c.*283_*284insT;NM_002779:c.*283_*284insT	.	.	0.987334022	0.012665969	8.75E-09	.	0.11541	0.10253	-1.322782544	4.759377212	234.01091	3.30663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	383	chr10	104162672	chr10:104162672	CA	C,CAA	70	PASS	AN=2;DP=383	GT	0/1
chr10	112840278	112840278	G	C	UTR3	ADRA2A	NM_000681:c.*1126G>C	.	.	.	.	.	.	0.18963	0.11371	.	.	204.06999	3.08511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	134	chr10	112840278	chr10:112840278	G	C	109	PASS	AN=2;DP=134	GT	0/1
chr10	118936242	118936242	T	C	intergenic	MIR3663HG;KCNK18	dist=7676;dist=20758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	175	chr10	118936242	chr10:118936242	T	C	43	PASS	AN=2;DP=175	GT	0/1
chr10	124640270	124640270	G	T	ncRNA_exonic	LOC399815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	chr10	124640270	chr10:124640270	G	T	.	PASS	AN=0;DP=71	GT	0/1
chr10	124802598	124802598	G	A	exonic	ACADSB	.	nonsynonymous SNV	ACADSB:NM_001330174:exon5:c.G412A:p.D138N,ACADSB:NM_001609:exon6:c.G718A:p.D240N	2.99E-08	0.301001539	0.698998431	.	0.50662	0.27521	-0.402212257	26.7338995	1017.15986	6.13626	0.194	0.258	T	0.001	0.067	B	0.003	0.080	B	0.000	0.481	N	1.000	0.588	D	2	0.545	M	-5.35	0.990	D	-2.59	0.574	D	0.061	0.045	0.805	0.945	D	0.897	0.966	D	0.075	0.722	D	3.099	0.432	22.5	0.997	0.835	0.876	0.468	D	c	-0.213	-0.070	1.000	0.517	0.706	0.609	0	4.72	0.591	3.285	0.512	1.030	0.653	0.976	0.346	0.436	0.260	10.917	0.462	Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain|Acyl-CoA oxidase/dehydrogenase, central domain;Acyl-CoA dehydrogenase/oxidase, N-terminal|Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain	.	.	0.5	.	49	chr10	124802598	chr10:124802598	G	A	.	PASS	AN=0;DP=49	GT	0/1
chr11	281553	281555	GAG	-	exonic	NLRP6	.	nonframeshift deletion	NLRP6:NM_001276700:exon4:c.1819_1821del:p.E611del,NLRP6:NM_138329:exon4:c.1819_1821del:p.E611del	.	.	.	.	0.13321	0.11045	1.271321208	93.65416372	1076.87015	6.29039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	60	chr11	281552	chr11:281552	AGAG	A	43	PASS	AN=2;DP=60	GT	0/1
chr11	2877402	2877402	T	-	ncRNA_intronic	KCNQ1-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.11	61	chr11	2877401	chr11:2877401	CT	C	10.11	PASS	AN=0;DP=61	GT	0/1
chr11	3047792	3047792	T	C	intronic	CARS	.	.	.	2.96E-06	0.999273135	0.000723902	DISEASE: Note=A chromosomal aberration involving CARS is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with ALK.; 	0.17352	0.23298	-0.394936437	27.02878037	1461.59792	7.13029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr11	3047792	chr11:3047792	T	C	.	PASS	AN=0;DP=93	GT	0/1
chr11	5878874	5878874	A	T	exonic	OR52E8	.	nonsynonymous SNV	OR52E8:NM_001005168:exon1:c.T59A:p.L20Q	0.016692038	0.709059944	0.274248018	.	0.14356	.	1.0858272	91.82000472	1046.46948	6.208	0.0	0.912	D	1.0	0.899	D	0.997	0.850	D	0.001	0.436	D	1	0.810	D	4.4	0.987	H	6.57	0.006	T	-5.25	0.840	D	0.79	0.780	-0.971	0.370	T	0.015	0.060	T	0.019	0.414	T	3.432	0.471	23.0	0.992	0.556	0.150	0.185	N	c	0.363	0.070	0.364	0.198	0.487	0.133	0	4.87	0.627	4.105	0.573	1.059	0.766	0.284	0.250	0.014	0.122	13.577	0.612	.	.	.	0.5	.	25	chr11	5878874	chr11:5878874	A	T	.	PASS	AN=0;DP=25	GT	0/1
chr11	5922816	5922816	C	A	intergenic	OR52E4;OR56A3	dist=16355;dist=45761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.618	0.256	13.95	0.693	0.086	0.085	0.143	N	n	0.674	-0.081	0.000	0.012	0.061	0.009	0	-2.6	0.058	-2.263	0.012	0.059	0.165	0.000	0.063	0.970	0.461	11.902	0.518	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	35	chr11	5922816	chr11:5922816	C	A	.	PASS	AN=0;DP=35	GT	0/1
chr11	10529781	10529781	A	G	UTR5	MTRNR2L8	NM_001190702:c.-8T>C	.	.	.	.	.	.	.	.	.	.	1.89325	0.05902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	197	chr11	10529781	chr11:10529781	A	G	80	PASS	AN=2;DP=197	GT	0/1
chr11	18291388	18291388	C	T	exonic	SAA1	.	nonsynonymous SNV	SAA1:NM_000331:exon4:c.C355T:p.P119S,SAA1:NM_199161:exon4:c.C355T:p.P119S,SAA1:NM_001178006:exon5:c.C355T:p.P119S	0.181814611	0.765265056	0.052920333	DISEASE: Note=Reactive, secondary amyloidosis is characterized by the extracellular accumulation in various tissues of the SAA1 protein. These deposits are highly insoluble and resistant to proteolysis; they disrupt tissue structure and compromise function. {ECO:0000269|PubMed:1463770}.; DISEASE: Note=Elevated serum SAA1 protein levels may be associated with lung cancer. {ECO:0000269|PubMed:1463770}.; 	0.07473	0.51812	0.103030231	61.2762444	286.88113	3.62775	0.05	0.395	D	0.999	0.764	D	0.996	0.832	D	0.000	0.477	D	0.997	0.437	D	2.925	0.847	M	2.78	0.113	T	-5.76	0.878	D	0.536	0.591	-0.884	0.495	T	0.107	0.390	T	0.004	0.093	T	5.605	0.763	26.5	0.998	0.926	0.843	0.431	D	c	0.630	0.481	1.000	0.517	0.581	0.326	0	3.55	0.396	3.416	0.522	0.932	0.445	1.000	0.715	0.989	0.536	12.917	0.574	.	.	.	0.5	.	97	chr11	18291388	chr11:18291388	C	T	.	PASS	AN=0;DP=97	GT	0/1
chr11	32976854	32976854	A	T	exonic	QSER1	.	nonsynonymous SNV	QSER1:NM_001076786:exon6:c.A4126T:p.T1376S	0.999935659	6.43E-05	1.10E-13	.	0.56585	0.09696	-0.231522913	36.36470866	711.28789	5.29998	0.117	0.303	T	0.041	0.200	B	0.016	0.166	B	0.122	0.190	N	0.982	0.250	N	1.95	0.526	M	2.11	0.255	T	-2.24	0.506	N	0.048	0.181	-1.041	0.171	T	0.046	0.196	T	0.005	0.114	T	1.775	0.274	14.84	0.970	0.314	0.942	0.601	D	c	-0.302	-0.185	0.000	0.070	0.732	0.924	0	1.53	0.221	3.408	0.522	1.140	0.893	1.000	0.715	1.000	0.888	5.019	0.136	.	.	.	0.5	.	40	chr11	32976854	chr11:32976854	A	T	.	PASS	AN=0;DP=40	GT	0/1
chr11	43348195	43348195	G	C	intronic	API5	.	.	.	0.999555019	0.000444981	2.98E-10	.	0.73412	0.11262	-0.339715008	30.06605331	24.0593	0.7911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	45	chr11	43348195	chr11:43348195	G	C	69	PASS	AN=2;DP=45	GT	0/1
chr11	45275989	45275989	A	T	intronic	SYT13	.	.	.	0.220165779	0.771535728	0.008298494	.	0.15386	0.125	-0.534490515	20.70063694	43.04749	1.24539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr11	45275989	chr11:45275989	A	T	.	PASS	AN=0;DP=35	GT	0/1
chr11	46539113	46539113	A	G	intronic	AMBRA1	.	.	.	0.999971641	2.84E-05	7.36E-14	.	0.36907	0.10363	-0.971800989	8.946685539	137.80881	2.55655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	155	chr11	46539113	chr11:46539113	A	G	62	PASS	AN=2;DP=155	GT	0/1
chr11	47270359	47270359	A	G	exonic	NR1H3	.	nonsynonymous SNV	NR1H3:NM_001251934:exon2:c.A5G:p.Q2R,NR1H3:NM_001251935:exon2:c.A5G:p.Q2R	0.856185983	0.143716688	9.73E-05	.	0.95723	0.54243	-0.646543901	16.44255721	37.64316	1.1206	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	0.855	0.284	N	.	.	.	.	.	.	.	.	.	0.058	0.041	.	.	.	.	.	.	.	.	.	0.826	0.173	9.625	0.648	0.074	0.004	0.019	N	n	0.972	3.363	1.0	0.983	0.047	0.003	1	-5.76	0.022	-0.697	0.052	-0.259	0.088	0.000	0.063	0.007	0.100	0.579	0.007	.	.	.	0.5	.	255	chr11	47270359	chr11:47270359	A	G	.	PASS	AN=0;DP=255	GT	0/1
chr11	49071098	49071098	C	A	intergenic	TRIM49B;TRIM64C	dist=11569;dist=4168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	chr11	49071098	chr11:49071098	C	A	.	PASS	AN=0;DP=118	GT	0/1
chr11	49214450	49214450	G	A	intronic	FOLH1	.	.	.	0.253396885	0.746592621	1.05E-05	.	0.15752	0.43198	1.332002318	94.20853975	2268.34509	8.81053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr11	49214450	chr11:49214450	G	A	.	PASS	AN=0;DP=39	GT	0/1
chr11	60531157	60531157	A	C	intronic	MS4A15	.	.	.	0.038468197	0.837478034	0.124053769	.	0.11624	.	0.705562627	85.52724699	3456.33473	11.29059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	35	chr11	60531157	chr11:60531157	A	C	87	PASS	AN=2;DP=35	GT	0/1
chr11	63886067	63886067	T	-	UTR3	FLRT1	NM_013280:c.*303delT	.	.	0.546319767	0.439707278	0.013972956	.	0.06239	0.11168	-0.705410796	14.77942911	67.31626	1.6983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	76	chr11	63886066	chr11:63886066	GT	G	79	PASS	AN=2;DP=76	GT	0/1
chr11	66249674	66249674	G	T	exonic	DPP3	.	nonsynonymous SNV	DPP3:NM_001256670:exon2:c.G3T:p.M1I,DPP3:NM_005700:exon2:c.G3T:p.M1I,DPP3:NM_130443:exon2:c.G3T:p.M1I	4.36E-09	0.939852021	0.060147975	.	.	0.29988	0.874458024	88.88888889	4443.48457	13.35156	0.034	0.538	D	0.225	0.342	B	0.047	0.264	B	0.000	0.843	D	1	0.810	D	.	.	.	1.98	0.433	T	-1.86	0.452	N	0.944	0.939	-1.010	0.269	T	0.093	0.355	T	0.050	0.642	D	4.266	0.571	23.9	0.996	0.722	0.995	0.970	D	c	0.323	0.476	1.000	0.747	0.742	0.980	0	5.71	0.890	7.961	0.874	0.948	0.535	1.000	0.715	1.000	0.888	15.355	0.740	.	.	.	0.5	.	98	chr11	66249674	chr11:66249674	G	T	.	PASS	AN=0;DP=98	GT	0/1
chr11	78423572	78423572	C	T	exonic	TENM4	.	nonsynonymous SNV	TENM4:NM_001098816:exon26:c.G4009A:p.G1337R	0.999718776	0.000281224	3.30E-14	.	0.59536	.	-1.696530647	2.589054022	1180.19147	6.52237	0.0	0.912	D	0.84	0.445	P	0.171	0.337	B	0.000	0.843	D	1	0.810	D	3.61	0.940	H	-4.07	0.966	D	-6.86	0.931	D	0.9	0.891	1.017	0.975	D	0.892	0.964	D	0.418	0.938	D	7.590	0.953	34	0.999	0.984	0.981	0.795	D	c	0.648	0.662	1.000	0.747	0.554	0.283	0	5.19	0.713	7.905	0.864	0.935	0.490	1.000	0.715	0.999	0.750	18.895	0.924	Six-bladed beta-propeller, TolB-like	.	.	0.5	.	105	chr11	78423572	chr11:78423572	C	T	.	PASS	AN=0;DP=105	GT	0/1
chr11	90017138	90017138	A	T	ncRNA_intronic	DISC1FP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	chr11	90017138	chr11:90017138	A	T	.	PASS	AN=0;DP=83	GT	0/1
chr11	100211936	100211936	A	G	exonic	CNTN5	.	nonsynonymous SNV	CNTN5:NM_175566:exon20:c.A2807G:p.K936R,CNTN5:NM_001243270:exon22:c.A3029G:p.K1010R,CNTN5:NM_014361:exon23:c.A3029G:p.K1010R	0.001354061	0.998643262	2.68E-06	.	0.29361	0.20972	-0.080831688	47.22222222	849.40801	5.69596	0.038	0.427	D	0.986	0.609	D	0.689	0.600	P	0.000	0.843	D	1.000	0.548	D	2.16	0.606	M	0.73	0.507	T	-1.83	0.429	N	0.602	0.670	-0.617	0.641	T	0.255	0.626	T	0.026	0.488	D	4.222	0.566	23.9	0.999	0.941	0.920	0.544	D	c	0.629	0.611	0.998	0.360	0.487	0.133	0	5.46	0.799	6.232	0.721	1.199	0.960	1.000	0.715	0.985	0.512	14.709	0.687	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	51	chr11	100211936	chr11:100211936	A	G	.	PASS	AN=0;DP=51	GT	0/1
chr11	107326435	107326435	C	G	exonic	CWF19L2	.	nonsynonymous SNV	CWF19L2:NM_152434:exon2:c.G173C:p.W58S	9.65E-09	0.500135179	0.499864811	.	0.17764	0.09681	0.626470967	83.55154518	3527.13215	11.45817	0.007	0.599	D	0.995	0.657	D	0.904	0.624	P	.	.	.	1.000	0.588	D	3.15	0.886	M	2.01	0.213	T	-7.78	0.959	D	0.6	0.651	-0.890	0.489	T	0.135	0.450	T	0.022	0.449	T	6.408	0.885	29.6	0.989	0.476	0.815	0.406	D	c	0.703	0.658	1.000	0.434	0.732	0.924	0	4.43	0.528	3.965	0.562	0.876	0.383	1.000	0.715	0.998	0.697	13.303	0.596	.	.	.	0.5	84	69	chr11	107326435	chr11:107326435	C	G	84	PASS	AN=2;DP=69	GT	0/1
chr11	128993822	128993822	G	T	intronic	ARHGAP32	.	.	.	0.98708852	0.01291148	3.11E-12	.	.	.	-2.151949495	1.450813871	693.40551	5.2506	0.308	0.141	T	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	1.26	0.363	T	-0.64	0.187	N	0.104	0.109	-0.892	0.488	T	0.168	0.508	T	.	.	.	2.643	0.379	20.5	0.913	0.200	0.878	0.472	D	c	0.447	0.541	0.992	0.326	0.638	0.428	0	5.93	0.959	3.281	0.511	1.048	0.713	1.000	0.715	0.997	0.653	12.787	0.567	.	.	.	0.5	.	40	chr11	128993822	chr11:128993822	G	T	.	PASS	AN=0;DP=40	GT	0/1
chr12	6438271	6438271	C	T	UTR3	TNFRSF1A	NM_001065:c.*207G>A;NM_001346092:c.*207G>A;NM_001346091:c.*207G>A	.	.	0.985476047	0.014516656	7.30E-06	DISEASE: Familial hibernian fever (FHF) [MIM:142680]: A hereditary periodic fever syndrome characterized by recurrent fever, abdominal pain, localized tender skin lesions and myalgia. Reactive amyloidosis is the main complication and occurs in 25% of cases. {ECO:0000269|PubMed:10199409, ECO:0000269|PubMed:10902757, ECO:0000269|PubMed:11443543, ECO:0000269|PubMed:13130484, ECO:0000269|PubMed:14610673}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis 5 (MS5) [MIM:614810]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:22801493}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. An intronic mutation affecting alternative splicing and skipping of exon 6 directs increased expression of isoform 4 a transcript encoding a C-terminally truncated protein which is secreted and may function as a TNF antagonist.; 	0.51029	0.91592	0.084621747	60.31493277	154.52417	2.71793	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr12	6438271	chr12:6438271	C	T	.	PASS	AN=0;DP=69	GT	0/1
chr12	15702158	15702158	T	A	exonic	PTPRO	.	nonsynonymous SNV	PTPRO:NM_030668:exon2:c.T2A:p.M1K,PTPRO:NM_030669:exon2:c.T2A:p.M1K,PTPRO:NM_030670:exon2:c.T2A:p.M1K,PTPRO:NM_030671:exon2:c.T2A:p.M1K,PTPRO:NM_002848:exon14:c.T2435A:p.M812K,PTPRO:NM_030667:exon14:c.T2435A:p.M812K	0.30462609	0.695373854	5.61E-08	DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. {ECO:0000269|PubMed:21722858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57353	.	-1.965936983	1.828261382	172.96294	2.86316	0.008	0.912	D	0.118	0.392	B	0.01	0.331	B	0.000	0.629	D	0.759	0.367	D	1.5	0.380	L	3.86	0.041	T	-1.22	0.543	N	0.809	0.798	-0.940	0.427	T	0.009	0.031	T	0.009	0.240	T	4.555	0.610	24.4	0.963	0.287	0.982	0.801	D	c	-0.019	0.148	0.999	0.372	0.706	0.609	0	4.63	0.570	3.957	0.562	1.061	0.807	1.000	0.715	1.000	0.888	14.514	0.673	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	47	chr12	15702158	chr12:15702158	T	A	.	PASS	AN=0;DP=47	GT	0/1
chr12	29521181	29521181	C	A	exonic	ERGIC2	.	nonsynonymous SNV	ERGIC2:NM_016570:exon4:c.G255T:p.K85N	0.320357206	0.678925092	0.000717702	.	0.84052	0.08503	-0.339715008	30.06605331	9.56131	0.35232	0.098	0.318	T	0.563	0.365	P	0.487	0.454	P	0.000	0.559	D	0.915	0.365	D	2.38	0.688	M	.	.	.	-2.07	0.537	N	0.192	0.282	-0.273	0.758	T	0.327	0.696	T	0.010	0.257	T	5.379	0.729	25.9	0.998	0.917	0.953	0.640	D	c	0.319	0.368	0.059	0.152	0.732	0.924	0	5.37	0.769	0.998	0.291	0.875	0.382	1.000	0.715	1.000	0.888	16.644	0.850	.	.	.	0.5	.	69	chr12	29521181	chr12:29521181	C	A	.	PASS	AN=0;DP=69	GT	0/1
chr12	31595764	31595764	C	A	exonic	DENND5B	.	nonsynonymous SNV	DENND5B:NM_144973:exon7:c.G1957T:p.G653W,DENND5B:NM_001308339:exon9:c.G2062T:p.G688W	0.999945504	5.45E-05	3.62E-13	.	.	.	-0.440847477	24.59896202	5379.04327	15.1245	0.001	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.695	0.791	M	3.38	0.098	T	-4.2	0.778	D	0.897	0.897	-1.050	0.143	T	0.092	0.352	T	0.024	0.470	T	7.733	0.955	35	0.996	0.754	0.981	0.796	D	c	0.796	0.752	1.000	0.747	0.706	0.609	0	4.77	0.603	7.705	0.835	0.892	0.403	1.000	0.715	1.000	0.888	18.000	0.891	.	.	.	0.5	.	47	chr12	31595764	chr12:31595764	C	A	.	PASS	AN=0;DP=47	GT	0/1
chr12	51874000	51874000	A	G	exonic	SLC4A8	.	synonymous SNV	SLC4A8:NM_001258403:exon17:c.A2238G:p.Q746Q	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	72	chr12	51874000	chr12:51874000	A	G	62	PASS	AN=2;DP=72	GT	0/1
chr12	58157466	58157466	G	T	exonic	CYP27B1	.	synonymous SNV	CYP27B1:NM_000785:exon8:c.C1341A:p.P447P	3.60E-06	0.806445692	0.193550707	.	0.09767	0.39937	-0.404032746	26.53338051	111.70148	2.30098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	chr12	58157466	chr12:58157466	G	T	.	PASS	AN=0;DP=85	GT	0/1
chr12	62148744	62148744	G	T	exonic	FAM19A2	.	nonsynonymous SNV	FAM19A2:NM_178539:exon3:c.C168A:p.N56K	0.54745717	0.438689922	0.013852908	.	0.48543	0.09934	0.21326276	67.71644256	15.92723	0.56478	0.017	0.555	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.984	0.810	D	2.52	0.738	M	.	.	.	-5.93	0.895	D	0.352	0.415	-0.189	0.780	T	0.421	0.767	T	0.070	0.709	D	5.694	0.777	26.8	0.998	0.909	0.962	0.676	D	c	0.739	0.709	0.000	0.071	0.554	0.246	0	5.42	0.786	4.717	0.614	1.048	0.713	1.000	0.715	1.000	0.888	10.800	0.455	.	.	.	0.5	.	51	chr12	62148744	chr12:62148744	G	T	.	PASS	AN=0;DP=51	GT	0/1
chr12	70329745	70329745	C	T	intronic	MYRFL	.	.	.	.	.	.	.	0.11494	.	.	.	3336.78291	11.06066	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.944	0.184	10.34	0.755	0.107	0.038	0.090	N	n	0.452	0.261	1.000	0.747	0.119	0.024	0	1.7	0.232	-0.248	0.088	0.855	0.374	0.000	0.063	0.574	0.284	4.496	0.112	.	.	.	0.5	.	73	chr12	70329745	chr12:70329745	C	T	.	PASS	AN=0;DP=73	GT	0/1
chr12	104461712	104461712	T	-	intronic	HCFC2	.	.	.	0.994468276	0.005531718	5.69E-09	.	0.54137	0.20015	0.084621747	60.31493277	202.17732	3.06842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	75	chr12	104461711	chr12:104461711	CT	C	92	PASS	AN=2;DP=75	GT	0/1
chr12	108012065	108012065	A	C	exonic	BTBD11	.	nonsynonymous SNV	BTBD11:NM_001017523:exon8:c.A973C:p.S325R,BTBD11:NM_001018072:exon10:c.A2362C:p.S788R	0.993432981	0.00656701	8.66E-09	.	0.42445	0.12301	-0.462894052	23.62585515	7389.82344	18.4572	0.047	0.403	D	0.838	0.715	P	0.367	0.649	B	0.000	0.843	D	1.000	0.810	D	1.355	0.339	L	1.28	0.396	T	-1.65	0.395	N	0.562	0.647	-0.867	0.508	T	0.172	0.515	T	0.019	0.417	T	3.696	0.501	23.3	0.998	0.917	0.959	0.666	D	c	0.473	0.512	1.000	0.489	0.638	0.428	0	5.07	0.680	5.381	0.657	1.199	0.960	1.000	0.715	1.000	0.888	15.123	0.720	.	.	.	0.5	.	87	chr12	108012065	chr12:108012065	A	C	.	PASS	AN=0;DP=87	GT	0/1
chr12	108913293	108913293	A	-	UTR3	FICD	NM_007076:c.*41delA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	175	chr12	108913292	chr12:108913292	GA	G	55	PASS	AN=2;DP=175	GT	0/1
chr12	109921356	109921356	C	A	UTR5	UBE3B	NM_130466:c.-1C>A;NM_001270449:c.-1C>A;NM_001270450:c.-1C>A;NM_001270451:c.-1C>A;NM_183415:c.-1C>A	.	.	0.009387706	0.990612131	1.63E-07	.	0.19362	0.09343	-2.232421897	1.315168672	170.30974	2.84773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	chr12	109921356	chr12:109921356	C	A	.	PASS	AN=0;DP=73	GT	0/1
chr12	111375005	111375005	T	C	ncRNA_exonic	LINC01405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	chr12	111375005	chr12:111375005	T	C	.	PASS	AN=0;DP=169	GT	0/1
chr12	120806124	120806124	C	-	intronic	MSI1	.	.	.	0.997146451	0.002853413	1.36E-07	.	0.66447	0.10166	-0.161524709	41.6430762	9.92984	0.36366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	198	chr12	120806123	chr12:120806123	TC	T	93	PASS	AN=2;DP=198	GT	0/1
chr12	132635999	132635999	G	T	intronic	NOC4L	.	.	.	.	.	.	.	0.5431	0.11298	-1.280491183	5.16631281	149.35551	2.66469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	chr12	132635999	chr12:132635999	G	T	.	PASS	AN=0;DP=54	GT	0/1
chr13	27830553	27830553	-	T	ncRNA_intronic	RPL21P28	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	45	chr13	27830553	chr13:27830553	C	CT	50	PASS	AN=2;DP=45	GT	0/1
chr13	46148944	46148944	G	-	intronic	ERICH6B	.	.	.	.	.	.	.	.	.	2.710287147	98.93842887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	15	chr13	46148943	chr13:46148943	TG	T	61	PASS	AN=2;DP=15	GT	0/1
chr13	46946629	46946629	G	T	UTR5	RUBCNL	NM_001286762:c.-19C>A;NM_001349772:c.-19C>A;NM_025113:c.-19C>A;NM_001286761:c.-19C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr13	46946629	chr13:46946629	G	T	.	PASS	AN=0;DP=31	GT	0/1
chr13	50746845	50746845	C	G	ncRNA_exonic	ST13P4	.	.	.	.	.	.	.	.	0.29632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	128	chr13	50746845	chr13:50746845	C	G	53	PASS	AN=2;DP=128	GT	0/1
chr13	102047543	102047543	G	T	exonic	NALCN	.	synonymous SNV	NALCN:NM_001350748:exon3:c.C282A:p.G94G,NALCN:NM_001350749:exon3:c.C282A:p.G94G,NALCN:NM_001350750:exon3:c.C282A:p.G94G,NALCN:NM_001350751:exon3:c.C282A:p.G94G,NALCN:NM_052867:exon3:c.C282A:p.G94G	0.000169004	0.999830996	3.03E-11	DISEASE: Hypotonia, infantile, with psychomotor retardation and characteristic facies (IHPRF) [MIM:615419]: A neurodegenerative disease characterized by variable degrees of hypotonia, speech impairment, intellectual disability, pyramidal signs, subtle facial dysmorphism, and chronic constipation. Some patients manifest neuroaxonal dystrophy, optic atrophy, unmyelinated axons and spheroid bodies in tissue biopsies. {ECO:0000269|PubMed:23749988, ECO:0000269|PubMed:24075186}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]: A disease characterized by congenital contractures of the limbs and face, resulting in characteristic facial features, abnormal tone, most commonly manifested as hypotonia, and variable degrees of developmental delay. {ECO:0000269|PubMed:25683120}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43129	0.10307	-1.611264137	2.984194385	137.54866	2.55255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr13	102047543	chr13:102047543	G	T	.	PASS	AN=0;DP=51	GT	0/1
chr13	102106265	102106265	C	A	exonic	ITGBL1	.	synonymous SNV	ITGBL1:NM_001271755:exon2:c.C130A:p.R44R,ITGBL1:NM_004791:exon2:c.C130A:p.R44R	0.170877824	0.828540578	0.000581598	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr13	102106265	chr13:102106265	C	A	.	PASS	AN=0;DP=46	GT	0/1
chr13	108518516	108518518	GCC	-	exonic	FAM155A	.	nonframeshift deletion	FAM155A:NM_001080396:exon1:c.427_429del:p.G143del	0.800415326	0.199346781	0.000237893	.	0.22573	.	-0.005381972	53.50908233	761.08845	5.47031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	114	chr13	108518515	chr13:108518515	TGCC	T	83	PASS	AN=2;DP=114	GT	0/1
chr14	19807304	19807304	T	A	intergenic	DUXAP10;LINC01296	dist=114388;dist=72905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	194	chr14	19807304	chr14:19807304	T	A	.	PASS	AN=0;DP=194	GT	0/1
chr14	22038042	22038042	C	A	exonic	OR10G3	.	synonymous SNV	OR10G3:NM_001005465:exon1:c.G834T:p.T278T	0.234560474	0.645560257	0.119879269	.	0.12713	0.09782	1.174022298	92.72823779	733.81635	5.37359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	chr14	22038042	chr14:22038042	C	A	.	PASS	AN=0;DP=108	GT	0/1
chr14	23533397	23533397	G	A	exonic	ACIN1	.	nonsynonymous SNV	ACIN1:NM_001164816:exon5:c.C505T:p.R169C,ACIN1:NM_001164817:exon6:c.C412T:p.R138C,ACIN1:NM_001164815:exon11:c.C2566T:p.R856C,ACIN1:NM_001164814:exon12:c.C2647T:p.R883C,ACIN1:NM_014977:exon12:c.C2686T:p.R896C	0.999998437	1.56E-06	2.59E-18	.	0.75733	0.42314	-0.435396074	24.70511913	7850.70685	19.11113	0.005	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.375	N	1.000	0.524	D	1.245	0.315	L	3.3	0.181	T	-3.22	0.789	D	0.423	0.728	-1.140	0.014	T	0.083	0.324	T	0.014	0.343	T	6.993	0.937	33	0.999	0.995	0.899	0.504	D	c	0.557	0.568	1.000	0.747	0.722	0.854	0	4.45	0.532	2.876	0.479	1.048	0.713	1.000	0.715	0.998	0.697	15.448	0.749	.	.	.	0.5	.	68	chr14	23533397	chr14:23533397	G	A	.	PASS	AN=0;DP=68	GT	0/1
chr14	23898326	23898326	G	A	intronic	MYH7	.	.	.	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr14	23898326	chr14:23898326	G	A	.	PASS	AN=0;DP=47	GT	0/1
chr14	23898530	23898530	C	T	exonic	MYH7	.	nonsynonymous SNV	MYH7:NM_000257:exon13:c.G1165A:p.G389R	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	.	.	.	1	0.810	D	3.195	0.893	M	-2.49	0.892	D	-6.18	0.903	D	0.821	0.809	1.040	0.979	D	0.882	0.961	D	0.963	0.998	D	6.768	0.922	32	0.999	0.997	0.975	0.749	D	c	0.750	0.608	1.000	0.747	0.487	0.133	0	4.04	0.461	3.965	0.562	0.847	0.346	1.000	0.715	1.000	0.888	16.373	0.831	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	55	chr14	23898530	chr14:23898530	C	T	.	PASS	AN=0;DP=55	GT	0/1
chr14	24507037	24507037	G	C	UTR5	DHRS4L1	NM_001277864:c.-33G>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	chr14	24507037	chr14:24507037	G	C	.	PASS	AN=0;DP=161	GT	0/1
chr14	24606081	24606081	G	A	intronic	PSME1	.	.	.	0.050880833	0.927571331	0.021547835	.	0.39132	0.11179	0.283038099	71.26680821	19.18514	0.66093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr14	24606081	chr14:24606081	G	A	.	PASS	AN=0;DP=43	GT	0/1
chr14	31174980	31174980	G	T	intronic	SCFD1	.	.	.	0.991579194	0.008420806	6.51E-10	.	0.22735	0.11778	-0.179930907	40.35739561	171.75077	2.85758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr14	31174980	chr14:31174980	G	T	.	PASS	AN=0;DP=32	GT	0/1
chr14	31290994	31290994	A	C	intergenic	SCFD1;COCH	dist=85961;dist=52747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	86	chr14	31290994	chr14:31290994	A	C	97	PASS	AN=2;DP=86	GT	0/1
chr14	38014894	38014894	C	G	intronic	MIPOL1	.	.	.	6.82E-06	0.899072397	0.100920787	.	0.05246	0.09163	-0.712684326	14.49634348	75.79942	1.82421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	32	chr14	38014894	chr14:38014894	C	G	54	PASS	AN=2;DP=32	GT	0/1
chr14	50361216	50361216	C	T	UTR3	ARF6	NM_001663:c.*234C>T	.	.	0.600609559	0.361887013	0.037503427	.	0.43767	0.41336	-0.141298762	42.87567823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr14	50361216	chr14:50361216	C	T	.	PASS	AN=0;DP=53	GT	0/1
chr14	52481092	52481092	G	C	exonic	NID2	.	synonymous SNV	NID2:NM_007361:exon16:c.C3333G:p.L1111L	6.95E-07	0.999989562	9.74E-06	.	0.75123	0.20667	3.602297049	99.53408823	1392.55812	6.9826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	chr14	52481092	chr14:52481092	G	C	.	PASS	AN=0;DP=76	GT	0/1
chr14	74876120	74876120	G	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.C328A:p.Q110K	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	1.0	0.010	T	0.008	0.135	B	0.011	0.145	B	0.684	0.061	N	1	0.090	N	2.135	0.597	M	-3.63	0.951	D	-0.64	0.187	N	0.169	0.204	-0.221	0.772	T	0.721	0.905	D	0.037	0.575	D	-1.358	0.020	0.004	0.562	0.054	0.437	0.269	N	c	-0.604	-0.574	0.999	0.371	0.615	0.372	0	3.69	0.413	2.897	0.481	0.994	0.605	0.344	0.255	0.004	0.083	13.224	0.592	.	.	.	0.5	.	57	chr14	74876120	chr14:74876120	G	T	.	PASS	AN=0;DP=57	GT	0/1
chr14	74876234	74876234	A	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.T214A:p.C72S	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	0.054	0.386	T	0.015	0.158	B	0.002	0.063	B	0.000	0.504	D	0.559	0.322	D	1.95	0.526	M	-3.57	0.949	D	0.07	0.381	N	0.321	0.466	0.162	0.853	D	0.656	0.880	D	0.067	0.703	D	1.292	0.220	12.23	0.800	0.126	0.977	0.762	D	c	-0.399	-0.235	1.000	0.747	0.657	0.484	0	3.28	0.365	4.515	0.600	0.082	0.190	1.000	0.715	0.996	0.625	9.099	0.356	.	.	.	0.5	.	42	chr14	74876234	chr14:74876234	A	T	.	PASS	AN=0;DP=42	GT	0/1
chr14	89629000	89629000	C	A	exonic	FOXN3	.	nonsynonymous SNV	FOXN3:NM_005197:exon6:c.G1165T:p.D389Y,FOXN3:NM_001085471:exon7:c.G1231T:p.D411Y	0.90779936	0.092051233	0.000149407	.	0.74209	0.17554	-0.356299879	29.31115829	47.54211	1.33837	0.002	0.721	D	0.997	0.689	D	0.863	0.596	P	0.000	0.491	D	0.999	0.462	D	2.395	0.694	M	-0.02	0.629	T	-3.17	0.650	D	0.739	0.736	-0.309	0.747	T	0.383	0.739	T	0.061	0.684	D	5.522	0.750	26.3	0.994	0.620	0.996	0.980	D	c	0.748	0.758	1.000	0.747	0.707	0.730	0	5.95	0.964	7.883	0.857	0.066	0.173	1.000	0.715	0.928	0.402	19.988	0.973	.	.	.	0.5	.	131	chr14	89629000	chr14:89629000	C	A	.	PASS	AN=0;DP=131	GT	0/1
chr14	94088721	94088721	C	T	exonic	UNC79	.	synonymous SNV	UNC79:NM_020818:exon30:c.C4611T:p.L1537L,UNC79:NM_001346218:exon31:c.C5292T:p.L1764L	1	2.61E-11	1.21E-30	.	0.13734	0.1172	-1.113491624	6.634819533	491.26186	4.56078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr14	94088721	chr14:94088721	C	T	.	PASS	AN=0;DP=35	GT	0/1
chr14	102801998	102801998	T	-	intronic	ZNF839	.	.	.	9.19E-05	0.935142117	0.064765993	.	0.0931	.	1.495467846	95.37626799	1511.89021	7.22302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	73	chr14	102801997	chr14:102801997	CT	C	56	PASS	AN=2;DP=73	GT	0/1
chr14	106095799	106095799	C	A	intergenic	MIR8071-2;MIR8071-2	dist=8282;dist=10706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	354	chr14	106095799	chr14:106095799	C	A	.	PASS	AN=0;DP=354	GT	0/1
chr14	106137413	106137413	A	-	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	270	chr14	106137412	chr14:106137412	GA	G,GAA	69	PASS	AN=2;DP=270	GT	0/1
chr14	106137413	106137413	-	A	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	270	chr14	106137412	chr14:106137412	GA	G,GAA	69	PASS	AN=2;DP=270	GT	0/1
chr14	106579211	106579211	A	T	intergenic	ADAM6;LINC00226	dist=140853;dist=165058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	chr14	106579211	chr14:106579211	A	T	.	PASS	AN=0;DP=160	GT	0/1
chr15	20434040	20434040	T	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=53957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	177	chr15	20434040	chr15:20434040	T	A	.	PASS	AN=0;DP=177	GT	0/1
chr15	20450231	20450231	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=37766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	394	chr15	20450231	chr15:20450231	C	A	.	PASS	AN=0;DP=394	GT	0/1
chr15	20489389	20489389	G	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	175	chr15	20489389	chr15:20489389	G	C	63	PASS	AN=2;DP=175	GT	0/1
chr15	20876452	20876452	G	A	ncRNA_exonic	NBEAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr15	20876452	chr15:20876452	G	A	.	PASS	AN=0;DP=87	GT	0/1
chr15	22368600	22368600	G	C	exonic;splicing	OR4M2;LINC02203	NR_015416:exon9:c.1264+1G>C	nonsynonymous SNV	OR4M2:NM_001004719:exon1:c.G25C:p.V9L	.	.	.	.	.	.	.	.	.	.	0.006	0.614	D	0.258	0.297	B	0.126	0.311	B	0.001	0.424	D	0.780	0.293	N	2.505	0.732	M	5.64	0.008	T	-2.37	0.522	N	0.395	0.454	-1.133	0.017	T	0.006	0.021	T	0.004	0.091	T	2.568	0.370	19.90	0.990	0.492	0.632	0.318	D	c	-0.194	-0.226	0.999	0.383	0.487	0.133	0	2.5	0.292	0.492	0.220	0.681	0.295	0.094	0.225	0.584	0.286	10.808	0.455	.	.	.	0.5	92	141	chr15	22368600	chr15:22368600	G	C	92	PASS	AN=2;DP=141	GT	0/1
chr15	22413972	22413972	C	A	ncRNA_exonic	OR4N3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	177	chr15	22413972	chr15:22413972	C	A	.	PASS	AN=0;DP=177	GT	0/1
chr15	22448402	22448402	G	T	ncRNA_exonic	IGHV1OR15-1;LOC102724760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	288	chr15	22448402	chr15:22448402	G	T	.	PASS	AN=0;DP=288	GT	0/1
chr15	23605348	23605348	C	A	ncRNA_intronic	GOLGA8S	.	.	.	0.004662616	0.877542935	0.117794449	.	.	.	.	.	7996.64766	19.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	304	chr15	23605348	chr15:23605348	C	A	.	PASS	AN=0;DP=304	GT	0/1
chr15	24921380	24921380	G	A	exonic	NPAP1	.	nonsynonymous SNV	NPAP1:NM_018958:exon1:c.G366A:p.M122I	0.273009366	0.721810072	0.005180563	.	0.05519	0.05806	3.546886998	99.49280491	286.08933	3.62008	0.082	0.332	T	0.001	0.067	B	0.0	0.013	B	0.005	0.010	N	1	0.090	N	0	0.065	N	3.37	0.059	T	-0.84	0.229	N	0.057	0.040	-0.978	0.356	T	0.009	0.034	T	0.000	0.001	T	-1.330	0.021	0.004	0.729	0.098	0.001	0.009	N	c	-1.563	-1.664	0.069	0.155	0.487	0.133	0	-3.13	0.049	-0.735	0.050	0.535	0.282	0.000	0.063	0.009	0.108	0.246	0.002	.	.	.	0.5	.	202	chr15	24921380	chr15:24921380	G	A	.	PASS	AN=0;DP=202	GT	0/1
chr15	25417793	25417793	G	A	ncRNA_exonic	SNORD115-2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr15	25417793	chr15:25417793	G	A	.	PASS	AN=0;DP=51	GT	0/1
chr15	30850264	30850264	G	C	intergenic	LOC100288203;DNM1P50	dist=67748;dist=10537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	250	chr15	30850264	chr15:30850264	G	C	144	PASS	AN=2;DP=250	GT	0/1
chr15	31233063	31233063	A	C	UTR3	MTMR10	NM_017762:c.*610T>G	.	.	0.035049797	0.964614838	0.000335366	.	0.04354	.	0.378498378	75.58386412	720.47875	5.32943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	39	chr15	31233063	chr15:31233063	A	C	78	PASS	AN=2;DP=39	GT	0/1
chr15	34642927	34642927	C	A	exonic	NUTM1	.	synonymous SNV	NUTM1:NM_001284293:exon3:c.C802A:p.R268R,NUTM1:NM_001284292:exon4:c.C832A:p.R278R,NUTM1:NM_175741:exon4:c.C748A:p.R250R	0.005981126	0.993096368	0.000922506	DISEASE: Note=A chromosomal aberration involving NUT is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with BRD4 which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:12543779}.; DISEASE: Note=A chromosomal aberration involving NUT is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;9)(q14;q34) with BRD3 which produces a BRD3-NUT fusion protein. {ECO:0000269|PubMed:12543779}.; 	0.10314	0.08894	1.431149089	95.02241095	2356.45511	9.00213	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	chr15	34642927	chr15:34642927	C	A	.	PASS	AN=0;DP=85	GT	0/1
chr15	42438404	42438404	C	G	exonic	PLA2G4F	.	synonymous SNV	PLA2G4F:NM_213600:exon14:c.G1455C:p.A485A	1.40E-09	0.985845067	0.014154932	.	0.06296	0.09823	1.32640619	94.10238264	1110.4377	6.37148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	192	chr15	42438404	chr15:42438404	C	G	124	PASS	AN=2;DP=192	GT	0/1
chr15	43638146	43638146	G	T	exonic	ADAL	.	nonsynonymous SNV	ADAL:NM_001012969:exon8:c.G520T:p.V174F,ADAL:NM_001159280:exon9:c.G520T:p.V174F,ADAL:NM_001324364:exon9:c.G520T:p.V174F,ADAL:NM_001324365:exon9:c.G520T:p.V174F,ADAL:NM_001324366:exon9:c.G520T:p.V174F,ADAL:NM_001324367:exon9:c.G520T:p.V174F,ADAL:NM_001324368:exon9:c.G520T:p.V174F	8.52E-09	0.044008879	0.955991112	.	0.06081	0.11351	0.260991686	70.25831564	135.20538	2.52983	0.001	0.784	D	0.993	0.657	D	0.971	0.742	D	0.000	0.843	D	1	0.810	D	3.35	0.913	M	-3.72	0.954	D	-4.13	0.759	D	0.976	0.980	1.058	0.983	D	0.936	0.979	D	0.446	0.943	D	6.431	0.887	29.8	0.996	0.738	0.986	0.846	D	c	0.943	0.904	1.000	0.747	0.732	0.924	0	5.87	0.942	7.503	0.803	1.048	0.713	1.000	0.715	0.987	0.523	18.072	0.893	Adenosine/AMP deaminase domain|Metal-dependent hydrolase	.	.	0.5	.	58	chr15	43638146	chr15:43638146	G	T	.	PASS	AN=0;DP=58	GT	0/1
chr15	56435086	56435086	G	A	exonic	RFX7	.	synonymous SNV	RFX7:NM_022841:exon4:c.C291T:p.A97A	0.999680946	0.000319054	1.32E-10	.	0.76512	0.10256	.	.	372.49082	4.07209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr15	56435086	chr15:56435086	G	A	.	PASS	AN=0;DP=32	GT	0/1
chr15	63447893	63447893	C	G	exonic	RPS27L	.	nonsynonymous SNV	RPS27L:NM_015920:exon3:c.G153C:p.Q51H	0.335851902	0.603407942	0.060740156	.	0.35212	0.08617	0.101211609	60.95777306	22.08009	0.7413	0.008	0.599	D	0.977	0.566	D	0.926	0.644	D	0.000	0.843	D	0.999	0.463	D	.	.	.	.	.	.	-4.7	0.806	D	0.937	0.931	-0.385	0.725	T	0.364	0.725	T	0.027	0.500	D	4.623	0.619	24.5	0.997	0.795	0.876	0.469	D	c	0.429	0.400	1.000	0.747	0.660	0.490	0	2.71	0.310	4.090	0.572	0.935	0.490	1.000	0.715	0.997	0.653	9.976	0.408	Ribosomal protein S27e, zinc-binding domain|Zinc-binding ribosomal protein	.	.	0.5	59	54	chr15	63447893	chr15:63447893	C	G	59	PASS	AN=2;DP=54	GT	0/1
chr15	71256253	71256253	A	G	exonic	LRRC49	.	synonymous SNV	LRRC49:NM_001199017:exon9:c.A918G:p.L306L,LRRC49:NM_017691:exon9:c.A903G:p.L301L,LRRC49:NM_001199018:exon10:c.A771G:p.L257L,LRRC49:NM_001284357:exon10:c.A873G:p.L291L	0.446510312	0.553478597	1.11E-05	.	0.18522	0.11023	-0.666770504	15.86459071	4621.78815	13.66012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	59	chr15	71256253	chr15:71256253	A	G	91	PASS	AN=2;DP=59	GT	0/1
chr15	75221479	75221480	TA	-	exonic	COX5A	.	frameshift deletion	COX5A:NM_004255:exon2:c.194_195del:p.I65Rfs*6	0.324238693	0.61012662	0.065634687	.	0.12532	0.28848	-0.163345027	41.24793583	8.88764	0.32735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	42	chr15	75221478	chr15:75221478	CTA	C	56	PASS	AN=2;DP=42	GT	0/1
chr15	76463300	76463300	G	T	intronic	TMEM266	.	.	.	.	.	.	.	0.25737	.	0.20030965	67.3566879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	chr15	76463300	chr15:76463300	G	T	.	PASS	AN=0;DP=86	GT	0/1
chr15	83658674	83658674	G	-	exonic	FAM103A1	.	frameshift deletion	FAM103A1:NM_031452:exon4:c.212delG:p.W73Gfs*53	0.828445215	0.167913869	0.003640916	.	0.0914	0.10748	0.25917371	70.05779665	177.4953	2.89591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	56	chr15	83658673	chr15:83658673	TG	T	93	PASS	AN=2;DP=56	GT	0/1
chr15	89416087	89416087	A	T	intronic	ACAN	.	.	.	0.999993945	6.06E-06	1.71E-15	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3407	0.5702	1.284310712	93.77211607	15528.89086	26.89264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr15	89416087	chr15:89416087	A	T	.	PASS	AN=0;DP=40	GT	0/1
chr16	2348569	2348569	C	A	intronic	ABCA3	.	.	.	7.48E-08	0.999990122	9.80E-06	DISEASE: Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:15044640}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13416	0.16987	-1.477690451	3.709601321	188.10316	2.97844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr16	2348569	chr16:2348569	C	A	.	PASS	AN=0;DP=45	GT	0/1
chr16	5040768	5040768	G	T	exonic	SEC14L5	.	nonsynonymous SNV	SEC14L5:NM_014692:exon5:c.G346T:p.V116F	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.537	D	1	0.810	D	2.79	0.817	M	2.21	0.184	T	-4.03	0.743	D	0.729	0.728	-0.781	0.563	T	0.148	0.475	T	0.058	0.674	D	6.411	0.885	29.7	0.996	0.712	0.984	0.824	D	c	0.865	0.784	1.000	0.747	0.615	0.372	0	4.37	0.517	9.492	0.969	1.048	0.713	1.000	0.715	0.953	0.430	17.101	0.865	PRELI/MSF1 domain	.	.	0.5	.	50	chr16	5040768	chr16:5040768	G	T	.	PASS	AN=0;DP=50	GT	0/1
chr16	9856337	9856337	C	A	UTR3	GRIN2A	NM_001134408:c.*875G>T;NM_001134407:c.*669G>T;NM_000833:c.*669G>T	.	.	0.998044808	0.001955191	4.49E-10	DISEASE: Epilepsy, focal, with speech disorder and with or without mental retardation (FESD) [MIM:245570]: A highly variable neurologic disorder with features ranging from severe early-onset seizures associated with delayed psychomotor development, persistent speech difficulties, and mental retardation to a more benign entity characterized by childhood onset of mild or asymptomatic seizures associated with transient speech difficulties followed by remission of seizures in adolescence and normal psychomotor development. The disorder encompasses several clinical entities, including Landau-Kleffner syndrome, epileptic encephalopathy with continuous spike and wave during slow-wave sleep, autosomal dominant rolandic epilepsy, mental retardation and speech dyspraxia, and benign epilepsy with centrotemporal spikes. {ECO:0000269|PubMed:20890276, ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:23933818, ECO:0000269|PubMed:23933819, ECO:0000269|PubMed:23933820, ECO:0000269|PubMed:24504326, ECO:0000269|PubMed:24903190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving GRIN2A has been found in a family with epilepsy and neurodevelopmental defects. Translocation t(16;17)(p13.2;q11.2).; DISEASE: Note=GRIN2A somatic mutations have been frequently found in cutaneous malignant melanoma, suggesting that the glutamate signaling pathway may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247, ECO:0000269|PubMed:24455489}.; 	0.37855	0.47307	-1.455091209	3.886529842	119.73741	2.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr16	9856337	chr16:9856337	C	A	.	PASS	AN=0;DP=33	GT	0/1
chr16	11121098	11121098	A	T	intronic	CLEC16A	.	.	.	0.010138957	0.989843481	1.76E-05	.	0.33524	0.17783	-1.010461444	8.197688134	250.55243	3.41106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr16	11121098	chr16:11121098	A	T	.	PASS	AN=0;DP=69	GT	0/1
chr16	18437726	18437726	C	A	ncRNA_exonic	LOC100288162;PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	351	chr16	18437726	chr16:18437726	C	A	.	PASS	AN=0;DP=351	GT	0/1
chr16	28906289	28906289	C	A	intronic	ATP2A1	.	.	.	7.04E-09	0.998563754	0.001436239	DISEASE: Brody myopathy (BRM) [MIM:601003]: A disorder of muscle function that is characterized by painless muscle cramping and exercise-induced impairment of muscle relaxation. {ECO:0000269|PubMed:10914677}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78274	.	-1.392555112	4.269874971	168.67085	2.83491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	chr16	28906289	chr16:28906289	C	A	.	PASS	AN=0;DP=54	GT	0/1
chr16	31368547	31368547	C	A	intronic	ITGAX	.	.	.	6.11E-05	0.999936982	1.90E-06	.	0.09861	.	-0.915030414	9.837225761	3879.17486	12.28742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	chr16	31368547	chr16:31368547	C	A	.	PASS	AN=0;DP=88	GT	0/1
chr16	33752655	33752655	G	T	intergenic	ENPP7P13;LINC00273	dist=165913;dist=208397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	290	chr16	33752655	chr16:33752655	G	T	.	PASS	AN=0;DP=290	GT	0/1
chr16	54967692	54967692	G	C	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon3:c.G1356C:p.L452F,IRX5:NM_005853:exon3:c.G1359C:p.L453F	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.045	0.912	D	0.998	0.715	D	0.996	0.832	D	0.001	0.434	D	1	0.810	D	1.04	0.263	L	0.15	0.608	T	-1.07	0.475	N	0.369	0.431	-0.567	0.662	T	0.296	0.668	T	0.022	0.446	T	2.369	0.346	18.62	0.986	0.426	0.941	0.598	D	c	0.604	0.608	1.000	0.747	0.598	0.340	0	4.77	0.603	5.274	0.652	1.048	0.713	1.000	0.715	1.000	0.888	17.973	0.890	.	.	.	0.5	.	158	chr16	54967692	chr16:54967692	G	C	.	PASS	AN=0;DP=158	GT	0/1
chr16	66967592	66967592	C	T	exonic	FAM96B	.	synonymous SNV	FAM96B:NM_016062:exon3:c.G273A:p.P91P	0.002103752	0.510385152	0.487511096	.	0.24177	0.10692	0.013025609	54.62962963	7.86023	0.28897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	chr16	66967592	chr16:66967592	C	T	.	PASS	AN=0;DP=44	GT	0/1
chr16	71967795	71967795	G	C	intronic	PKD1L3	.	.	.	.	.	.	.	.	0.11058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	60	chr16	71967795	chr16:71967795	G	C	71	PASS	AN=2;DP=60	GT	0/1
chr16	89293717	89293717	G	C	exonic	ZNF778	.	nonsynonymous SNV	ZNF778:NM_182531:exon6:c.G937C:p.E313Q,ZNF778:NM_001201407:exon7:c.G1021C:p.E341Q	1.63E-15	0.003467761	0.996532239	.	.	.	1.302520887	93.9195565	439.77574	4.37018	0.325	0.133	T	0.041	0.210	B	0.052	0.280	B	.	.	.	1	0.090	N	1.195	0.303	L	2.21	0.184	T	-0.71	0.202	N	0.113	0.186	-0.992	0.320	T	0.031	0.133	T	0.001	0.007	T	0.336	0.126	6.040	0.525	0.047	0.010	0.039	N	c	-0.964	-1.071	0.106	0.165	0.566	0.321	0	1.13	0.197	-0.251	0.088	0.635	0.291	0.000	0.063	0.001	0.043	8.198	0.304	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	77	61	chr16	89293717	chr16:89293717	G	C	77	PASS	AN=2;DP=61	GT	0/1
chr16	89986075	89986075	G	T	exonic	MC1R	.	nonsynonymous SNV	MC1R:NM_002386:exon1:c.G409T:p.A137S	3.25E-07	0.052370692	0.947628983	DISEASE: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:17434924, ECO:0000269|PubMed:19338054}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.68939	0.34168906	73.72611465	1416.53832	7.03613	0.012	0.654	D	0.7	0.399	P	0.519	0.463	P	0.001	0.392	U	0.994	0.236	N	3.31	0.908	M	2.11	0.199	T	-2.03	0.466	N	0.058	0.332	-1.056	0.128	T	0.082	0.323	T	0.015	0.355	T	4.232	0.567	23.9	0.996	0.738	0.669	0.330	D	c	-0.007	-0.082	1.000	0.747	0.615	0.372	0	1.64	0.228	2.657	0.461	0.091	0.195	0.997	0.399	0.004	0.083	9.907	0.404	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	69	chr16	89986075	chr16:89986075	G	T	.	PASS	AN=0;DP=69	GT	0/1
chr17	982599	982599	T	A	exonic	ABR	.	nonsynonymous SNV	ABR:NM_001092:exon5:c.A560T:p.K187M,ABR:NM_001159746:exon6:c.A533T:p.K178M,ABR:NM_001322840:exon6:c.A533T:p.K178M,ABR:NM_001322841:exon6:c.A1448T:p.K483M,ABR:NM_021962:exon6:c.A671T:p.K224M	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	0.002	0.721	D	0.979	0.764	D	0.905	0.736	P	0.000	0.629	D	0.999	0.453	D	2.725	0.800	M	-0.13	0.648	T	-3.2	0.658	D	0.556	0.686	-0.257	0.762	T	0.405	0.755	T	0.115	0.795	D	6.051	0.833	28.0	0.996	0.750	0.982	0.806	D	c	0.593	0.532	1.000	0.747	0.767	0.994	0	4.12	0.473	5.317	0.654	0.964	0.580	1.000	0.715	1.000	0.888	9.380	0.373	Dbl homology (DH) domain	.	.	0.5	.	55	chr17	982599	chr17:982599	T	A	.	PASS	AN=0;DP=55	GT	0/1
chr17	1359255	1359255	C	T	exonic	CRK	.	nonsynonymous SNV	CRK:NM_005206:exon1:c.G157A:p.E53K,CRK:NM_016823:exon1:c.G157A:p.E53K	0.864536311	0.135055982	0.000407707	.	0.73088	0.53296	-0.339715008	30.06605331	5.16406	0.19181	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.305	0.328	L	1.82	0.885	T	-3.75	0.711	D	0.463	0.753	-1.044	0.161	T	0.131	0.443	T	0.835	0.987	D	6.949	0.934	33	0.999	0.992	0.933	0.577	D	c	0.689	0.684	1.0	0.983	0.442	0.072	0	4.93	0.643	7.593	0.818	0.907	0.419	1.000	0.715	0.998	0.697	16.011	0.801	SH2 domain	.	.	0.5	.	65	chr17	1359255	chr17:1359255	C	T	.	PASS	AN=0;DP=65	GT	0/1
chr17	1641029	1641029	G	A	UTR3	WDR81	NM_001163673:c.*50G>A;NM_152348:c.*50G>A;NM_001163811:c.*50G>A;NM_001163809:c.*50G>A	.	.	1.26E-05	0.997783337	0.002204062	.	0.26554	.	-1.758449269	2.335456476	3904.13594	12.33658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	258	chr17	1641029	chr17:1641029	G	A	.	PASS	AN=0;DP=258	GT	0/1
chr17	6665416	6665416	G	T	intronic	XAF1	.	.	.	2.07E-08	0.073341496	0.926658483	.	0.05763	0.08526	0.995816767	90.62278839	600.13477	4.95792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr17	6665416	chr17:6665416	G	T	.	PASS	AN=0;DP=59	GT	0/1
chr17	6920052	6920052	G	A	ncRNA_intronic	MIR497HG;RNASEK-C17orf49	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	114	chr17	6920052	chr17:6920052	G	A	.	PASS	AN=0;DP=114	GT	0/1
chr17	6978296	6978296	G	T	UTR3	CLEC10A	NM_006344:c.*77C>A;NM_182906:c.*77C>A;NM_001330070:c.*77C>A	.	.	4.25E-08	0.203022746	0.796977211	.	0.05732	0.1098	1.218120595	93.15876386	329.25844	3.85744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	chr17	6978296	chr17:6978296	G	T	.	PASS	AN=0;DP=166	GT	0/1
chr17	7323892	7323892	G	T	intronic	SPEM1	.	.	.	0.023453063	0.913435787	0.06311115	.	0.03702	.	0.485092724	79.37603208	739.00476	5.3966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	141	chr17	7323892	chr17:7323892	G	T	86	PASS	AN=2;DP=141	GT	0/1
chr17	9086212	9086212	C	G	intronic	NTN1	.	.	.	.	.	.	.	0.95071	0.25454	-0.626318434	17.03231894	24.88991	0.81675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	157	chr17	9086212	chr17:9086212	C	G	.	PASS	AN=0;DP=157	GT	0/1
chr17	10219247	10219247	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon28:c.C3834A:p.N1278K	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.057	0.379	T	0.06	0.217	B	0.314	0.398	B	.	.	.	0.982	0.250	N	2.39	0.691	M	-1.11	0.775	T	-1.37	0.340	N	0.092	0.143	-0.238	0.767	T	0.522	0.822	D	0.072	0.714	D	4.382	0.587	24.1	0.998	0.882	0.361	0.252	N	c	-0.290	-0.338	0.000	0.012	0.497	0.185	0	1.08	0.194	-0.472	0.066	0.939	0.529	0.000	0.063	1.000	0.888	8.421	0.317	Myosin tail	.	.	0.5	.	89	chr17	10219247	chr17:10219247	G	T	.	PASS	AN=0;DP=89	GT	0/1
chr17	11697016	11697016	A	-	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	27	chr17	11697015	chr17:11697015	GA	G	64	PASS	AN=2;DP=27	GT	0/1
chr17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	599	chr17	20416895	chr17:20416895	A	C	126	PASS	AN=2;DP=599	GT	0/1
chr17	21030283	21030283	C	A	UTR5	DHRS7B	NM_015510:c.-2C>A	.	.	4.76E-08	0.117359366	0.882640587	.	0.1878	0.08946	-0.049474214	50.01179523	36.48054	1.09338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	chr17	21030283	chr17:21030283	C	A	.	PASS	AN=0;DP=136	GT	0/1
chr17	25640358	25640358	T	G	UTR3	WSB1	NM_001348350:c.*963T>G;NM_134265:c.*963T>G;NM_015626:c.*963T>G	.	.	0.92319404	0.076786985	1.90E-05	.	0.35908	0.18099	-0.448125345	24.19202642	3046.97495	10.4928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	chr17	25640358	chr17:25640358	T	G	.	PASS	AN=0;DP=38	GT	0/1
chr17	27419327	27419327	C	A	intronic	MYO18A	.	.	.	0.999417504	0.000582496	3.26E-16	.	0.45342	0.14389	-1.618952458	2.895730125	551.10541	4.7741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	chr17	27419327	chr17:27419327	C	A	.	PASS	AN=0;DP=70	GT	0/1
chr17	28999185	28999185	A	-	intergenic	LOC107133515;SUZ12P1	dist=34701;dist=37441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	226	chr17	28999184	chr17:28999184	GA	G	59	PASS	AN=2;DP=226	GT	0/1
chr17	29701671	29701671	T	-	UTR3	NF1	NM_000267:c.*498delT;NM_001042492:c.*498delT	.	.	0.999999846	1.54E-07	1.06E-27	DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.6001	0.90845	-3.091147521	0.471809389	198.4465	3.04463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	79	chr17	29701670	chr17:29701670	CT	C	55	PASS	AN=2;DP=79	GT	0/1
chr17	30263821	30263821	C	G	upstream	SUZ12	dist=208	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	90	chr17	30263821	chr17:30263821	C	G	102	PASS	AN=2;DP=90	GT	0/1
chr17	36875820	36875820	G	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon13:c.G1993A:p.E665K	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.996	0.670	D	0.99	0.774	D	0.000	0.513	D	1	0.810	D	1.895	0.505	L	.	.	.	.	.	.	0.232	0.721	-1.157	0.008	T	0.071	0.288	T	0.008	0.223	T	4.628	0.620	24.5	0.999	0.955	0.979	0.776	D	c	0.677	0.661	1.000	0.747	0.726	0.872	0	4.73	0.593	7.708	0.835	1.029	0.652	1.000	0.715	1.000	0.888	16.627	0.848	.	.	.	0.5	.	225	chr17	36875820	chr17:36875820	G	A	.	PASS	AN=0;DP=225	GT	0/1
chr17	36923775	36923775	A	C	UTR3	PIP4K2B	NM_003559:c.*2169T>G	.	.	0.989205104	0.010791372	3.52E-06	.	0.18019	0.12112	-0.049474214	50.01179523	29.81132	0.95121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	42	chr17	36923775	chr17:36923775	A	C	54	PASS	AN=2;DP=42	GT	0/1
chr17	36965911	36965911	C	A	intronic	CWC25	.	.	.	0.008010166	0.977729099	0.014260735	.	0.2055	0.10468	-0.115612493	45.12856806	76.64648	1.83775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr17	36965911	chr17:36965911	C	A	.	PASS	AN=0;DP=55	GT	0/1
chr17	36965912	36965912	C	T	intronic	CWC25	.	.	.	0.008010166	0.977729099	0.014260735	.	0.2055	0.10468	-0.115612493	45.12856806	76.64648	1.83775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr17	36965912	chr17:36965912	C	T	.	PASS	AN=0;DP=55	GT	0/1
chr17	38644861	38644861	C	A	exonic	TNS4	.	nonsynonymous SNV	TNS4:NM_032865:exon3:c.G800T:p.R267L	0.000130733	0.997996452	0.001872815	.	0.08569	0.10973	-0.24061166	36.28214201	2886.90526	10.1786	0.174	0.225	T	0.01	0.144	B	0.009	0.133	B	0.000	0.002	N	1.000	0.090	N	0.635	0.160	N	2.13	0.196	T	-1.64	0.393	N	0.099	0.101	-1.022	0.231	T	0.034	0.148	T	0.007	0.178	T	1.838	0.282	15.21	0.879	0.170	0.184	0.201	N	c	-0.845	-0.774	1.000	0.517	0.497	0.185	0	2.35	0.280	0.509	0.223	0.060	0.166	0.000	0.063	0.994	0.587	6.436	0.209	.	.	.	0.5	.	190	chr17	38644861	chr17:38644861	C	A	.	PASS	AN=0;DP=190	GT	0/1
chr17	39411615	39411615	A	G	intronic	KRTAP9-9	.	.	.	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	136	chr17	39411615	chr17:39411615	A	G	82	PASS	AN=2;DP=136	GT	0/1
chr17	39776818	39776818	A	-	intronic	KRT17	.	.	.	7.07E-06	0.722413326	0.2775796	DISEASE: Pachyonychia congenita 2 (PC2) [MIM:167210]: An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma and hyperhidrosis, follicular hyperkeratosis, multiple epidermal cysts, absent/sparse eyebrow and body hair, and by the presence of natal teeth. {ECO:0000269|PubMed:10571744, ECO:0000269|PubMed:11348474, ECO:0000269|PubMed:11874497, ECO:0000269|PubMed:11886499, ECO:0000269|PubMed:15102078, ECO:0000269|PubMed:15795125, ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18547302, ECO:0000269|PubMed:19470054, ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:23278621, ECO:0000269|PubMed:23855588, ECO:0000269|PubMed:7539673, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Steatocystoma multiplex (SM) [MIM:184500]: Disease characterized by round or oval cystic tumors widely distributed on the back, anterior trunk, arms, scrotum, and thighs. {ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.; 	.	0.22756	-0.244249595	36.17008728	729.66866	5.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	325	chr17	39776817	chr17:39776817	GA	G	90	PASS	AN=2;DP=325	GT	0/1
chr17	41960509	41960509	C	A	intronic	MPP2	.	.	.	0.002580507	0.994325869	0.003093623	.	0.58879	0.11658	-1.021348453	7.997169144	72.75543	1.7805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr17	41960509	chr17:41960509	C	A	.	PASS	AN=0;DP=112	GT	0/1
chr17	48195470	48195470	G	T	intronic	SAMD14	.	.	.	0.02026443	0.975990271	0.003745299	.	0.19905	0.10658	-0.53631094	20.53550366	50.42659	1.39709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	chr17	48195470	chr17:48195470	G	T	.	PASS	AN=0;DP=137	GT	0/1
chr17	48750766	48750766	C	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chr17	48750766	chr17:48750766	C	T	.	PASS	AN=0;DP=48	GT	0/1
chr17	48750768	48750768	G	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chr17	48750768	chr17:48750768	G	T	.	PASS	AN=0;DP=48	GT	0/1
chr17	56332206	56332206	C	A	exonic	LPO	.	synonymous SNV	LPO:NM_001160102:exon7:c.C891A:p.A297A,LPO:NM_006151:exon9:c.C1140A:p.A380A	2.91E-11	0.264081682	0.735918318	.	0.15837	0.32199	-1.240018202	5.461193678	1144.41107	6.45117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr17	56332206	chr17:56332206	C	A	.	PASS	AN=0;DP=93	GT	0/1
chr17	59974795	59974795	T	-	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	151	chr17	59974794	chr17:59974794	CT	C,CTTT	78	PASS	AN=2;DP=151	GT	0/1
chr17	59974795	59974795	-	TT	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	151	chr17	59974794	chr17:59974794	CT	C,CTTT	78	PASS	AN=2;DP=151	GT	0/1
chr17	61949621	61949621	G	T	exonic	CSH2	.	nonsynonymous SNV	CSH2:NM_022645:exon3:c.C234A:p.D78E,CSH2:NM_020991:exon5:c.C519A:p.D173E	0.458223921	0.515305	0.026471079	.	0.04737	0.07342	-0.139478553	43.29440906	29.18154	0.93272	0.044	0.784	D	0.887	0.715	P	0.86	0.818	P	0.002	0.009	N	1	0.810	D	2.675	0.786	M	-2.3	0.885	D	-2.76	0.634	D	0.516	0.569	-0.268	0.759	T	0.868	0.956	D	0.018	0.404	T	3.095	0.432	22.5	0.995	0.660	0.671	0.330	D	c	0.430	0.263	0.000	0.042	0.447	0.083	0	2.96	0.332	0.749	0.258	0.973	0.593	0.999	0.424	0.739	0.319	6.177	0.195	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	.	305	chr17	61949621	chr17:61949621	G	T	.	PASS	AN=0;DP=305	GT	0/1
chr17	62290515	62290515	C	A	exonic	TEX2	.	nonsynonymous SNV	TEX2:NM_001288732:exon2:c.G1063T:p.G355W,TEX2:NM_001288733:exon2:c.G1063T:p.G355W,TEX2:NM_018469:exon2:c.G1063T:p.G355W	0.44097988	0.559019647	4.74E-07	.	0.17386	0.08006	-0.946125119	9.377211607	521.90393	4.66418	0.001	0.784	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	0.998	0.445	D	1.67	0.430	L	0.46	0.563	T	-2.27	0.506	N	0.593	0.620	-0.538	0.673	T	0.305	0.676	T	0.053	0.654	D	6.215	0.858	28.7	0.946	0.245	0.931	0.571	D	c	0.696	0.709	1.000	0.747	0.615	0.372	0	6.03	0.978	4.527	0.600	0.935	0.490	1.000	0.715	0.912	0.389	20.557	0.993	.	.	.	0.5	.	48	chr17	62290515	chr17:62290515	C	A	.	PASS	AN=0;DP=48	GT	0/1
chr17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	116	chr17	62852056	chr17:62852056	A	G	72	PASS	AN=2;DP=116	GT	0/1
chr17	66251815	66251815	A	G	intronic	AMZ2	.	.	.	1.55E-08	0.116628489	0.883371495	.	0.13213	0.10068	0.507139401	80.10143902	66.56149	1.68126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	96	chr17	66251815	chr17:66251815	A	G	63	PASS	AN=2;DP=96	GT	0/1
chr17	74017493	74017501	CCGCCCCTG	-	intronic	EVPL	.	.	.	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	52	chr17	74017492	chr17:74017492	CCCGCCCCTG	C	65	PASS	AN=2;DP=52	GT	0/1
chr17	78321111	78321111	C	T	exonic	RNF213	.	synonymous SNV	RNF213:NM_001256071:exon29:c.C8976T:p.D2992D	1.68E-29	0.999999941	5.86E-08	DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.; 	0.27678	.	1.993454751	97.65274829	3964.07552	12.4561	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr17	78321111	chr17:78321111	C	T	.	PASS	AN=0;DP=42	GT	0/1
chr17	78321189	78321189	C	G	exonic	RNF213	.	nonsynonymous SNV	RNF213:NM_001256071:exon29:c.C9054G:p.I3018M	1.68E-29	0.999999941	5.86E-08	DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.; 	0.27678	.	1.993454751	97.65274829	3964.07552	12.4561	0.004	0.654	D	0.964	0.539	D	0.679	0.516	P	0.000	0.559	D	0.880	0.280	N	2.685	0.788	M	1.68	0.272	T	-2.44	0.534	N	0.399	0.495	-0.903	0.477	T	0.112	0.401	T	0.026	0.490	D	3.964	0.533	23.6	0.756	0.108	0.405	0.262	N	c	0.293	0.205	0.020	0.132	0.719	0.830	0	4.85	0.622	0.411	0.207	0.935	0.490	0.042	0.209	0.975	0.474	9.228	0.364	.	.	.	0.5	65	74	chr17	78321189	chr17:78321189	C	G	65	PASS	AN=2;DP=74	GT	0/1
chr18	20572852	20572852	-	A	exonic	RBBP8	.	frameshift insertion	RBBP8:NM_002894:exon11:c.1063dupA:p.H358Tfs*7,RBBP8:NM_203291:exon11:c.1063dupA:p.H358Tfs*7,RBBP8:NM_203292:exon11:c.1063dupA:p.H358Tfs*7	0.000108379	0.999790809	0.000100812	DISEASE: Seckel syndrome 2 (SCKL2) [MIM:606744]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:21998596}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jawad syndrome (JWDS) [MIM:251255]: A syndrome characterized by congenital microcephaly, moderately severe mental retardation, and symmetrical digital anomalies. Digital malformations of variable degree include hallux valgus, syndactyly of toes 4 and 5, short fifth fingers, single flexion crease of fifth fingers, polydactyly and synpolydactyly. {ECO:0000269|PubMed:21998596}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variability in RBBP8 is noted as a factor in BRCA1-associated breast cancer risk (PubMed:21799032). Exhibits sensitivity to tamoxifen in certain breast cancer cell lines (PubMed:18171986). {ECO:0000269|PubMed:18171986, ECO:0000269|PubMed:21799032}.; 	0.82222	.	-0.641086234	16.6784619	66.92298	1.69043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.22	49	chr18	20572852	chr18:20572852	G	GA	12.22	PASS	AN=0;DP=49	GT	0/1
chr18	30350917	30350917	C	T	intronic	KLHL14	.	.	.	0.082722189	0.916851004	0.000426807	.	0.49787	.	-0.979072682	8.752064166	49.14169	1.37053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	chr18	30350917	chr18:30350917	C	T	.	PASS	AN=0;DP=129	GT	0/1
chr18	60791966	60791966	T	-	UTR3	BCL2	NM_000633:c.*3892delA	.	.	0.337855764	0.602211203	0.059933033	DISEASE: Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. {ECO:0000269|PubMed:2875799, ECO:0000269|PubMed:3285301}.; 	0.95405	0.98331	-0.185391282	39.67916962	463.55581	4.46164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	95	chr18	60791965	chr18:60791965	CT	C	79	PASS	AN=2;DP=95	GT	0/1
chr18	77254927	77254927	A	T	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	chr18	77254927	chr18:77254927	A	T	.	PASS	AN=0;DP=144	GT	0/1
chr18	77894260	77894260	-	C	exonic	ADNP2	.	frameshift insertion	ADNP2:NM_014913:exon4:c.965dupC:p.A325Cfs*58	0.346937921	0.652481031	0.000581048	.	0.17091	0.1058	-1.497391194	3.603444209	154.16578	2.71378	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	253	chr18	77894260	chr18:77894260	T	TC	66	PASS	AN=2;DP=253	GT	0/1
chr19	1360699	1360699	G	C	exonic	MUM1	.	nonsynonymous SNV	MUM1:NM_032853:exon5:c.G782C:p.R261T	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	0.069	0.355	T	0.48	0.464	P	0.062	0.460	B	0.613	0.057	N	1	0.090	N	1.87	0.498	L	1.88	0.245	T	-1.01	0.266	N	0.088	0.084	-1.043	0.163	T	0.046	0.198	T	0.017	0.380	T	2.487	0.360	19.38	0.906	0.193	0.110	0.162	N	c	-0.805	-0.992	1.000	0.747	0.742	0.982	0	-2.63	0.057	-0.138	0.103	0.898	0.412	0.000	0.063	0.002	0.062	1.389	0.021	.	.	.	0.5	.	141	chr19	1360699	chr19:1360699	G	C	.	PASS	AN=0;DP=141	GT	0/1
chr19	3620937	3620937	C	A	intronic	CACTIN	.	.	.	0.999345096	0.0006549	3.77E-09	.	0.11116	.	-0.753139731	13.67067705	1251.44006	6.67662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr19	3620937	chr19:3620937	C	A	.	PASS	AN=0;DP=45	GT	0/1
chr19	5587282	5587282	G	-	exonic	SAFB2	.	frameshift deletion	SAFB2:NM_014649:exon21:c.2834delC:p.P945Rfs*48	0.999582501	0.000417499	5.16E-11	.	0.17843	0.15468	-0.929520514	9.683887709	138.84431	2.56776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	225	chr19	5587281	chr19:5587281	CG	C	42	PASS	AN=2;DP=225	GT	0/1
chr19	6477251	6477251	G	-	exonic	DENND1C	.	frameshift deletion	DENND1C:NM_001290331:exon6:c.359delC:p.P120Lfs*28,DENND1C:NM_024898:exon8:c.491delC:p.P164Lfs*28	0.036005999	0.963928827	6.52E-05	.	0.12173	.	1.249272484	93.46543996	1257.08513	6.68696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.26	135	chr19	6477250	chr19:6477250	AG	A	25.26	PASS	AN=0;DP=135	GT	0/1
chr19	10599904	10599904	C	T	exonic	KEAP1	.	nonsynonymous SNV	KEAP1:NM_012289:exon5:c.G1672A:p.G558R,KEAP1:NM_203500:exon5:c.G1672A:p.G558R	0.251629058	0.748110764	0.000260179	.	0.23809	0.20935	-1.133409319	6.434300543	28.06422	0.90037	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.04	0.868	M	-1.64	0.825	D	-2.86	0.601	D	0.957	0.955	0.795	0.944	D	0.792	0.929	D	0.291	0.906	D	7.438	0.951	34	0.999	0.995	0.996	0.982	D	c	0.935	0.862	1.000	0.747	0.672	0.522	0	5.56	0.836	7.701	0.834	0.887	0.390	1.000	0.715	0.977	0.480	17.087	0.864	Galactose oxidase, beta-propeller	.	.	0.5	.	86	chr19	10599904	chr19:10599904	C	T	.	PASS	AN=0;DP=86	GT	0/1
chr19	11227485	11227485	C	T	intronic	LDLR	.	.	.	2.59E-16	0.058594457	0.941405543	DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis). {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.70}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42568	0.94311	-1.853858183	2.028780373	654.09994	5.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	chr19	11227485	chr19:11227485	C	T	.	PASS	AN=0;DP=61	GT	0/1
chr19	11227498	11227498	C	T	intronic	LDLR	.	.	.	2.59E-16	0.058594457	0.941405543	DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis). {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.70}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42568	0.94311	-1.853858183	2.028780373	654.09994	5.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr19	11227498	chr19:11227498	C	T	.	PASS	AN=0;DP=66	GT	0/1
chr19	11917481	11917481	C	G	exonic	ZNF491	.	nonsynonymous SNV	ZNF491:NM_152356:exon3:c.C713G:p.T238R	5.13E-07	0.405347903	0.594651584	.	0.19959	.	0.88921411	89.24274593	196.96831	3.03569	0.0	0.912	D	0.999	0.764	D	0.967	0.699	D	.	.	.	0.943	0.374	D	1.53	0.389	L	1.78	0.257	T	-4.81	0.807	D	0.171	0.214	-0.860	0.513	T	0.130	0.439	T	0.001	0.010	T	4.157	0.557	23.8	0.979	0.360	0.001	0.004	N	c	-0.249	-0.575	0.249	0.187	0.554	0.246	0	0.981	0.188	0.146	0.159	0.643	0.292	0.000	0.063	0.007	0.100	9.569	0.384	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	117	62	chr19	11917481	chr19:11917481	C	G	117	PASS	AN=2;DP=62	GT	1/0
chr19	11978253	11978253	C	T	exonic	ZNF439	.	synonymous SNV	ZNF439:NM_152262:exon3:c.C369T:p.S123S,ZNF439:NM_001348718:exon4:c.C393T:p.S131S,ZNF439:NM_001348719:exon4:c.C384T:p.S128S,ZNF439:NM_001348721:exon4:c.C330T:p.S110S,ZNF439:NM_001348722:exon4:c.C228T:p.S76S,ZNF439:NM_001348720:exon5:c.C330T:p.S110S,ZNF439:NM_001348723:exon5:c.C228T:p.S76S	3.21E-08	0.174571486	0.825428482	.	0.20448	.	0.953537969	90.08610521	391.8226	4.16553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr19	11978253	chr19:11978253	C	T	.	PASS	AN=0;DP=46	GT	0/1
chr19	18276930	18276930	G	T	intronic	PIK3R2	.	.	.	0.939626884	0.060371032	2.08E-06	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47036	0.41833	-0.534490515	20.70063694	216.25734	3.17643	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.055	0.037	.	.	.	.	.	.	.	.	.	-0.137	0.081	1.468	0.187	0.006	0.089	0.146	N	n	-0.268	-0.222	0.290	0.191	0.563	0.310	0	-6.35	0.018	-0.578	0.059	-0.982	0.023	0.000	0.063	0.001	0.043	2.325	0.039	.	.	.	0.5	.	67	chr19	18276930	chr19:18276930	G	T	.	PASS	AN=0;DP=67	GT	0/1
chr19	18390732	18390732	-	T	UTR3	JUND	NM_001286968:c.*518_*519insA;NM_005354:c.*518_*519insA	.	.	0.560887374	0.389592916	0.04951971	.	0.5238	.	.	.	36.56701	1.09595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	56	chr19	18390732	chr19:18390732	A	AT	39	PASS	AN=2;DP=56	GT	0/1
chr19	20728254	20728254	C	G	exonic	ZNF737	.	nonsynonymous SNV	ZNF737:NM_001159293:exon4:c.G755C:p.S252T	1.11E-07	0.186556737	0.813443152	.	.	.	2.2177395	98.14225053	1976.98707	8.19153	1.0	0.010	T	0.0	0.026	B	0.002	0.063	B	.	.	.	0.993	0.237	N	-0.235	0.039	N	2.64	0.128	T	3.08	0.001	N	0.056	0.039	-0.951	0.408	T	0.011	0.041	T	0.001	0.015	T	-2.207	0.006	0.001	0.090	0.001	0.001	0.004	N	c	-1.873	-1.913	0.001	0.084	0.615	0.372	0	-0.2	0.125	-0.363	0.076	-0.719	0.036	0.007	0.175	0.001	0.043	5.437	0.157	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	87	100	chr19	20728254	chr19:20728254	C	G	87	PASS	AN=2;DP=100	GT	0/1
chr19	21132532	21132532	T	C	exonic	ZNF85	.	synonymous SNV	ZNF85:NM_001256173:exon3:c.T1020C:p.G340G,ZNF85:NM_003429:exon4:c.T1212C:p.G404G,ZNF85:NM_001256171:exon5:c.T1302C:p.G434G	2.28E-10	0.03733675	0.962663249	.	0.16722	0.10724	2.577929865	98.74970512	348.08165	3.9535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	161	chr19	21132532	chr19:21132532	T	C	80	PASS	AN=2;DP=161	GT	0/1
chr19	21990546	21990546	T	C	exonic	ZNF43	.	nonsynonymous SNV	ZNF43:NM_001256651:exon3:c.A2098G:p.K700E,ZNF43:NM_001256654:exon3:c.A2098G:p.K700E,ZNF43:NM_001256653:exon4:c.A2320G:p.K774E,ZNF43:NM_003423:exon4:c.A2293G:p.K765E,ZNF43:NM_001256650:exon6:c.A2275G:p.K759E,ZNF43:NM_001256648:exon7:c.A2275G:p.K759E,ZNF43:NM_001256649:exon7:c.A2275G:p.K759E	2.15E-08	0.254407834	0.745592144	.	0.34703	0.07168	0.378498378	75.58386412	64.23103	1.64447	0.782	0.033	T	0.001	0.067	B	0.003	0.080	B	.	.	.	1.000	0.090	N	0.1	0.085	N	3.1	0.083	T	0.77	0.020	N	0.195	0.239	-0.929	0.442	T	0.008	0.029	T	0.001	0.005	T	0.058	0.099	3.160	0.238	0.010	0.002	0.009	N	c	-1.327	-1.311	0.001	0.083	0.651	0.465	0	0.672	0.170	-3.816	0.004	-1.599	0.009	0.000	0.063	0.003	0.074	0.178	0.001	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2;Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	80	85	chr19	21990546	chr19:21990546	T	C	80	PASS	AN=2;DP=85	GT	0/1
chr19	22868521	22868521	A	G	intergenic	ZNF492;ZNF99	dist=18049;dist=66464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	196	chr19	22868521	chr19:22868521	A	G	80	PASS	AN=2;DP=196	GT	0/1
chr19	22940344	22940344	A	G	exonic	ZNF99	.	synonymous SNV	ZNF99:NM_001080409:exon4:c.T2367C:p.Y789Y	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	106	chr19	22940344	chr19:22940344	A	G	111	PASS	AN=2;DP=106	GT	0/1
chr19	24310450	24310450	A	G	exonic	ZNF254	.	nonsynonymous SNV	ZNF254:NM_001278678:exon2:c.A1393G:p.K465E,ZNF254:NM_001278663:exon3:c.A1393G:p.K465E,ZNF254:NM_001278664:exon3:c.A1429G:p.K477E,ZNF254:NM_203282:exon4:c.A1648G:p.K550E,ZNF254:NM_001278661:exon5:c.A1525G:p.K509E,ZNF254:NM_001278662:exon5:c.A1525G:p.K509E,ZNF254:NM_001278677:exon6:c.A1525G:p.K509E	9.15E-27	5.71E-07	0.999999429	.	0.18622	0.0746	0.560331224	81.70559094	1143.56	6.44823	1.0	0.010	T	0.002	0.090	B	0.004	0.093	B	.	.	.	1	0.090	N	-1.06	0.011	N	3.19	0.074	T	2.42	0.003	N	0.1	0.153	-0.929	0.443	T	0.008	0.029	T	0.000	0.002	T	-1.524	0.016	0.002	0.732	0.099	0.000	0.001	N	c	-1.448	-1.483	0.000	0.044	0.651	0.465	0	-0.481	0.114	-2.687	0.009	-0.516	0.050	0.000	0.063	0.008	0.104	4.412	0.108	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	55	124	chr19	24310450	chr19:24310450	A	G	55	PASS	AN=2;DP=124	GT	0/1
chr19	45973823	45973824	GT	-	intronic	FOSB	.	.	.	0.852916177	0.146576388	0.000507435	.	0.56755	0.4303	-0.117432389	44.89266336	34.12794	1.04651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	203	chr19	45973822	chr19:45973822	GGT	G	74	PASS	AN=2;DP=203	GT	0/1
chr19	48533848	48533848	A	-	intronic	CABP5	.	.	.	0.004220803	0.864684114	0.131095083	.	0.35156	0.12664	1.216305531	93.13517339	1299.91454	6.78329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	38	chr19	48533847	chr19:48533847	GA	G,GAA	55	PASS	AN=2;DP=38	GT	0/1
chr19	48533848	48533848	-	A	intronic	CABP5	.	.	.	0.004220803	0.864684114	0.131095083	.	0.35156	0.12664	1.216305531	93.13517339	1299.91454	6.78329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	38	chr19	48533847	chr19:48533847	GA	G,GAA	55	PASS	AN=2;DP=38	GT	0/1
chr19	53209576	53209576	T	C	exonic	ZNF611	.	synonymous SNV	ZNF611:NM_001161500:exon5:c.A732G:p.S244S,ZNF611:NM_001161501:exon5:c.A525G:p.S175S,ZNF611:NM_001161499:exon6:c.A732G:p.S244S,ZNF611:NM_030972:exon7:c.A732G:p.S244S	1.16E-17	0.000188316	0.999811684	.	0.14705	.	0.806491657	87.72705827	2377.17021	9.04647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	chr19	53209576	chr19:53209576	T	C	.	PASS	AN=0;DP=68	GT	0/1
chr19	54759055	54759055	C	-	intronic	LILRB5	.	.	.	7.17E-12	0.124265917	0.875734083	.	0.05934	0.06828	0.786269343	87.29063458	2895.36837	10.19483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	145	chr19	54759054	chr19:54759054	AC	A	44	PASS	AN=2;DP=145	GT	0/1
chr20	5155828	5155828	G	T	splicing	CDS2	NM_003818:exon3:c.195-1G>T	.	.	6.78E-05	0.977355656	0.022576536	.	0.08157	0.08152	-0.315847836	31.68789809	624.29254	5.04006	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.201	0.702	25.5	0.995	0.686	0.998	0.992	D	c	1.213	1.054	1.000	0.747	0.140	0.025	0	5.1	0.688	9.972	0.991	1.048	0.713	1.000	0.715	0.880	0.369	17.433	0.874	.	.	.	0.5	.	36	chr20	5155828	chr20:5155828	G	T	.	PASS	AN=0;DP=36	GT	0/1
chr20	5974276	5974276	A	G	exonic	MCM8	.	nonsynonymous SNV	MCM8:NM_001281522:exon17:c.A2224G:p.R742G,MCM8:NM_001281520:exon18:c.A2365G:p.R789G,MCM8:NM_001281521:exon18:c.A2485G:p.R829G,MCM8:NM_032485:exon18:c.A2365G:p.R789G,MCM8:NM_182802:exon18:c.A2317G:p.R773G	1.93E-10	0.954436717	0.045563282	DISEASE: Premature ovarian failure 10 (POF10) [MIM:612885]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:25437880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24617	0.19778	1.407269618	94.78650625	3710.46351	11.88891	0.022	0.486	D	0.214	0.305	B	0.139	0.319	B	0.000	0.843	D	0.999	0.466	D	2.395	0.694	M	4.08	0.030	T	-3.62	0.695	D	0.857	0.872	-0.994	0.315	T	0.017	0.069	T	0.017	0.384	T	4.539	0.608	24.3	0.994	0.619	0.941	0.599	D	c	0.118	0.272	0.701	0.227	0.732	0.924	0	5.82	0.927	4.299	0.586	1.199	0.960	1.000	0.715	1.000	0.888	12.092	0.528	MCM domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	78	62	chr20	5974276	chr20:5974276	A	G	78	PASS	AN=2;DP=62	GT	0/1
chr20	9498657	9498657	-	CTGCCAGCAGGAGGGGC	intronic	LAMP5	.	.	.	3.84E-08	0.10400326	0.895996702	.	0.42339	.	0.260991686	70.25831564	2514.20203	9.34534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	40	chr20	9498657	chr20:9498657	T	TCTGCCAGCAGGAGGGGC	119	PASS	AN=2;DP=40	GT	1/0
chr20	21695452	21695452	C	A	UTR3	PAX1	NM_006192:c.*11C>A;NM_001257096:c.*252C>A	.	.	0.616084026	0.382224632	0.001691342	DISEASE: Otofaciocervical syndrome 2 (OFC2) [MIM:615560]: A disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. {ECO:0000269|PubMed:23851939}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.80187	0.30248	0.350995466	74.37485256	224.51285	3.24104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	chr20	21695452	chr20:21695452	C	A	.	PASS	AN=0;DP=81	GT	0/1
chr20	23584198	23584198	A	T	exonic	CST9	.	synonymous SNV	CST9:NM_001008693:exon2:c.T429A:p.G143G	0.095109295	0.769080073	0.135810632	.	0.08285	0.10564	0.505321956	80.00707714	973.5092	6.03439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	chr20	23584198	chr20:23584198	A	T	.	PASS	AN=0;DP=64	GT	0/1
chr20	34855890	34855890	G	T	intergenic	AAR2;DLGAP4	dist=11027;dist=38355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	chr20	34855890	chr20:34855890	G	T	.	PASS	AN=0;DP=129	GT	0/1
chr20	35390803	35390803	A	-	intronic	DSN1	.	.	.	1.72E-06	0.659001624	0.340996652	.	0.08232	0.07785	-0.139478553	43.29440906	80.07637	1.892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	165	chr20	35390802	chr20:35390802	CA	C	63	PASS	AN=2;DP=165	GT	0/1
chr20	36642083	36642083	G	A	exonic	TTI1	.	stopgain	TTI1:NM_001303457:exon2:c.C136T:p.Q46X,TTI1:NM_014657:exon3:c.C136T:p.Q46X	0.000238871	0.9958859	0.003875229	.	0.18744	0.09392	-0.523584927	20.93654164	285.45946	3.61803	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.198	0.973	37	0.998	0.856	0.992	0.928	D	c	1.092	0.968	1.000	0.747	0.722	0.854	0	5.33	0.756	8.813	0.915	1.048	0.713	1.000	0.715	1.000	0.888	18.192	0.897	Armadillo-type fold	.	.	0.5	.	29	chr20	36642083	chr20:36642083	G	A	.	PASS	AN=0;DP=29	GT	0/1
chr20	40744702	40744702	C	A	intronic	PTPRT	.	.	.	0.999998893	1.11E-06	2.26E-19	.	0.39705	0.11014	-1.027089224	7.873319179	360.34688	4.01687	0.017	0.512	D	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	1.3	0.356	T	-0.02	0.073	N	0.276	0.334	-1.019	0.241	T	0.110	0.397	T	0.031	0.533	D	2.427	0.353	19.00	0.985	0.412	0.658	0.326	D	c	0.048	0.054	0.000	0.029	0.487	0.133	0	1.64	0.228	1.715	0.374	0.935	0.490	1.000	0.715	1.000	0.888	5.047	0.137	PTP type protein phosphatase|Protein-tyrosine phosphatase-like	.	.	0.5	.	19	chr20	40744702	chr20:40744702	C	A	.	PASS	AN=0;DP=19	GT	0/1
chr20	43961750	43961750	C	A	intronic	SDC4	.	.	.	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr20	43961750	chr20:43961750	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr20	55012547	55012547	G	T	exonic	CASS4	.	nonsynonymous SNV	CASS4:NM_001164115:exon2:c.G364T:p.G122W,CASS4:NM_020356:exon2:c.G364T:p.G122W,CASS4:NM_001164116:exon3:c.G364T:p.G122W	0.296175209	0.702950464	0.000874326	.	0.12766	0.08393	-0.10469683	45.64755839	558.21824	4.79883	0.026	0.469	D	0.961	0.670	D	0.72	0.617	P	0.987	0.079	N	1.000	0.090	N	2.125	0.592	M	2.5	0.217	T	-1.84	0.431	N	0.344	0.405	-1.021	0.232	T	0.091	0.348	T	0.015	0.353	T	3.884	0.524	23.5	0.984	0.409	0.041	0.095	N	c	-0.159	-0.364	1.000	0.404	0.554	0.283	0	0.396	0.155	-0.627	0.056	0.138	0.222	0.000	0.063	0.486	0.268	2.216	0.037	.	.	.	0.5	.	77	chr20	55012547	chr20:55012547	G	T	.	PASS	AN=0;DP=77	GT	0/1
chr20	55099658	55099658	G	T	intronic	GCNT7	.	.	.	.	.	.	.	0.03282	.	.	.	752.86612	5.44146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	chr20	55099658	chr20:55099658	G	T	.	PASS	AN=0;DP=97	GT	0/1
chr20	60892812	60892812	C	A	exonic	LAMA5	.	nonsynonymous SNV	LAMA5:NM_005560:exon54:c.G7262T:p.R2421L	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	0.247	0.173	T	0.08	0.230	B	0.051	0.240	B	0.986	0.079	U	1	0.090	N	2.125	0.592	M	2.9	0.101	T	-2.57	0.555	D	0.1	0.103	-0.969	0.374	T	0.021	0.091	T	0.028	0.505	D	3.729	0.505	23.3	0.950	0.253	0.146	0.183	N	c	-1.149	-1.191	1.000	0.454	0.707	0.730	0	-3.58	0.043	-1.086	0.035	-1.185	0.016	0.000	0.063	0.370	0.249	10.203	0.421	Laminin alpha, domain I	.	.	0.5	.	95	chr20	60892812	chr20:60892812	C	A	.	PASS	AN=0;DP=95	GT	0/1
chr20	62203414	62203414	T	C	intronic	HELZ2	.	.	.	1.26E-09	0.999300381	0.000699618	.	.	.	-0.147490202	42.30360934	4463.72358	13.40473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	195	chr20	62203414	chr20:62203414	T	C	.	PASS	AN=0;DP=195	GT	0/1
chr21	11047490	11047490	C	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*227G>T;NM_182481:c.*227G>T;NM_181704:c.*442G>T;NM_182484:c.*442G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	119	chr21	11047490	chr21:11047490	C	A	.	PASS	AN=0;DP=119	GT	0/1
chr21	11047491	11047491	C	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*226G>T;NM_182481:c.*226G>T;NM_181704:c.*441G>T;NM_182484:c.*441G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	119	chr21	11047491	chr21:11047491	C	A	.	PASS	AN=0;DP=119	GT	0/1
chr21	14756846	14756846	C	A	intergenic	ANKRD30BP2;MIR3156-3	dist=266275;dist=21859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr21	14756846	chr21:14756846	C	A	.	PASS	AN=0;DP=42	GT	0/1
chr21	32253409	32253409	A	T	exonic	KRTAP11-1	.	stopgain	KRTAP11-1:NM_175858:exon1:c.T435A:p.C145X	0.00426873	0.662516423	0.333214847	.	0.22409	0.09008	0.659651797	84.35362114	3007.85811	10.41393	.	.	.	.	.	.	.	.	.	0.012	0.291	N	1.000	0.548	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.303	0.962	35	0.989	0.474	0.164	0.192	N	c	0.137	-0.081	0.000	0.029	0.487	0.133	0	0.372	0.153	0.081	0.146	-0.546	0.048	0.645	0.279	0.981	0.494	8.509	0.322	.	.	.	0.5	.	83	chr21	32253409	chr21:32253409	A	T	.	PASS	AN=0;DP=83	GT	0/1
chr21	32554907	32554907	C	A	exonic	TIAM1	.	synonymous SNV	TIAM1:NM_003253:exon16:c.G2718T:p.L906L	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr21	32554907	chr21:32554907	C	A	.	PASS	AN=0;DP=79	GT	0/1
chr21	40559106	40559106	C	T	exonic	BRWD1	.	nonsynonymous SNV	BRWD1:NM_018963:exon42:c.G6809A:p.R2270Q	0.999999462	5.38E-07	6.53E-23	.	0.64569	0.10719	-0.821412236	11.77164426	5050.46205	14.54368	0.0	0.912	D	0.999	0.764	D	0.766	0.548	P	0.013	0.291	N	0.584	0.324	D	2.725	0.800	M	0.2	0.601	T	-1.06	0.277	N	0.371	0.463	-0.432	0.710	T	0.320	0.689	T	0.019	0.408	T	7.195	0.945	34	0.999	0.999	0.844	0.432	D	c	0.604	0.593	1.000	0.747	0.615	0.372	0	5.64	0.864	3.427	0.523	0.935	0.490	0.992	0.373	1.000	0.888	18.257	0.899	.	.	.	0.5	.	42	chr21	40559106	chr21:40559106	C	T	.	PASS	AN=0;DP=42	GT	0/1
chr21	43299197	43299197	G	A	exonic	PRDM15	.	nonsynonymous SNV	PRDM15:NM_022115:exon2:c.C155T:p.A52V	0.753744615	0.246255384	1.22E-09	.	0.0747	0.10154	-2.001084103	1.733899505	875.44322	5.75655	0.069	0.355	T	0.099	0.241	B	0.01	0.139	B	.	.	.	1	0.810	D	0	0.065	N	2.89	0.102	T	-0.21	0.103	N	0.088	0.084	-0.985	0.337	T	0.014	0.056	T	0.270	0.899	D	3.673	0.498	23.3	0.996	0.732	0.002	0.010	N	c	-0.654	-0.578	1.000	0.747	0.623	0.393	0	1.37	0.211	0.388	0.203	-0.175	0.105	0.643	0.279	0.996	0.625	8.310	0.310	.	.	.	0.5	.	55	chr21	43299197	chr21:43299197	G	A	.	PASS	AN=0;DP=55	GT	0/1
chr21	44524456	44524456	G	A	exonic	U2AF1;U2AF1L5	.	nonsynonymous SNV	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320646:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320648:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320650:exon2:c.C16T:p.L6F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	.	.	.	.	.	.	.	.	.	.	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	3.875	0.960	H	0.88	0.460	T	-5.64	0.869	D	0.87	0.858	0.082	0.839	D	0.410	0.759	T	0.127	0.810	D	6.826	0.927	32	0.999	0.935	0.981	0.797	D	c	1.044	0.963	1.0	0.983	0.722	0.854	0	5.47	0.803	9.053	0.933	1.044	0.665	1.000	0.715	1.000	0.888	19.317	0.942	Zinc finger, CCCH-type	.	.	0.5	.	87	chr21	44524456	chr21:44524456	G	A	.	PASS	AN=0;DP=87	GT	0/1
chr21	47614405	47614405	C	A	exonic	LSS	.	nonsynonymous SNV	LSS:NM_001145437:exon19:c.G1748T:p.R583L,LSS:NM_001001438:exon20:c.G1988T:p.R663L,LSS:NM_001145436:exon20:c.G1955T:p.R652L,LSS:NM_002340:exon20:c.G1988T:p.R663L	0.000604838	0.999353008	4.22E-05	.	0.09964	0.38626	0.540106923	81.09813635	1845.09003	7.92325	0.152	0.327	T	0.995	0.670	D	0.805	0.566	P	0.000	0.843	D	1	0.810	D	2.755	0.808	M	1.97	0.221	T	-4.99	0.829	D	0.796	0.824	-1.141	0.013	T	0.078	0.312	T	0.045	0.620	D	5.650	0.770	26.7	0.996	0.740	0.965	0.692	D	c	0.480	0.465	1.000	0.747	0.707	0.730	0	5.07	0.680	7.647	0.825	0.935	0.490	1.000	0.715	0.289	0.235	18.434	0.905	Squalene cyclase, C-terminal|Terpene synthase, conserved site|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid;Squalene cyclase, C-terminal|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid	.	.	0.5	.	79	chr21	47614405	chr21:47614405	C	A	.	PASS	AN=0;DP=79	GT	0/1
chr22	16255875	16255875	G	T	downstream	POTEH	dist=457	.	.	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	184	chr22	16255875	chr22:16255875	G	T	.	PASS	AN=0;DP=184	GT	0/1
chr22	17054314	17054314	G	T	intergenic	OR11H1;CCT8L2	dist=604510;dist=17334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr22	17054314	chr22:17054314	G	T	.	PASS	AN=0;DP=47	GT	0/1
chr22	20847401	20847401	C	A	intronic	KLHL22	.	.	.	0.702611047	0.297235373	0.00015358	.	0.52594	0.11209	-1.199555187	5.761972163	26.86408	0.8677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr22	20847401	chr22:20847401	C	A	.	PASS	AN=0;DP=31	GT	0/1
chr22	21470329	21470329	C	A	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	242	chr22	21470329	chr22:21470329	C	A	.	PASS	AN=0;DP=242	GT	0/1
chr22	26422845	26422845	C	A	exonic	MYO18B	.	stopgain	MYO18B:NM_001318245:exon43:c.C6908A:p.S2303X,MYO18B:NM_032608:exon43:c.C6905A:p.S2302X	2.61E-15	0.99999606	3.94E-06	.	0.16167	0.10792	1.205427351	93.02311866	5231.65918	14.90607	.	.	.	.	.	.	.	.	.	0.005	0.329	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.780	0.978	38	0.991	0.513	0.308	0.240	N	c	0.235	-0.047	0.697	0.226	0.554	0.246	0	3.57	0.399	2.155	0.417	0.935	0.490	0.057	0.215	0.282	0.234	8.680	0.332	.	.	.	0.5	.	53	chr22	26422845	chr22:26422845	C	A	.	PASS	AN=0;DP=53	GT	0/1
chr22	27019121	27019121	C	A	intronic	CRYBA4	.	.	.	6.69E-08	0.257581927	0.742418006	DISEASE: Cataract 23 (CTRCT23) [MIM:610425]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT23 is a zonular cataract. Zonular or lamellar cataracts are opacities, broad or narrow, usually consisting of powdery white dots affecting only certain layers or zones between the cortex and nucleus of an otherwise clear lens. The opacity may be so dense as to render the entire central region of the lens completely opaque, or so translucent that vision is hardly if at all impeded. Zonular cataracts generally do not involve the embryonic nucleus, though sometimes they involve the fetal nucleus. Usually sharply separated from a clear cortex outside them, they may have projections from their outer edges known as riders or spokes. {ECO:0000269|PubMed:16960806}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20946	0.13306	0.21689899	68.12927577	150.50912	2.67784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr22	27019121	chr22:27019121	C	A	.	PASS	AN=0;DP=52	GT	0/1
chr22	30374873	30374873	T	-	intronic	MTMR3	.	.	.	0.994951612	0.005048388	3.77E-11	.	0.241	0.11999	-0.902027742	10.1556971	326.83215	3.84289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	chr22	30374872	chr22:30374872	CT	C	42	PASS	AN=2;DP=11	GT	0/1
chr22	30772228	30772228	-	T	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	84	chr22	30772228	chr22:30772228	C	CT,CTT	12.94	PASS	AN=0;DP=84	GT	0/1/.
chr22	30772228	30772228	-	TT	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	84	chr22	30772228	chr22:30772228	C	CT,CTT	12.94	PASS	AN=0;DP=84	GT	0/1/.
chr22	35659263	35659263	T	-	intronic	HMGXB4	.	.	.	0.218813415	0.780833648	0.000352936	.	0.88512	0.11014	-0.492218069	22.35786742	1952.80292	8.13335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	104	chr22	35659262	chr22:35659262	AT	A	50	PASS	AN=2;DP=104	GT	0/1
chr22	37771139	37771139	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G436T:p.A146S	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.111	0.290	T	0.989	0.609	D	0.907	0.627	P	0.000	0.843	D	1	0.810	D	1.09	0.274	L	0.56	0.546	T	-1.05	0.275	N	0.457	0.509	-0.628	0.637	T	0.269	0.641	T	0.035	0.560	D	4.486	0.601	24.3	0.994	0.648	0.993	0.939	D	c	0.605	0.586	1.000	0.747	0.701	0.575	0	4.66	0.577	7.796	0.843	0.823	0.336	1.000	0.715	1.000	0.888	17.923	0.888	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	46	chr22	37771139	chr22:37771139	C	A	.	PASS	AN=0;DP=46	GT	0/1
chr22	37771523	37771523	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G52T:p.G18C	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.032	0.446	D	0.979	0.571	D	0.635	0.501	P	0.169	0.174	N	1	0.090	N	1.445	0.365	L	0.64	0.529	T	-3.6	0.693	D	0.471	0.521	-0.927	0.446	T	0.165	0.503	T	0.042	0.603	D	3.682	0.500	23.3	0.990	0.505	0.343	0.248	N	c	0.041	-0.054	0.999	0.396	0.646	0.450	0	4.52	0.546	1.359	0.335	0.852	0.362	0.003	0.159	0.091	0.185	13.204	0.590	.	.	.	0.5	.	100	chr22	37771523	chr22:37771523	C	A	.	PASS	AN=0;DP=100	GT	0/1
chrX	36178819	36178819	C	A	exonic	CFAP47	.	nonsynonymous SNV	CFAP47:NM_001304548:exon39:c.C5959A:p.P1987T	.	.	.	.	0.06402	.	0.371224249	75.12384996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.282	0.121	5.518	0.584	0.058	0.735	0.357	D	.	.	.	0.000	0.064	.	.	.	2.99	0.335	3.862	0.555	-0.046	0.123	0.992	0.373	0.035	0.152	9.479	0.379	.	.	.	0.5	.	54	chrX	36178819	chrX:36178819	C	A	.	PASS	AN=0;DP=54	GT	0/1
chrX	70823980	70823980	T	C	exonic	GCNA	.	nonsynonymous SNV	GCNA:NM_052957:exon8:c.T853C:p.S285P	.	.	.	.	.	.	.	.	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-0.55	0.024	N	1.55	0.299	T	-0.32	0.123	N	0.057	0.040	-1.021	0.234	T	0.032	0.137	T	0.007	0.198	T	-2.254	0.005	0.001	0.117	0.002	0.003	0.016	N	.	.	.	0.917	0.265	.	.	.	-0.28	0.122	-2.462	0.011	-3.315	0.001	0.000	0.063	0.000	0.016	4.696	0.121	.	.	.	0.5	.	106	chrX	70823980	chrX:70823980	T	C	.	PASS	AN=0;DP=106	GT	0/1
chrX	109561058	109561060	CCG	-	exonic	AMMECR1	.	nonframeshift deletion	AMMECR1:NM_001025580:exon1:c.240_242del:p.G82del,AMMECR1:NM_015365:exon1:c.240_242del:p.G82del	0.910792997	0.088538552	0.00066845	DISEASE: Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. {ECO:0000269|PubMed:10049589}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.89609	0.33817	-0.09720619	46.20193442	15.37972	0.5519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	80	chrX	109561057	chrX:109561057	CCCG	C	45	PASS	AN=2;DP=80	GT	0/1
chrX	128927042	128927042	T	C	exonic	SASH3	.	synonymous SNV	SASH3:NM_018990:exon7:c.T879C:p.N293N	0.891377605	0.108394024	0.000228371	.	0.3591	0.26327	-0.448125345	24.19202642	28.8003	0.92063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	chrX	128927042	chrX:128927042	T	C	.	PASS	AN=0;DP=60	GT	0/1
chrX	129536209	129536209	C	-	intronic	RBMX2	.	.	.	0.772803906	0.225526116	0.001669978	.	0.0606	0.39625	0.170987912	65.5579146	19.54878	0.67128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	403	chrX	129536208	chrX:129536208	AC	A	87	PASS	AN=2;DP=403	GT	0/1
chrX	129630630	129630630	T	C	ncRNA_exonic	FAM45BP	.	.	.	.	.	.	.	.	0.06956	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	89	chrX	129630630	chrX:129630630	T	C	53	PASS	AN=2;DP=89	GT	0/1
